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Résumé:  
Les cellules souches embryonnaires (cellules ES) 
constituent un excellent système modèle pour étudier 
les mécanismes épigénétiques contrôlant la 
transcription du génome mammifère. Un nombre 
important de membres de la famille des facteurs de 
remodelage de chromatine ATP-dépendants ont une 
fonction essentielle pour l’auto-renouvellement des 
cellules ES, ou au cours de la différentiation. On 
pense que ces facteurs exercent ces rôles essentiels 
en régulant l’accessibilité de la chromatine au niveau 
des éléments régulateurs de la transcription, en 
modulant la stabilité et le positionnement des 
nucléosomes. Dans ce projet, nous avons conduit une 
étude génomique à grande échelle du rôle d’une 
dizaine des remodeleurs (Chd1, Chd2, Chd4, Chd6, 
Chd8, Chd9, Ep400, Brg1, Smarca3, Smarcad1, 
Smarca5, ATRX et Chd1l) dans les cellules ES. Une 
double stratégie expérimentale a été utilisée.  
Des expériences d’immunoprécipitation de la 
chromatine suivi par un séquençage à haute-débit 
(ChIP-seq) sur des cellules ES étiquetées pour les 
différents remodeleurs pour étudier leur distribution 
sur le génome, et un approche transcriptomique sur 
des cellules déplétées de chaque remodeleur par 
traitement avec des vecteurs shRNA (knockdown). 
Nous avons établi les profils de liaison des 
remodeleurs sur des éléments régulateurs 
(promoteurs, enhancers et sites CTCF) sur le 
génome, et montré que ces facteurs occupent toutes 
les catégories d’éléments régulateurs du génome. La 
corrélation entre les données ChIP-seq et les données 
transcriptomiques nous a permis d’analyser le rôle 
des remodeleurs dans les réseaux de transcription 
essentiels des cellules ES.  Nous avons notamment 
démontré l’importance particulière de certains 
remodeleurs comme Brg1, Chd4, Ep400 et 
Smarcad1 dans la régulation de la transcription chez 
les cellules ES.  
 
  
 
 
Title : Genome-wide analysis of ATP-dependent chromatin remodeling factors functions in embryonic stem 
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Abstract:  
The characteristics of embryonic stem cells (ES 
cells) make them one of the best models to study the 
epigenetic regulation exerted by different actors in 
order to control the transcription of the mammalian 
genome. Members of the Snf2 family of ATP-
dependent chromatin remodeling factors were 
shown to be of specific importance for ES cell self-
renewal and during differentiation. These factors are 
believed to play essential roles in modifying the 
chromatin landscape through their capacity to 
position nucleosomes and determine their 
occupancy throughout the genome, making the 
chromatin more or less accessible to DNA binding 
factors. 
In this project, a genome-wide analysis of the 
function of a number of ATP-dependent chromatin 
remodelers (Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, 
Brg1, Ep400, ATRX, Smarca3, Smarca5, Smarcad1 
and Alc1) in mouse embryonic stem (ES) cells was 
conducted.  
This was done using a double experimental strategy. 
First, a ChIP-seq (Chromatin Immunoprecipitation 
followed by deep sequencing) strategy was done on 
ES cells tagged for each factor in the goal of 
revealing the genomic binding profiles of the 
remodeling factors. Second, loss-of-function studies 
followed by transcriptome analysis in ES cells were 
performed in order to understand the functional role 
of remodelers. Data from both studies were 
correlated to acquire a better understanding of the 
role of remodelers in the transcriptional network of 
ES cells.   
Specific binding profiles of remodelers on 
promoters, enhancers and CTCF binding sites were 
revealed by our study. Transcriptomic data analysis 
of the deregulated genes upon remodeler factor 
knockdown, revealed the essential role of Chd4, 
Ep400, Smarcad1 and Brg1 in the control of 
transcription of ES cell genes. Altogether, our data 
highlight how the distinct chromatin remodeling 
factors cooperate to control the ES cell state. 
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Chapter I. Embryonic Stem Cells: Definition and Regulatory 
Pathways 
 
A. What are Embryonic Stem Cells? 
Embryonic stem cells or ES cells are derived from the blastocyst which is formed during 
embryogenesis and is composed of two parts: an outer layer of cells, the trophectoderm, that 
will form the placenta and an inner clump of cells, called the inner cell mass (ICM), that is 
responsible for the formation of the entire body. The isolation and culture of cells derived 
from the ICM under appropriate conditions, gives rise to Embryonic Stem cells. 
1. The Major Characteristics of Embryonic Stem Cells 
Embryonic stem cells possess several distinct features that set them apart from other cell 
types. The two major characteristics that define ES cells are self-renewal and pluripotency or 
the ability to give rise to all the different types of cells of the body. 
a. Self-renewal 
ES cells can divide symmetrically and for a long period of time, where mother cells give rise 
to identical daughter cells in a continuous fashion. This property is defined as self-renewal. 
ES cells were initially established and maintained by Evans an Kaufman in 1981 (Evans and 
Kaufman, 1981).  The proliferation of ES cells is assured and maintained by the presence of 
very specific extrinsic factors (like LIF or the Leukemia inhibitory Factor (Smith et al., 1988)) 
that provoke a series of intrinsic signaling responses necessary for self-renewal preservation.  
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b. Pluripotency 
The first attempt to produce different cell lineages from embryonic stem cells goes back to the 
experiments done by Evans and Kaufman using mouse embryonic carcinoma cells by forming 
embryoid bodies (Evans and Kaufman, 1981). Embryoid bodies were given this name due to 
their marvelously similar composition to actual embryos (Figure 2). The pluripotent nature of 
mouse ES cells was demonstrated by their ability to contribute to all tissues of adult mice 
following their injection into host blastocysts (Bradley et al., 1984). In addition to their 
developmental potential in vivo, ES cells display a remarkable capacity to form differentiated 
cell types in culture (Keller, 1995). This capacity to give rise to all types of body cells is 
called pluripotency (Figure 1).  
 
Figure 1   Embryonic Stem Cells and Pluripotency 
 
 
Figure 2    The various aspects of ES cells and Embryoid Bodies. A) Mouse ES cells colonies cultured on feeder cells. 
B)  The differentiation of mouse ES cells. Embryoid body formation (Differentiation day 7) 
 
A B 
Introduction  Embryonic stem cells 
11 
 
2. Important signaling pathways that control the mouse ES cells state 
The three major signaling pathways that control the ES cell state comprise: The LIF-
dependent (Leukemia Inhibiting Factor dependent) signaling pathways, the Wnt pathway and 
BMP (Bone Morphogenetic Protein) signaling pathway that act with different mechanisms to 
assure the correct transcriptional profile for ES cell maintenance (Figure 3). 
 
Figure 3  Pathways known to contribute to the maintenance of embryonic stem cell pluripotency (Nakashima et al., 
2004) 
 
a. The LIF-dependent signaling pathways 
LIF belongs to the interleukin-6 cytokine family. It binds a heterodimeric receptor consisting 
of the low-affinity LIF receptor and gp130, with downstream signals being transmitted 
through gp130. The gp130 downstream signaling pathways include: the STAT3, 
phosphatidylinositol 3-kinase (PI3K) and Ras/Erk pathways (Figure 4). Maintaining the 
balance among the three pathways allows fine-tuning of the LIF-dependent maintenance of 
ES cell self-renewal. 
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Figure 4  A schematic representation of LIF-dependent pathways (Graf et al., 2011) 
 
The LIF/STAT3 pathway 
Signaling through gp130 leads to activation of Janus-associated tyrosine kinases (JAKs), 
which in turn phosphorylate STAT3. Phosphorylated STAT3 homodimerizes and moves to 
the nucleus, where it functions as a transcription factor. In mouse ES cells, the STAT3 
pathway plays a critical role in the maintenance of self-renewal. When STAT3 is down-
regulated, ES cells undergo differentiation (Boeuf et al., 1997; Niwa et al., 1998; Ying et al., 
2008). Artificial activation of the STAT3 pathway can maintain ES cell self-renewal even in 
the absence of LIF (Matsuda et al., 1999).  
STAT3 was shown to bind to the regulatory regions of several self-renewal genes in ES cells 
(Chen et al., 2008a; Kidder et al., 2008). One major role of the LIF/STAT3 pathway is to 
form transcriptional networks with other key TFs such as Oct3/4, Sox2, Nanog, c-Myc, Klf4 
and Esrrb (Transcriptional regulatory networks will be developed in Chapter II). These 
STAT3-regulated TFs bind to the regulatory regions of other important factors and induce 
Introduction  Embryonic stem cells 
13 
 
their expression. In this way, the LIF/STAT3 pathway participates in the formation of self-
renewal transcriptional networks.  
The LIF/PI3K pathway 
PI3K phosphorylates phosphoinositides leading to activation of the serine/threonine protein 
kinase Akt, a serine/threonine kinase implicated in the regulation of cell cycle progression, 
cell death, adhesion, migration, metabolism and tumorigenesis (Brazil et al., 2004). Activated 
Akt then phosphorylates its target molecules, such as glycogen synthase kinase (GSK)-3 and 
pro-apoptotic BCL2-antagonist of death (BAD) protein, blocking their activity. Similarly to 
STAT3, the PI3K pathway positively regulates self-renewal  as inhibition of PI3K and Akt 
induces differentiation of mouse and human ES cells, suggesting that PI3K/Akt signaling is 
necessary for the maintenance of ES cell pluripotency (Paling et al., 2004; Watanabe et al., 
2006). 
The Ras/Erk (MAPK) pathway  
Ras is capable of the sequential activation of the Raf/MEK/Erk kinase cascade, leading to 
phosphorylation of Erk target molecules, including the transcription factor Elk-1, proapoptotic 
protein caspase-9, and p90 ribosomal S6 protein kinase (RSK). The activation of the Ras/Erk 
pathway leads to ES cell differentiation into the endoderm lineage (Yoshida-Koide et al., 
2004) while suppressing the Ras/Erk signaling promotes self-renewal (Burdon et al., 1999). 
b. Other signaling pathways 
The Wnt pathway 
Wnt signaling pathways play an important role in the lineage specification of the vertebrate 
embryo (Amerongen and Nusse, 2009; Clevers, 2006) and regulate pluripotency in ES cells 
(Nusse et al., 2008; Wend et al., 2010). It was shown that Wnt proteins act through various 
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Frizzled receptors and LRP5/6 co-receptors to trigger downstream events that eventually 
cause the inactivation of the β-catenin-degradation complex. By this manner, ES cell 
pluripotency is facilitated by the inhibition of GSK3 (Aubert et al., 2002; Doble et al., 2007), 
a protein kinase that phosphorylates β-catenin, marking it for ubiquitin-dependent degradation 
(Clevers, 2006; MacDonald et al., 2009). Further on, β-catenin interacts with TcF (T-cell 
Factor) proteins, the terminal nuclear effectors of the Wnt pathway, to regulate the 
transcription of specific target genes (Figure 5). In the absence of Wnt signaling, TcF proteins 
act as transcriptional repressors (Behrens et al., 1996; Cadigan, 2002).  
 
Figure 5 Schematic of the canonical vertebrate Wnt signaling pathway (Sokol, 2011) 
TcF3, a member of the TcF family is highly expressed in mouse ES cells, and is critical in 
early mouse development (Korinek et al., 1998; Merrill et al., 2001; Pereira et al., 2006). It 
was shown that TcF3 acts to repress Nanog gene in ES cells (Pereira et al., 2006). 
Interestingly, a study highlights the importance of TcF3 in pluripotency, as it was 
demonstrated that TcF3 co-occupies the ES cell genome with the pluripotency factors Oct4 
and Nanog (Cole et al., 2008). This study suggests that TcF3 affects the balance between 
pluripotency and differentiation in ES cells (Figure 6). At standard conditions there is a 
balance between the core TFs, the TcF3 activating complex and the TcF3 repressing complex. 
Upon TcF3 knockdown, the repressive effect of TcF3 is eliminated and the expression of core 
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TFs increases, pluripotency is favored and differentiation is inhibited. Upon Wnt stimulation, 
TcF3 becomes more of an activating complex of pluripotency, assuring the maintenance of 
the ES cell state. Upon loss of pluripotency gene expression, the Tcf3 repressive complex 
takes hold of the expression of pluripotency genes and differentiation is favored.  
 
Figure 6 Model depicting the influence of Wnt pathway components on pluripotency and differentiation in ES cells 
(Cole et al., 2008) 
 
The BMP pathway 
BMPs or Bone Morphogenetic Proteins belong to the transformation growth factor beta 
(TGFβ) superfamily. They were shown to play important roles cell proliferation, 
differentiation, and apoptosis making them essential actors during embryonic development 
and pattern formation (Massagué, 1998). It was long known that BMPs protect the 
pluripotency state of ES cells, inhibit the differentiation into neural lineages (Di-Gregorio et 
al., 2007; Ying et al., 2003a) and prime ES cells for mesoderm formation (Davis et al., 2004; 
Lawson et al., 1999; Mishina et al., 1995). BMP activates Smad proteins that in turn act 
through the transcriptional up regulation of Inhibitor of Differentiation (Id) factors (Ying et 
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al., 2003a; Zhang et al., 2010), where these factors inhibit bHLH neurogenesis TFs, thus 
inhibiting neurogenesis (Norton, 2000). Furthermore, the BMP/Id complex was shown to 
protect pluripotent stem cells from differentiating especially into neural lineages through the 
maintenance of the expression of E-cadherin (Malaguti et al., 2013). Moreover, the 
maintenance of the high expression of E-cadherin by BMP/Id was shown to impose a 
proximal posterior identity on epiblast cells priming them for mesodermal lineages (Malaguti 
et al., 2013). 
The capacity of the BMP signaling pathway to maintain pluripotency is assured by the 
coordination with LIF signaling pathways. On one hand,  BMP/Smad signaling inhibits  
neural lineages (Tropepe et al., 2001; Ying et al., 2003b)  and induces other lineages, on the 
other hand; LIF/STAT3 signaling inhibits non-neural lineages and possibly regulates Smad 
function (Ying et al., 2003a) . The balance between LIF and BMP signaling pathways is 
essential to assure pluripotency of ES cells, as it was shown that the constitutive expression of 
Smad over rides the effect of LIF/STAT3 and differentiates ES cells into non-neural lineages 
(Figure 7). 
 
Figure 7 Cooperative lineage restriction by LIF/STAT3 and BMP/Smad (Ying et al., 2003a) 
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B. Naïve and primed pluripotency 
1. Mouse ES cell in serum versus 2i medium 
For a long time, the derivation and culture of mouse ES cells was poorly understood. Most of 
the derived mouse ES cells were from a specific mice strain which is the 129 strain. This 
strain was thought to have genetic and/or epigenetic profiles permissive for ES cell 
establishment (Brook and Gardner, 1997). Back then, the mouse ES cell culture conditions 
used were on feeder cells in serum-supplemented medium, these conditions supplemented the 
cells with the necessary LIF and BMP required for self-renewal through the activation of 
STAT pathway and the inhibition of differentiation pathways. However, such culture 
conditions restrained the derivation of mouse ES cells from most of the other mouse strains. 
This marked variability between the  strains was later shown to be due to the level of ERK 
signaling (Batlle-Morera et al., 2008), a pathway important to promote differentiation and 
inhibit self-renewal. For the inhibition of ERK pathway was shown to improve the derivation 
of mouse ES cells from mouse strains other the 129 strain (Batlle-Morera et al., 2008; Buehr 
and Smith, 2003).  
Later on, this strain specificity was eliminated by the discovery of a new approach where 
certain kinase inhibitors were used. This novel approach, called the 2i culture approach, 
makes it possible to culture mouse ES cells without serum by using two small molecules that 
inhibit kinases in combination with LIF (Ying et al., 2008). The two inhibitors are 
PD0325901 and CHIR99021 that respectively target the mitogen-activated protein kinase 
(MEK) and the glycogen synthase kinase-3 (GSK3). 
 The 2i medium provides a more-tuned environment for mouse ES cells, as a mosaic 
expression of some of the pluripotency factors (Chambers et al., 2007; Niwa et al., 2009; 
Toyooka et al., 2008) is observed in serum and eliminated upon culture in 2i conditions (Wray 
Introduction  Embryonic stem cells 
18 
 
et al., 2010), establishing a more naïve ground state. However, several studies show that this 
heterogeneous expression of some of the core TFs is not an only characteristic of ES cells 
cultured in serum, rather it is also observed in 2i-grown ES cells (Abranches et al., 2014, 
2014; Morgani et al., 2013). In these studies the expression of Nanog was observed, were it 
was shown to be in a continuous fluctuation in individual cells, suggesting a certain role for 
such fluctuations in the capacity of ES cells to maintain a state where different differentiation 
opportunities are considered. Another study showed that Oct4 and Sox2 transcriptional 
heterogeneities are also observed in ES cells under the 2 different culture conditions (Faddah 
et al., 2013); however, these variations were not as prominent as Nanog fluctuations. This 
observation supports the hypothesis that the permissive nature of the chromatin and the noisy 
mRNA transcription observed (Gaspar-Maia et al., 2011) might cause the variable 
transcription of Oct4 and Sox2, as their expression contrary to that of Nanog seems to be quite 
homogeneous.  
 
2. EpiS cells versus ES cells 
ES cells are derived from the inner cell mass (ICM) of the mature blastocyst (the 
preimplantation epiblast). After implantation, the epiblast becomes primed for lineage 
specification and commitment in response to stimuli from the extraembryonic tissues. EpiS 
cells could be experimentally derived from the epiblast at this stage of development. Mouse 
ES cells grow in culture as compact domed colonies, while EpiS cells are larger and grow as a 
monolayer (Figure 8). Several differences demarcate ES cells from EpiS cells, as these two 
present different developmental stages. Although both cell types retain their pluripotency 
capacity and express the core TFs, EpiS cells are not able to form chimera when injected to 
blastocysts (Guo et al., 2009; Rossant, 2008; Tesar et al., 2007). 
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Moreover, EpiS cells have different signaling mechanisms that control their pluripotency and 
self-renewal states.  Therefore, culture requirements differ between the two cell states, while 
ES cells need a LIF containing medium to survive, EpiS cells have different requirements 
including Fgf2 and Activin  (Brons et al., 2007; Nichols and Smith, 2009; Tesar et al., 2007). 
The various differences that characterize ES cells and EpiS cells are listed in Table 1. 
Compared to ES cells, EpiS cells are defined by a more restricted, primed pluripotency state. 
 
Figure 8 The two phases of pluripotency (Nichols and Smith, 2009) 
                                                
 
Table 1  Differences between the ground and primed cell states. Adapted from (Nichols and Smith, 2009) 
 
Property Ground State Primed State 
Embryonic tissue Early epiblast Egg cylinder or embryonic disc 
Culture stem cells Rodent ES cells Rodent EpiS cells; primate “ES” 
cells 
Blastocyst chimaeras Yes No 
Teratomas Yes Yes 
Differentiation bias None Variable 
Pluripotency factors Oct4, Nanog, Sox2, Klf2, Klf4 Oct4, Nanog, Sox2 
Naïve markers Rex1, NrOb1, Fgf4 Absent 
Specification markers Absent Fgf5 
Response to LIF/STAT3 Self-renewal  None 
Response to Fgf/Erk Differentiation Self-renewal 
Clonogenicity High Low 
XX status XaXa XaXi 
Response to 2i Self-renewal Differentiation/death 
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C. Human ES cells 
Human ES cells were first isolated by Thomson and collegues in 1998. These cells were 
capable to differentiate to the different cell lineages (Thomson et al., 1998). Although the core 
transcription regulatory network is conserved; however, these cells require different culture 
conditions. Human “ES” cells do not respond to LIF nor are they sustained by Erk inhibition; 
on the contrary, they depend on Erk signaling for continued proliferation. This signaling is 
assured in hESCs by the Activin/Nodal pathway (Figure 9) through Smad2/3 that control the 
expression of the pluripotency factor, Nanog, which in turn blocks the expression of 
neuroectoderm genes induced by FGF (Vallier et al., 2009).  The most probable explanation 
for this difference is that human ES cells correspond to a more advanced developmental state, 
more similar to the mouse EpiS cells (Brons et al., 2007; Tesar et al., 2007).  
 
Figure 9 Model explaining the regulation of Nanog in hESCs/mEpiSCs and its function in both cell types (Vallier et al., 
2009) 
This EpiS cell state might be due to the longer period of culture required for the appearance of 
human ES cells, that would allow these cells to progress in vitro to a state equivalent to post 
implantation mouse embryos (Figure 10) (Nichols and Smith, 2011). 
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Figure 10  Comparison of pluripotent cell line derivation protocols for (A) mouse and (B) human embryos. This figure 
highlights the difference in timing of mouse and human development in vivo (in days), and the appearance of 
pluripotent cell lines in vitro (Nichols and Smith, 2011). 
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Chapter II. The Transcriptional and Epigenetic Control of the 
Embryonic Stem Cell State 
 
The genome of ES cells is tightly controlled at the transcriptional level. This control is exerted 
by a large number of actors, including transcription factors (TFs) and elements of the 
transcriptional machinery, as well as chromatin regulators that determine the epigenetic state 
of DNA. It has been suggested that ES cells possess a more ‘open’ chromatin, where 
chromatin proteins are in a hyper-dynamic state (Meshorer et al., 2006a). This chromatin state 
would work in parallel with a specific gene expression program that favors the expression of 
self-renewal genes and poises the differentiation genes.  So how do TFs and epigenetic 
modifications operate in order to maintain pluripotency in ES cells and start differentiation 
under the appropriate cues? 
 
A. The Transcription Factor Network for ES state maintenance 
 
1. The Core Transcriptional Regulatory Network 
Pluripotency maintenance was shown to be mainly controlled and assured by three major TF 
that form the core regulatory network. These factors are Oct4, Sox2 and Nanog (Chambers 
and Smith, 2004; Niwa, 2007; Silva and Smith, 2008). 
a. Oct4 
Oct4 or the octamer-binding transcription factor 4 belongs to the POU family and is encoded 
by the gene Pou5f1. The POU family is characterized by the presence of the POU domain: a 
75 amino acid amino-terminal POU specific (POUs) region and a 60 amino-acid carboxyl-
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terminal homeodomain (POUh). This domain binds the octamer consensus sequence 
ATGCAAAT on DNA (Pan et al., 2002).  
It has been shown that Oct4 is a pivotal factor and a gatekeeper that prevents ES cells from 
differentiation (Nichols et al., 1998). Moreover, Oct4 is almost exclusively expressed in ES 
cells (Nichols et al., 1998; Pesce and Scholer, 2000; Pesce and Schöler, 2001). Studies 
indicate that during embryonic development, Oct4 is first expressed in all blastomeres. Later 
on, it becomes only expressed in the ICM; however; at maturity, Oct4 expression becomes 
restricted to the developing germ cells
 
(Pesce and Scholer, 2000; Pesce and Schöler, 2001). 
When Oct4 was disrupted in mice, the embryos lacked a pluripotent ICM (Nichols et al., 
1998)
 
, further emphasizing its role in pluripotency.  
More interestingly, the correct level of expression of Oct4 is essential in the determination of 
the cell state, as quantitative analysis of Oct4 expression showed that a high level of Oct4 
expression drives ES cells towards mesoderm or endoderm lineages, while low levels of Oct4 
drive trophectodermal lineages. To maintain the ES cells pluripotency state, a normal level of 
Oct4 is required
 
(Niwa et al., 2000).  
Oct4 is considered to be a pioneer transcription factor, where it was shown not only to bind 
nucleosome depleted regions and adopt different configurations depending on whether it 
binds alone or in cooperation with other factors from the core transcriptional regulatory 
network, but also can bind compacted chromatin structures at the beginning of 
reprogramming (Soufi et al., 2012). Oct4 was shown to bind the regulatory elements, in 
particular enhancers, of both pluripotency-related genes and differentiation genes, conferring 
its role in both activation and repression in order to maintain the ES cell state (Chen et al., 
2008b). In addition, Oct4 works mostly in association with the other two core TFs Sox2 and 
Nanog in order to assure the proper transcriptional regulation (to be more detailed further on). 
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Proteomic analyses of Oct4 interactome revealed a wide range of actors that interact in a 
direct or indirect manner with Oct4 (van den Berg et al., 2010a; Pardo et al., 2010). This 
interactome revealed various actors including TFs such as Esrrb and Klf4, chromatin 
remodeling complexes such as members of NuRD, esBAF and Tip60 and cofactors most of 
them known to play an important role in pluripotency maintenance. 
b. Sox2 
Sox2 or the Sex determining region Y-box 2 is a member of the Sox family of TFs. This 
family is characterized by the presence of a conserved high-mobility-group (HMG) that binds 
DNA on an CTTTG(T/A)(T/A) motif (Chambers and Smith, 2004). Sox2 has distinct 
biological functions and is essential during development. This distinct functionality is due to 
the interaction of Sox2 with various cofactors during development. Many factors have been 
shown to influence binding of Sox proteins to their target genes (Wegner, 2010). Sox2 
expression is first detected at the morula stage, later on , it becomes located in the ICM of the 
developing blastocyst and the epiblast (Avilion et al., 2003). The deletion of Sox2 at the 
zygotic level cause embryonic lethality due the incapacity of the formation of a pluripotent 
epiblast; however, Sox2 doesn’t seem to affect the formation of the trophoectoderm (Wegner, 
2010).  
Interestingly, during development, Sox2 continues to be expressed, majorly in the central 
nervous system after gastrulation, conferring its possible role in neural differentiation 
(Wegner and Stolt, 2005).  Sox2 induces neural differentiation by repressing key regulators of 
other lineage-linked genes (Thomson et al., 2011; Wang et al., 2012; Zhao et al., 2004). This 
ES cell specification control was not only observed for Sox2 but also for the other two TFs 
Oct4 and Nanog where they rather promote the differentiation to mesendoderm lineages 
(Thomson et al., 2011). 
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c. Oct4/Sox2 complex  
Oct4 and Sox2 were found to be co-expressed in several pluripotent cells such as the cells of 
the morula, ICM, epiblast, and germ cells. It was demonstrated that the Oct4/Sox2 complex 
works in a synergic way to control transcription, where a physical interaction was detected 
between the two proteins (Ambrosetti et al., 1997). It was further shown that the octamer 
elements within the enhancers of Oct4 controlled genes were found in proximity to Sox2-
binding sox elements (Avilion et al., 2003) creating a juxtaposed oct-sox binding motif. 
Moreover, a cooperative Oct4/Sox2 mechanism was observed at Oct4 target genes, where oct-
sox binding motifs were present (Loh et al., 2006). Indeed, Sox2 CHIP showed its binding at 
the majority of Oct4-occupied loci (especially at key regulatory regions of Pou5f1, Sox2, 
Nanog, Fgf4 and other pluripotency related genes) emphasizing the cooperation of these two 
factors to control the gene expression of their targets (Loh et al., 2006), and showing that not 
only does this Oct4/Sox2 complex control other genes, but also they auto regulate their own 
enhancer elements. However, Masui et al. demonstrated that Sox2 is not essential for the 
activation of these oct-sox enhancer motifs, as the deletion effect of Sox2 can be saved by a 
forced expression of Oct4, conferring its probable role as rather an Oct4 stabilizer at its motifs 
(Masui et al., 2007). 
d. Nanog 
Nanog is the last discovered transcription factor of the three core TFs (Chambers et al., 2003; 
Mitsui et al., 2003). It is a homeobox transcription factor that recognizes the consensus 
sequences ATTAT (Mitsui et al., 2003). In Nanog null mice, the ICM has impaired 
development. Nanog transcripts were shown to appear at maximal levels between the late 
morula and the mid-blastocyst and down regulated just prior to implantation (Chambers et al., 
2003). It was proposed that Nanog interferes at the blastocyst stage, after the initial action of 
Oct4 that begins at the morula stage and determines whether cells should remain pluripotent 
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or become a trophoectoderm. At the later blastocyst stage, Nanog interferes and determines 
whether cells of the ICM remain pluripotent or differentiate into primitive endoderm (Figure 
11) (Mitsui et al., 2003). 
 
Figure 11 The proposed function of Oct4 and Nanog in preimplantation embryos (upper) and in ES cells (lower) 
(Mitsui et al., 2003). 
 
Nanog discovery by Mitsui and Chambers have opened the gate to the characterization of 
LIF/STAT3 independent pathways that control the pluripotency of ES cells. They further 
demonstrate that the over expression of Nanog is enough to maintain the pluripotency of ES 
cells; where this was not the case of the over expression of the other core transcription factor 
Oct4, where ES cells differentiate into endoderm (Niwa et al., 2000). Therefore, it was 
proposed that Nanog has an essential role in pluripotency maintenance independently from 
the LIF/STAT3 pathway and the over expression of Nanog is sufficient to maintain the ES 
cell state in the absence of LIF. 
The importance of Nanog in the maintenance of pluripotency was debated in later studies. A 
study has shown that Nanog null ES cells conserve their pluripotency characteristics and are 
capable to differentiate correctly confirming that LIF pathways can maintain pluripotency 
independently of Nanog, but the self-renewal capacities of such Nanog null ES cells seems to 
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be hindered (Chambers et al., 2007). Indeed, Chambers demonstrates that Nanog is required 
for primordial germ cells to prosecute the germ-cell development program beyond E11.5.  
Moreover, it was shown that Nanog has different expression levels across ES colonies and can 
vary in each ES cell itself when in culture. This notion of a heterogeneous expression of 
Nanog reflects that ES cells are maintained in a condition where high levels of Nanog 
preserve pluripotency and lower levels give a window of opportunity for lineage commitment 
(Chambers et al., 2007). Indeed, an exogeneous control of Nanog expression can help produce 
a more homogeneous ES cell population (MacArthur et al., 2012). Furthermore, Abranches 
emphasizes more the role of Nanog and speculates that not only does it allow ES cells to 
explore their commitment opportunities, but also acts as an autonomous component of the 
pluripotency gene regulatory network, where it buffers the molecular heterogeneity and 
controls cellular decision-making in ES cells (Abranches et al., 2013, 2014). 
At the transcriptional level, Nanog doesn’t work alone (even though it might belong to 
differential signaling pathways), it rather cooperates with Oct4 in order to govern the ES cell 
state (Liang et al., 2008a; Loh et al., 2006). Loh et al. show that Nanog and Oct4 binding 
patterns overlap and depletion of either one of these factors influences a common important 
target of genes; conferring the interconnection between the two factors in order to control 
pluripotency, self-renewal and fate determination of ES cells. 
e. Interplay between the core regulatory factors to regulate transcription 
The role of the Oct4/Sox2/Nanog trio in the control of ES cell state resides in two 
mechanisms (Figure12): First, the three TFs co-occupy enhancer regions and positively 
control the transcription of genes necessary for pluripotency maintenance (Chen et al., 2008b; 
Loh et al., 2006); on the other hand they occupy repressed genes encoding for differentiation 
regulators by recruiting different repressing complexes to such gene sites (Bilodeau et al., 
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2009; Loh et al., 2006; Pasini et al., 2008). Second, the core TFs are capable to regulate their 
own promoters forming an interconnected autoregulatory loop that provides positive feedback 
expression for pluripotency maintenance. The deregulation of one of the core TFs alters this 
loop and causes the cell entrance in the different differentiation programs (Boyer et al., 2006; 
Loh et al., 2006).  
 
Figure 12 Oct4, Sox2 and Nanog collaborate to control their own promoters forming an autoregulatory loop. Together 
these core transcription factors function to activate pluripotency genes and inhibit developmental genes. Adapted 
from (Young, 2011). 
 
2. The Expanded Transcriptional Regulatory Network 
The core TFs Oct4, Sox2 and Nanog form the central unit of transcriptional control in ES 
cells. However, these factors are a part of a much bigger transcriptional regulatory network, 
composed of a large number of additional TFs, cofactors, chromatin regulators and non-
coding RNAs.  
a. Important transcription factors in ES cells 
As mentioned in Chapter I, the main signaling pathways that control the ES cell state are the 
LIF, Wnt and BMP pathways. These external signaling cues have downstream internal 
transcription responses. Three main TFs play essential roles in communicating the various 
signaling cues into the core transcription network. They include, STAT3 (LIF signaling), 
Tcf3 (Wnt signaling) and Smad1 (BMP signaling), these factors’ importance was discussed 
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in Chapter I. Several studies have expanded gradually the transcription regulatory network 
responsible for the control of the ES cell state.  
c-Myc: 
Myc (Myelocytomatosis oncogene) belongs to a family of helix-loop-helix/leucine zipper 
TFs. It’s potential role in ES cells was speculated through studies on human tumors where it 
was shown to delay differentiation and promote cell proliferation (Knoepfler et al., 2002; 
MacLean-Hunter et al., 1994; Pelengaris et al., 1999; Schreiner et al., 2001). Further studies 
showed that high c-Myc expression is required for the ES cell self-renewal through 
downstream the LIF/STAT3 signaling pathway (the overexpression of c-Myc replaces the 
need for LIF supplement) and inhibiting c-Myc causes ES cell differentiation (Cartwright et 
al., 2005).  c-Myc was shown to control the transcription in ES cells through its capacity to 
bind E box sequences at core promoters and stimulating RNA polymerase II pause release 
(Rahl et al., 2010). Moreover, c-Myc was shown to be mostly bound on the regulatory 
elements of transcribed genes along with the core TFs (Young, 2011). c-Myc  is one of the 
TFs essential in reprogramming into induced pluripotent stem cells (Takahashi and 
Yamanaka, 2006). 
Esrrb: 
The estrogen related receptor beta is an orphan nuclear receptor shown to be a part of the core 
pluripotency network, where it was shown to interact with Oct4 (van den Berg et al., 2010a; 
Chen et al., 2008b; Loh et al., 2006). The importance of Essrb in self-renewal was revealed by 
RNA interference studies where it was shown to be essential in ES cell self-renewal and its 
absence triggers ES cell differentiation (Ivanova et al., 2006; Loh et al., 2006).  Interestingly, 
Essrb overexpression was shown to substitute for a short-term LIF requirement (Zhang et al., 
2008). 
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Furthermore, Essrb was shown to regulate Nanog’s activity where it mediates the positive 
regulatory effect of Oct4 (van den Berg et al., 2008). Moreover, recent studies have shown 
that Essrb overexpression can even substitute Nanog function in ES cells and its deletion 
causes severe impaired self-renewal (Festuccia et al., 2012). However, the derivation of Essrb 
null ES is possible (like Nanog null ES cells), in contrast to the absolute requirement of Oct4, 
this reflects the relative importance of such factors, where Essrb, like Nanog seem to help 
more in the fine tuning of the gene expression in ES cells.  
Sall4: 
Sall4 belongs to the Spalt family of zinc-finger TFs, mutations in the Sall4 gene cause 
numerous developmental defects (Al-Baradie et al., 2002; Kohlhase et al., 2002). Sall4 null 
mice die shortly after implantation; however these mice do not present ICM defects and ES 
cells isolated from such ICM retain their pluripotency with a slower proliferation rate (Sakaki-
Yumoto et al., 2006).  
The role of Sall4 was studied in several reports. Sall4 RNA interference experiments have 
demonstrated that Sall4 depleted ES cells differentiate and fail to maintain their self-renewal 
on feeder free culture conditions (Zhang et al., 2006). Furthermore, Zhang et al show that 
Sall4 binds to Pou5f1 regulatory elements where it affects Oct4 expression in a dosage-
dependent manner. Additional studies also show that Sall4 binds Nanog regulatory elements 
and Nanog gene targets (Wu et al., 2006), conferring its involvement in the core transcription 
circuitry. Nevertheless, the absolute necessity of Sall4 in ES cell pluripotency is debated. As a 
study shows that Sall4 null ES cells retain their pluripotency even on feeder-free culture 
conditions (Yuri et al., 2009). This study suggests that Sall4 acts as a stabilizer of the ES cell 
state by repressing trophoectoderm lineage differentiation.   
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Tbx3: 
The T-box transcription factor family was shown to be important in a variety of 
developmental processes (Miller et al., 2008). Tbx3 is expressed early in the mouse inner cell 
mass, and it is later expressed in extra embryonic endoderm cells (Chapman et al., 1996). In 
ES cells, Tbx3 was reported to be essential for ES cell self-renewal (Ivanova et al., 2006), and 
the continuous expression of Tbx3 allows the maintenance of  ES cell in an undifferentiated 
state in the absence of LIF (Niwa et al., 2009). Interestingly, Niwa et al. show that Tbx3 is an 
upstream regulator of Nanog gene along with Klf4 where it boosts the expression of core 
pluripotency genes (Figure 13) without being essential in pluripotency maintenance. Indeed, 
Tbx3 was reported to improve the germ-line competency of induced pluripotent stem cells 
(Han et al., 2010).  
Klf4: 
The Krüppel-like factor (Klf) family is an evolutionarily conserved family of zinc finger TFs 
that play a role in different biological processes, including proliferation, differentiation, 
development and apoptosis (McConnell et al., 2007). Klf4 is a member of the Klf family, 
studies have shown to interact with Oct4 in order to activate Oct4/Sox2 target genes 
(Nakatake et al., 2006). Klf4 is one of the TFs used in reprogramming into induced 
pluripotent stem cells (Takahashi and Yamanaka, 2006). 
 The overexpression of Klf4 prevents differentiation of ES cells, emphasizing more its role in 
self-renewal (Li et al., 2005). However, Klf4 depletion does not seem to effect on ES cell 
morphology or self-renewal (Jiang et al., 2008; Nakatake et al., 2006), due to the presence of 
other Klf proteins, mainly Klf2 and Klf5 with redundant functions in ES cells. Indeed, the 
depletion of the three factors caused the differentiation of ES cells (Jiang et al., 2008). 
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Klf2/4/5 TFs were also shown to be bound to regulatory elements of key pluripotency genes 
such as Pou5f1, Sox2, Nanog and Essrb.  
 
Figure 13 Transcription control by Klf4 and Tbx3.  Klf4 and Tbx3 mainly activate Sox2 and Nanog, respectively, and 
maintain expression of Oct3/4. Transcription of all these transcription factors is positively regulated by Oct3/4, Sox2 
and Nanog (Niwa et al., 2009). 
Foxd3: 
Foxd3 belongs to the family of fork head box TFs. Initially, it was solely identified in ES cell 
and their malignant progenitors (Sutton et al., 1996). Later on, it was demonstrated that Foxd3 
is also expressed during embryogenesis in the epiblast and even the neural crest (Dottori et al., 
2001; Hromas et al., 1999; Labosky and Kaestner, 1998). Foxd3 knockdown mice die early 
during embryogenesis with a loss of the epiblast; moreover Foxd3 knockdown cells fail to 
proliferate and give a normal ICM (Hanna et al., 2002).  
Zfx: 
Zfx is a zinc finger TFs of the Zfy family, a family highly conserved in vertebrates 
(Schneider-Gädicke et al., 1989). It was shown to be required in ES cell renewal but not 
essential for pluripotency, where Zfx deletion caused impaired cell proliferation and increase 
apoptosis but did not influence the differentiation potential (Galan-Caridad et al., 2007). 
Interestingly, Zfx was shown to upregulate the expression of c-Myc in order to enhance self-
renewal (Fang et al., 2014). 
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Ronin: 
Ronin, referring to the master-less Japanese samurai, is a zinc finger transcription factor. This 
factor was shown not to have a direct relationship with the core TFs and it seemed to be able 
to partially override the necessity for Oct4 (Dejosez et al., 2008). Moreover, Ronin 
independency from the core transcription network was further demonstrated with its persistent 
expression upon knockdown of Oct4, Sox2 and Nanog. 
 Ronin knockdown causes ES cell death, probably due to the activation of repressed genes 
simultaneously or due to an unknown effect on apoptosis pathways. Moreover, Ronin knock 
down during embryonic development show a common phenotype with Oct4 deletion, where 
there is failure of ICM formation and embryo lethality (Dejosez et al., 2008).  
Dax1: 
Dax1 (DSS-AHC on X chromosome gene) is an atypical orphan nuclear receptor that has 
been shown to play a role in ES cell pluripotency (Kelly et al., 2010; Niakan et al., 2006; Sun 
et al., 2009). DAX1 gene knockdown caused mouse ES cell differentiation (Niakan et al., 
2006). It was demonstrated that Dax1 interacts with Esrrb and represses its function (Uranishi 
et al., 2013). Moreover, Dax1 was shown to regulate in a negative way the expression of 
Oct4, where it seems to fine tune the expression of Oct4 in order to maintain ES cell 
pluripotency (Sun et al., 2009). 
Other transcription factors with potential roles in ES cells: 
Several core pluripotency factors interactome studies revealed a large number of involved TFs 
with potential roles in the regulation of the ES cell state (van den Berg et al., 2010a; Pardo et 
al., 2010; Wang et al., 2006a). Some of these factors are: Rex1, Rif1, Nac1, Tcfcp2l1, Sox18, 
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and Zfp281 shown to be a part of the ES cell transcriptional regulatory network with potential 
roles in the optimal maintenance of the ES cell state.  
 
b. Additional actors important in ES cell self-renewal  
Transcription Cofactors: 
Cofactors are capable to interact selectively and non-covalently with TFs and the basal 
transcription machinery in order to regulate transcription. They can either activate 
(coactivators) or repress (corepressors) gene transcription. Cofactors generally do not bind 
DNA, but rather assure the protein-protein interactions between TFs and the transcription 
machinery. They are expressed in all cell types, but ES cells seem to be quite sensitive to 
reduced levels of such cofactors (Fazzio and Panning, 2010; Kagey et al., 2010).  
Mediator is one of the most important coactivators of transcription. In ES cells, the mediator 
was shown to physically link Oct4/Sox2/Nanog bound enhancers to the promoters of active 
genes (Kagey et al., 2010). This physical link is assured by a second cofactor, the cohesin 
(Figure 14). Cohesin was shown to assure the DNA looping needed to approach regulatory 
elements and activate transcription in ES cells (Kagey et al., 2010). ChIP-seq data 
demonstrate the co-occupancy of mediator and cohesion with the core TFs at regulatory 
elements (Young, 2011). 
 
Figure 14 Model for DNA looping by mediator and cohesion (Young, 2011) 
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The proper chromatin structure and condensation is assured by an additional cofactor, the 
condensin. Condensin complexes were shown to be required in ES cells where the deletion of 
such complexes causes various phenotypic alterations at the level of the chromatin structure 
(Fazzio and Panning, 2010). 
Corepressors were also found to play a role in the maintenance of ES cells. Cnot3 (Ccr4-Not) 
and Trim28 (Tripartite motif-containing 28) are two corepressors shown to co-occupy 
promoter regions with important TFs in ES cells such as c-Myc and Zfx (Hu et al., 2009a). 
The down-regulation of Cnot3 and Trim28 causes ES cell differentiation into trophectoderm 
and primitive ectoderm respectively, conferring their role in self-renewal. Moreover, Hu et al. 
demonstrate that c-Myc/Zfx/Cnot3/Trim28 form a distinct pluripotency module from the 
Oct4/Sox2/Nanog module, indicating the increased transcriptional regulatory network 
complexity in ES cells. 
Chromatin regulators: 
Many chromatin regulators were shown to play important roles in ES cells (Fazzio and 
Panning, 2010; Kagey et al., 2010; Leeb et al., 2010; Meissner, 2010; Niwa, 2007). 
Chromatin regulators can be divided into four groups: Cohesin/condensing complexes 
(discussed earlier), histone-modifying enzymes, ATP-dependent chromatin remodeling 
complexes and DNA methyltransferases (Young, 2011).  
Histone-modifying enzymes encompass a significant number of different complexes that 
participate in either the activation or repression of transcription in ES cells. They include 
Polycomb complexes, SetDB1, Tip60 and TrxG proteins, the function of these proteins will 
be detailed further in this chapter. 
ATP-dependent chromatin remodeling factors were shown to regulate transcription, 
presumably through their capacity to modify nucleosome positioning and occupancy (Clapier 
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and Cairns, 2009a; Ho and Crabtree, 2010). Several remodeling factors were shown to be 
involved in the control of the ES cell state. The different remodeling complexes involved in 
ES cell transcriptional control will be discussed later in Chapter II and more widely in 
Chapter III. 
DNA methylation does not seem to be essential in ES cell maintenance. Indeed, although 
DNA methyltransferases (Dnmts) are expressed in ES cells and about 60-80% of the CpG 
islands are methylated, ES cells can be established and maintained in the absence of Dnmts 
and DNA methylation (Meissner, 2010). However, DNA methylation becomes required 
during differentiation, as Dnmt-deficient ES cells fail to properly differentiate (Jackson et al., 
2004). 
Noncoding RNAs:  
miRNAs 
Evidence have shown that several microRNAs (miRNAs) play essential roles during 
developmental, where they were demonstrated to regulate the expression of a large number of 
genes (Farh et al., 2005). A group of miRNAs was shown to play a role in the control of the 
ES cell identity (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2008). 
Furthermore, these miRNA polycistrons where shown to be controlled by the core TFs 
Oct4/Sox2/Nanog (Marson et al., 2008a). Marson et al. demonstrate that the core TFs regulate 
the transcription of miRNAs in ES cells. miRNA genes involved in ES cell maintenance and 
proliferation are activated, where these miRNAs (mainly the most abundant mir 290-295 
cluster) fine-tune the expression of the ES TFs. On the other hand, Oct4/Sox2/Nanog occupy 
the genes of developmental miRNAs along with repressing complexes poising their 
expression (Marson et al., 2008b).    
lncRNAs: 
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Recent studied have revealed the role of long non-coding RNAs (lncRNAs) in the control of 
the ES cell state (Guttman et al., 2009; Khalil et al., 2009). It was shown that a set of lncRNA 
genes are bound by the core TFs, and the downregulation of such lncRNAs results in dramatic 
effects on the expression of the core circuitry  indicating a potential feedback loop created by 
lncRNAs (Sheik Mohamed et al., 2010). On the other hand; lncRNAs were also shown to be 
involved during differentiation. A lncRNA called Xist is responsible for X chromosome 
imprinting during development and ES cell lineage commitment (Navarro and Avner, 2009). 
Moreover, lncRNAs where shown to be involved in later developmental steps, inducing the 
expression of lineage associated genes ( Ng et al., 2012). Interestingly, the expression of 
lncRNAs was shown to be correlated with the development potential of induced pluripotent 
stem cells (Liu et al., 2010). 
 
3. Pluripotency transcription factors and iPS cell generation 
a. Scientific milestones leading to induced pluripotent stem cell generation 
Reprogramming of somatic cells into pluripotent embryonic stem cells first started using 
nuclear transfer (NT) approaches. The early experiments in amphibians and later in mammals 
showed that terminally differentiated somatic cells were able to generate cloned animals 
(Briggs and King, 1952; Gurdon, 1962; Wilmut et al., 1997). This ability of a somatic cell to 
revert to an early embryonic state rose questions about the nature of genome changes upon 
differentiation, introducing the probable role of epigenetics (Hochedlinger and Jaenisch, 
2002). Moreover, this capacity of somatic cells to dedifferentiate in oocyte conditions led to 
the speculation of the presence of specific factors in the oocyte that are capable to induce 
pluripotency. 
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Another strategy to induce the reprogramming is fusing adult somatic cells with ES cells in 
culture generating tetraploid hybrid cells (Cowan et al., 2005; Tada et al., 1997, 2001). These 
observations indicated that there are some nuclear factors present in ES cells (as in oocytes) 
that are responsible for this reprogramming mechanism (Do and Schöler, 2004; Egli et al., 
2007). More recent studies have demonstrated that the overexpression of pluripotency factors 
such as Nanog enhances the formation of the reprogrammed hybrids about 200 folds (Silva et 
al., 2006). Indeed, previous work have demonstrated that the expression of certain TFs in 
certain mature terminally differentiated cells is sufficient to reprogram them into certain adult 
stem cell progenitors; by the same manner, the deletion of certain TFs can lead to 
reprogramming to multipotent progenitors (Davis et al., 1987; Laiosa et al., 2006; Nutt et al., 
1999). These observations have led to the rational thinking that the overexpression of ES cells 
TFs in somatic cells could lead to their stable reprogramming. 
b. Induced pluripotent stem cell generation from mouse and human somatic cells   
The first attempt to generate induced pluripotent stem cells (iPS cells) from somatic mouse 
cells was conducted by Takahashi and Yamanaka. Experiments were conducted on mouse 
fibroblasts, where 24 ES cell TFs were introduced with retroviral vectors and reprogrammed 
cells were drug selected for the ES cell-specific gene Fbx15 (Takahashi and Yamanaka, 
2006). In those experiments, Takahashi and Yamanaka were capable of identifying the 4 TFs 
Oct4, Sox2, Klf4 and c-Myc (the OSKM factors) sufficient to reprogram mouse fibroblasts 
into iPS cells. This first generation of iPS cells was similar to ES cells but not identical, as 
transcriptional and epigenetic patterns appeared to be only partially reset and such cells could 
not form mouse chimeras when injected into blastocysts (partially reprogrammed cells).  
Later studies, gave rise to the second generation of iPS cells from mouse fibroblasts. The iPS 
cell drug selection was based this time on the usage of essential pluripotency genes such as 
Pouf51 (Oct4) and Nanog (Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007). This 
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second generation of ES cells with transcriptional and epigenetic patterns highly similar to 
those in ES cells and can form chimeric mice. The different steps and the molecular changes 
involved in the direct reprogramming to iPS cells are demonstrated in Figure 15.  
 
Figure 15 Steps involved in direct reprogramming to pluripotency. The starting, intermediate and end stages of 
reprogramming to pluripotency that can be identified during the generation of iPS cells (Hochedlinger and Plath, 
2009) 
Since the iPS cell derivation from mouse fibroblasts, a dozen of studies have been capable to 
derivate iPS cells from various cell types including the blood, liver, stomach, pancreas, brain, 
intestine and adrenals. Furthermore, the generation of human iPS cells was also successful 
from fibroblasts (Lowry et al., 2008; Park et al., 2008; Takahashi et al., 2007) and 
keratinocytes (Aasen et al., 2008; Maherali et al., 2007) using the OSKM cocktail or a variant 
combination of factors such as the core TFs Oct4/Sox2/Nanog with a miRNA called LIN28 
(shown to enhance c-Myc function) (Yu et al., 2007).  
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B. Chromatin Modifying Enzymes and the Control of the ES Cell State 
 
Chromatin, DNA packaged with histones, assures cell-specific gene expression. The 
chromatin structure is under the control of different chromatin modifying enzymes. 
Chromatin modifying enzymes fall into two major groups: Histone modifying enzymes that 
remove or add covalent histone modifications to histone tails and ATP-dependent chromatin 
remodeling factors that use the energy of ATP to modify the nucleosomal chromatin 
architecture. Several proteomic and loss-of-function RNA interference studies were 
conducted to reveal the participation of such enzymes in the transcriptional regulatory 
network in ES cells. 
1. Proteomic interactome studies reveal numerous chromatin modifying 
enzymes as a part of the transcriptional regulatory network 
The interactome of the core transcription regulatory network has been the subject of a number 
of studies interested in revealing the different actors that play a role in the regulation of the ES 
cell state. 
A number of studies show the presence of chromatin modifying enzymes as part of the core 
transcription factor proteomic interactome (Liang et al., 2008a; Pardo et al., 2010; van den 
Berg et al., 2010b). 
 A FLAG-affinity based mass spectrometry study revealed a great number of Oct4 interacting 
proteins (van den Berg et al., 2010b). Van den Berg et al. presents an Oct4 interactome that 
identified a number of TFs and chromatin modifying complexes with previously known roles 
in the regulation of ES cell state, in addition to a series of newly identified actors. Primary 
immune-precipitation of Oct4 partners revealed a list of about 50 proteins, including about 22 
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TFs, some of them with known roles in ES cells (such as Sall4, Essrb, Klf5 and Sox2); 
moreover, a number of chromatin modifying enzymes (histone modifying enzymes and 
chromatin remodeling factors) were identified with the majority of these proteins found to be 
essential during development. This set included the various subunits of the NuRD repressive 
complex (including the histone deacetylases Hdac1/2 and the chromatin remodeling factor 
Chd4), members of the SNF family of chromatin remodeling factors (Brg1, also known as 
Smarca4), subunits of the repressive Polycomb complex (PRC1), members of the LSD1 
histone demethylase complex and subunits of the Trrap/p400 complex including the 
chromatin remodeling factor Ep400. Van den Berg et al. further purify the four different TFs 
Sall4, Essrb, Dax1 and Tcfcp2l1 shown to be partners in the Oct4 proteomic interactome, 
which revealed common and unique sets of interacting proteins. The combined interactomes 
from the five TFs resulted in a dense Oct4 regulatory network of about 160 different partners 
(Figure 16). Interestingly, Nanog was not identified in this network although several previous 
studies showed Nanog interactions with pluripotency TFs (including Sall4 and Oct4) (Liang 
et al., 2008a; Wang et al., 2006b; Wu et al., 2006), maybe due to the fact it might be hard to 
detect by mass spectrometry (resistance to digestion). 
Similarly a second Oct4 proteomic interactome study using tagged Oct4 followed by mass 
spectrometry revealed a broader interactome (Pardo et al., 2010). Mass spectrometry results 
identified 92 proteins in the tagged Oct4 purifications (Figure 17A). A considerable number 
of these factors were also identified in van den Berg et al. interactome. However, Pardo et al. 
identified Nanog in the Oct4 partners and an additional series of chromatin remodeling factors 
such as INO80, Smarca5, Chd1. Moreover, about 80% of the Oct4 interacting proteins were 
shown to be essential in development, as the deletion of these proteins is lethal (Figure 17B). 
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Analysis of Nanog proteomic interactome also revealed the association of chromatin 
modifying enzymes with this core TFs (such as members of the NuRD complex and the SNF2 
remodeler Brg1) (Liang et al., 2008b).  
 
 
Figure 16 Protein Interaction Network of Oct4 and Its Associated Proteins Sall4, Dax1, Tcfcp2l1, and Esrrb (van den 
Berg et al., 2010b) 
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Figure 17 The Oct4 network and its importance during development. A) Network of protein-protein interactions 
within the Oct4 dataset. Blue circles are proteins downregulated upon ES cell differentiation. Red fill indicates 
proteins whose absence results in embryonic lethality in the mouse B) Percentage Distribution of Phenotypes Caused 
by Mutations in the Genes Encoding Oct4-Associated Proteins (Pardo et al., 2010). 
 
2. RNA interference-based screens for pluripotency controlling factors reveal 
a series of important chromatin remodeling enzymes 
ATP-dependent chromatin remodeling factors or remodelers were shown to be essential 
during development. Several studies have shown that mutations in key remodelers such as 
Ep400 (also known as  (p400) and Brg1 (Smarca4) are lethal in preimplantation embryos 
(Bultman et al., 2000; Gorrini et al., 2007).  Several RNA interference (RNAi)-based screens 
identified a series of chromatin remodelers as regulators of the ES cell identity (Fazzio et al., 
2008; Gaspar-Maia et al., 2009).   
A 
B 
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In one study, Fazzio et al. show the importance of the chromatin regulatory complex 
Tip60/p400 in the maintenance of ES cell features (Fazzio et al., 2008). Tip60/p400 has 
histone acetyltransferase and nucleosome remodeling functions and it was shown that 
mutations in Tip60 or Trrp (a component of the Tip60/p400 complex) cause preimplantation 
lethality (Gorrini et al., 2007; Herceg et al., 2001). In the goal of identifying chromatin 
regulatory complexes involved in ES cell maintenance and differentiation, Fazzio et al. 
performed a large-scale RNAi-based screen of about 1008 genes encoding chromatin proteins. 
They identified 68 genes with phenotypes resulting from the knock-down. Among the 68 
targets, subunits of the Tip60/p400 complex were revealed to be important in ES cells. The 
down regulation of the ATP-dependent chromatin remodeling factor p400 (Ep400) induces a 
change in ES cell morphology associated to loss of pluripotency. In addition, the KD of 
Ep400 effected the expression of about 802 genes, with about 128 upregulated and 674 down 
regulated genes conferring a rather repressive role of Ep400. Indeed, most of the upregulated 
genes are key developmental loci. However, the expression of key transcriptional factors was 
not changed suggesting a role of Ep400 rather downstream the ES core TFs. Interestingly, 
Nanog knock down showed an overlap in the transcriptomic deregulation profile with Ep400 
suggesting a mutual regulation of a set of genes. Moreover, a strong correlation between 
H3K4me3 and Ep400 binding was observed both at active and silent genes (presenting the 
H3K27me3: bivalent genes) with highest binding at the most active genes. In addition, Nanog 
was shown to be indirectly involved in the binding of Ep400 to its target genes suggesting that 
the Tip60/p400 complex to be an important effector of Nanog transcriptional repression.  
A second study reveals the role of a different chromatin remodeling factor in the maintenance 
of the ES cell profile. RNAi screening of 41 candidate factors in the regulation of 
pluripotency identified Chd1 (Chromodomain1), an ATP-dependent chromatin remodeling 
factor as an important factor in ES cell pluripotency and self-renewal (Gaspar-Maia et al., 
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2009). The authors of this study have shown that Chd1 knock down in ES cells caused defects 
in cell expansion and a lower activity of the Oct4 promoter, concordant with recent data 
where Chd1 was identified as an Oct4 interacting partner (Pardo et al., 2010). However, Chd1 
knock down resulted in a small number of downregulated genes and a more important 
upregulation of genes involved in differentiation processes. Indeed, knock down ES cells for 
Chd1 show increased propensity for abnormal neural differentiation coupled with a loss of 
endoderm formation capacity. However, ES with low levels of Chd1 keep their global ES 
transcriptome, suggesting that such levels of Chd1 are sufficient to maintain an appropriate 
ES cell state. Furthermore, Chd1 was shown to be coupled with active transcription (Sims et 
al., 2007), where it was demonstrated to be coupled with euchromatin by binding to 
H3K4me3 not only in ES cells but also in differentiated cells. Similarly, Gaspar-Maia et al. 
show that Chd1 knockdown causes the increase in the number of heterochromatin marks such 
as H3K9me3. To sum up, Chd1 was shown to be required for open chromatin in ES cells and 
for heterochromatin-poor pluripotent cell state maintenance. 
Several additional studies that discussed the global transcription implication of chromatin 
remodeling factors in ES cell maintenance (Efroni et al., 2008; Ho et al., 2011a) revealed that 
the depletion by RNAi of Brg1 (Smarca4) caused both proliferation and differentiation 
deficient phenotypes; on the other hand the depletion of a second remodeler (Chd1l), caused 
severe proliferative defects but had no effect on the differentiation capacities. 
 
C. The Epigenetic Regulatory Landscape of the ES Genome 
The chromatin in ES stem cells was suggested to be in a hyper-dynamic state, as a selection of 
chromatin proteins were found more loosely bound to genomic DNA in ES cells compared to 
in vitro differentiated ES cells (Meshorer et al., 2006b). This particular chromatin state might 
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contribute to the transcriptional levels of the different genes essential in the conservation of 
pluripotency and self-renewal. However, silencing of developmental genes to prevent their 
inappropriate expression in ES cell should also be achieved despite this more dynamic state of 
the chromatin. It is currently unclear how the mechanisms of transcriptional control might be 
affected by the particular nature of ES cell chromatin. In this last part of this chapter, I will 
discuss the current knowledge on the mechanisms that control transcription in ES cells. 
1. Promoters in ES cells 
a. Promoters and H3K4me3 
Promoters are regulatory genome regions that initiate transcription of their target genes. The 
identification of promoters is usually associated with a particular epigenetic mark which is the 
trimethylation of the lysine 4 of H3 histone (H3K4me3). The activating Trithorax group of 
chromatin modifying enzymes is responsible for the deposition of this mark.   
Epigenetic control by the Trithorax (TrxG) group and its counterpart repressive group 
Polycomb (PcG) was first discovered in Drosophila melanogaster as activators and repressors 
of Hox genes, which are a group of TFs that play a role in the cell specification of segmented 
animals (Brock and Fisher, 2005; Ringrose and Paro, 2004; Simon and Tamkun, 2002). The 
attribution of the H3K4 methyltransferase activity to TrxG was first given after the 
identification of the TrxG homologue Ash2 in the yeast Set1 H3K4 methyltransferase 
complex (Roguev et al., 2001).  
Similarly a TrxG orthologue was identified in mammals (Mll1) (Milne et al., 2010).  There 
are six Set1/Trithorax like H3K4me3 methyltransferases identified in mammals (Glaser et al., 
2006), all present in similar complexes based on the Set1C/Ash2 scaffold (Ruthenburg et al., 
2007; Yokoyama et al., 2004). They include Mll1, Mll2, Mll3, Mll4 (which are Trithorax-
like) and Set1A and Set1B (which are Set1 complex-like).  
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In yeast, deposition of  H3K4me3 is associated with active genes (Ng et al., 2003; Santos-
Rosa et al., 2002); on the other hand, in mammals the mark is associated with both active and 
inactive promoters, however at distinct levels (Barski et al., 2007; Guenther et al., 2007). 
Moreover, it was shown that the deposition of H3K4me3 mark is strongly correlated with the 
presence of CpG rich islands at promoter regions : (Guenther et al., 2007; Mikkelsen et al., 
2007). Initial studies have identified CxxC zinc finger proteins that bind to CpG islands (Lee 
et al., 2001). Cfp1 or CxxC-finger protein one was shown to be a part of both Set1A and 
Set1B complexes (Lee and Skalnik, 2005). Similarly Mll proteins also present similar CxxC 
zinc finger domains (Bach et al., 2009; Birke et al., 2002).  
The deposition of the H3K4me3 histone modification in ES cells was intensively investigated 
in two recent studies (Clouaire et al., 2012; Denissov et al., 2014).  
In a genome-wide study Clouaire et al. demonstrate the importance of Set1 complex, 
particularly the Cfp1 CxxC zinc finger protein, in the deposition of the H3K4me3 mark on 
active promoters. The absence of Cfp1 in ES cells does not affect self-renewal; however such 
cells cannot differentiate (Carlone et al., 2005) and somatic cells deficient in Cfp1 have 
detrimental phenotypes (Thomson et al., 2010; Young and Skalnik, 2007). However, upon 
Cfp1 deletion in ES cells, there is a wide loss of H3K4me3 at active genes with no effect on 
poised genes (Clouaire et al., 2012). This loss of H3K4me3 at active genes was coupled with 
an aberrant reorganization of H3K4me3 on different regulatory elements such as enhancers 
and CTCF binding sites, suggesting a probable role of Cfp1 in the targeted recruitment of the 
Set1 methyltransferase complex onto active promoters with rich unmethylated CpG islands. 
Indeed, a mutant Cfp1 that does not recognize CpG islands is not capable of inhibiting the 
aberrant Set1 binding at regulatory elements. 
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The authors further speculate about the real importance of the H3K4me3 mark in activating 
transcription, as the aberrant H3K4me3 deposition in ES cells did not seem to have an effect 
on the transcription. However, this could be due to the non-total depletion of this mark, 
suggesting a redundancy in the function of different H3K4me3 methyltransferases in the 
global deposition of H3K4me3 on active and poised promoters. Indeed, the identification of 
Mll1/2 importance early during development (Andreu-Vieyra et al., 2010; Glaser et al., 2006) 
and the dominance of Set1 in later stages prove the various roles CxxC proteins play in 
determining the chromatin landscape (Ardehali et al., 2011). Interestingly, the depletion of 
subunits of the Set1 and Mll1/2 complexes causes the decrease in H3K4me3 at both active 
and poised promoters (Ang et al., 2011; Jiang et al., 2011), suggesting an interplay between 
the different methyltrasnferases in the deposition of the H3K4me3 mark in the ES cell 
genome and a probable role of Mll1/2 methyltransferases in the deposition of H3K4me3 on 
poised promoters. 
The role of Mll1/2 proteins, more particularly Mll2, was further investigated (Denissov et al., 
2014). Mll2 as mentioned previously was shown to be required during oogenesis where it 
seems to be the major H3K4me3 methyltransferase (Andreu-Vieyra et al., 2010). Denissov et 
al. demonstrate that Mll2 is required for the deposition of H3K4me3 on poised promoters 
(bivalent genes with the both the activating H3K4me3 and H3K27me3 marks, discussed later 
in this chapter). CHIP-seq analysis of genome-wide H3K4me3 upon Mll2 depletion shows 
loss of this mark at a set of bivalent genes but not at active genes. However, Mll2 binds both 
active and poised promoters, but its depletion only affects H3K4me3 at poised ones. The 
depletion of H3K4me3 at the set of bivalent genes was not concordant with a loss of 
differentiation gene activation, with only a small set of influenced genes. Denissov et al. 
propose a variant hypothesis about the recruitment of Set1 complex on active genes. They 
propose that Mll2 with its CxxC domain defines CpG rich islands at transcription start sites 
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(TSS) in active and bivalent promoters, and further loss of the H3K27me3 repressive mark 
and recruitment of Mll1 and the Set1 complex is required in order to activate genes (Figure 
18). 
 
Figure 18 Model for the relationships between Mll and Set1 complexes on bivalent and active promoters (Denissov et 
al., 2014) 
 
b. Bivalent genes and Polycomb complex 
The Polycomb group proteins (PcG) were shown to play a role in the silencing of a wide 
range of genes during the different developmental stages (Simon and Kingston, 2013). As 
mentioned previously, this group was initially discovered in Drosophila Melanogaster. PcG 
proteins form two distinct complexes, PRC1 (Polycomb Repressive Complex 1) and PRC2 
(Margueron and Reinberg, 2011a; Müller and Verrijzer, 2009; Simon and Kingston, 2013). 
PRC2  includes Ezh2, which catalyzes the deposition of H3K27me3 (Cao et al., 2002; 
Kuzmichev et al., 2002; Müller et al., 2002). PRC1 complex is responsible for the 
ubiquitylation of histone H2A on K119 (Cao et al., 2005) and the  nonenzymatic compaction 
of polynucleosomes (Francis et al., 2004).  
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In mammals PRC2 is composed of the core subunits EZH2, EED, SUZ12 and RbAp48 
(Margueron and Reinberg, 2011b). EZH2 is responsible for the catalytic activity of PRC2 and 
catalyzes the di/trimethylation of H3K27, but the other two core components SUZ12 and EED 
were also shown to be necessary for the repressive role of PRC2 (Cao and Zhang, 2004; 
Pasini et al., 2007). PRC2 components are usually recruited near promoters of repressed genes 
(Cao and Zhang, 2004; Kimura et al., 2004; Kirmizis et al., 2004); in addition to their 
important role in the inactivation of the X chromosome during development (Plath et al., 
2003; Umlauf et al., 2004). The recruitment of PRC2 subunits to the genome is still a matter 
of debate. It might be achieved in part similarly to TrxG subunits, by the recognition of CpG 
rich islands (Deaton and Bird, 2011; Ku et al., 2008). 
PRC1 complexes are usually formed around a RING1/2 subunit with the binding six PcG 
RING finger proteins (PCGF). Such heterodimers form a core unit that is responsible for the 
ubiquitination of the lysine 119 of histone 2A (H2AK119ub) (Schwartz and Pirrotta, 2013). 
The canonical PRC1 subunits have chromobox-containing (CBX) subunits that are capable of 
recognizing the H3K27me3. In addition, several non-canonical PRC1 variants have different 
roles like a stronger ubiquitination activity or capacity to demethylate the transcription 
elongation histone marks H3K36me3, necessary to repress transcription (Farcas et al., 2012; 
He et al., 2013).  
The mechanism by which the two PcG groups PRC1 and PRC2 cooperate in order to repress 
transcription has been debated in recent studies. Initially it was speculated that PRC2 is 
recruited to CpG islands of repressed genes and later on PRC1 recognizes the H3K27me3 
deposited by PRC2, adds the H2AK119ub thus impedes RNA Polymerase activity and further 
compacts the chromatin (Stock et al., 2007; Zhou et al., 2008). Contrary to this hypothesis, 
recent studies inverse the recruitment steps of PRC1 and PRC2 (Blackledge et al., 2014; 
Cooper et al., 2014; Schwartz and Pirrotta, 2013). They argue that the genome peaks of 
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H3K27me3 form a broad signal while H2AK119ub give sharp well-defined peaks. In these 
studies they rather speculate that the first step is the recruitment of the PRC1 complex with its 
non-canonical components that recognize CpG islands with defined H3K27me3 (through the 
CBX subunits), this step recruits the rest of the PRC1 complex (canonical subunits) that add 
the H2AK119ub mark. Later on, PRC2 recognizes this mark through one of its two non-core 
subunits JARID2 or AEBP2, this causes a broad deposition of the H3K27me3 mark nearby 
repressed promoter regions (Kalb et al., 2014). The authors further consider the presence of a 
self-reinforcing loop where the ubiquitination stimulates more PRC1 and PRC2 binding, 
where PRC2 methyltransferase activity recruits again more the PRC1 complex. EZH1 of the 
PRC2 complex is responsible for the deposition of the H3K27me3 repressive mark on 
bivalent domains (Shen et al., 2008). 
The notion of bivalent promoters was first described by Berstein et al. The authors describe 
the presence of a particular histone modification pattern in ES cells (Bernstein et al., 2006) on 
the promoter region, with both H3K4me3 activating mark and H3K27me3 repressive mark. 
They show that these bivalent domains are specific for ES cells and are present at promoter 
regions of developmental genes that are poised (kept in an inactive state, ready to be activated 
at specific cues) for expression, while differentiated cells present active or repressive histone 
modifications depending on the cell type (Figure 19). The presence of bivalent domains was 
also found in other cell types such as multi-potent neural, hematopoietic stem cells and 
embryonic fibroblasts (Barski et al., 2007; Cui et al., 2009; Mikkelsen et al., 2007). 
Furthermore, they demonstrate that genes with bivalent promoters have low transcription 
levels. Interestingly bivalent domains co-localize with the core TFs, where these factors aid in 
the maintenance of the poised state.  
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Figure 19 Bivalent chromatin domains mark the promoters of developmentally important genes in pluripotent ES 
cells. PRC2 and TrxG proteins catalyze the tri-methylation of histone H3 on lysine 27 and 4, respectively. PRC1 is also 
recruited to many of these genes t to add the H2AK119ub mark (Boyer, 2009) 
 
c. CpG content and promoter state in ES cells 
As discussed earlier, the deposition of both the H3K4me3 activating and the H3K27me3 
repressive marks is assured by the PcG/TrxG duo. The recognition of the promoter regions by 
subunits of both complexes is likely done through the recognition of CpG regions.  
An interesting study highlights the link between CpG composition in promoters and the nature 
of genes in both ES cells and lineage-commited cells (Mikkelsen et al., 2007). The authors 
describe two types of promoters, high CpG promoters (HCP) and low CpG promoters (LCP).  
They show that CpG high promoters are usually linked to housekeeping and developmental 
gene, while low CpG promoters are associated to more tissue-specific specialized genes. HCP 
in ES cells are mostly marked by H3K4me3, where this trimethylation level is directly 
proportional to gene expression level. However; not all genes with H3K4me3 are expressed, a 
certain percentage present the repressing H3K27me3 marks (bivalent genes), that keep one or 
both marks during differentiation. Moreover, the authors identify that H3K4me3 monovalent 
promoters are most of the time linked to housekeeping genes that are always expressed. 
Bivalent genes associate with development genes, TFs and other factors that require a more 
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complex transcriptional control. On the other hand, LCP show little H3K4me3 and almost no 
H3K27me3. These promoters are usually inactive by default, while the small percentage of 
genes associated with H3K4me3 usually belong to very specialized tissue-specific genes and 
could be activated in a selective manner according to the cell type.  
2. Distal regulatory sequences 
In addition to the promoters, which are the proximal regulatory elements of each gene, the 
genome includes a larger number of distal regulatory elements (enhancers and insulators) that 
play an essential role in the control of transcription.  
a. Enhancers and super-enhancers 
Enhancers are identified as cis-regulatory elements that control transcription in a positive 
manner (Blackwood and Kadonaga, 1998; Pennacchio et al., 2013). Enhancers are capable to 
exert this transcriptional control on target genes independent of genomic distance or 
orientation (Visel et al., 2009). In addition, they do not necessarily control the most proximal 
genes; in fact, they can even control more than one gene (Mohrs et al., 2001). Adding to the 
complexity of enhancer identification, is that they can be found anywhere in the genome 
(intergenic region or even within introns).  
Enhancer identification was primarily conducted by individual characterization of disease-
related distal regulatory elements (Bulger and Groudine, 1999) and on a larger scale by 
conservational comparative genomics (Boffelli et al., 2004). Later on, genome-wide studies 
have permitted the identification of thousands of putative enhancers across different cell-
types. As in the case of promoters (active or bivalent), enhancer identification is also based on 
histone modification signatures. The initial histone modification used in genome-wide studies 
to identify enhancers is the monomethylation of lysine 4 of Histone H3 (H3K4me1) where the 
enhancer patterns obtained were cell-type specific (Ghisletti et al., 2010; Heintzman et al., 
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2009; Heinz et al., 2010; Kim et al., 2010). Other studies also noticed an enrichment of the 
histone acetyltransferase p300 on enhancer regions (Visel et al., 2009).  
The usage of the H3K4me1 mark alone is not sufficient to identify active enhancers, as a 
number of identified putative enhancers according to H3K4me1 did not show any activity. 
This phenomena lead to the identification of the different enhancer states, with active or 
poised enhancers dependent on the cell-type. Active enhancers were shown to carry in 
addition to the H3K4me1 mark, the H3K27 acetylation (H3K27ac) (Creyghton et al., 2010). 
Creyghton el al. demonstrated the presence of about 135000 putative enhancers in ES cells 
and a number of differentiated cells based on the double histone marks. Further on, they 
demonstrate the variation in the enhancer state upon differentiation of ES cells, where some 
poised/inactive enhancers become active and vice-versa in order to sustain the new cell state. 
In ES cells enhancer elements were also shown to be bound by the core TFs 
Oct4/Sox2/Nanog. Interestingly, these factors bind both active and poised, conferring a role of 
the core regulatory network in the both the maintenance of the pluripotency/self-renewal 
enhancers and the repression of developmental enhancers.  
Later studies have identified the presence of multiple classes of enhancers. In one study, the 
ES cell/ differentiation system was explored in order to better understand the different 
enhancer states throughout development (Zentner et al., 2011). Using CHIP-seq and DNase 
hypersensitivity analysis the authors identified; in addition, to the active (H3K4me1/H3K4ac) 
and poised (only H3K4me1) enhancers, the H3K27me3 mark enriched on certain enhancers. 
So the authors reclassify enhancers into three major classes: Active (H3K4me1/H3K27ac), 
intermediate (H3K4me1) and poised (H3K4me1/H3K27me3 or H3K9me3). Active enhancers 
were further sub-classified according to their transcriptional level (using the H3K36me3 
transcriptional elongation mark), with the most active enhancers with the highest eRNA 
transcripts. Upon the differentiation of mouse ES cells, the enhancer classes resolved to 
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different enhancer states depending on the developmental state (Zentner et al., 2011). Active 
enhancers retained their active state, became neutral (no mark) or lost H3K4me1 and acquired 
H3K27me3. Poised enhancers might acquire H3K27ac to become active, lose all marks to 
become neutral or lose H3K4me3 and retain H3K27me3. On the other hand, intermediate 
enhancers showed transition between the neutral and poised state but failed to lose their 
H3K4me1 or acquire H3K27me3. 
In a more recent study, a special type of enhancer clusters was identified. Those enhancer 
clusters were called super-enhancers (Whyte et al., 2013). In ES cells these super enhancer 
clusters were shown to be occupied with five essential TFs (Oct4, Sox2, Nanog, Klf4 and 
Essrb) in addition to the mediator (facilitator of enhancer/promoter interactions). However, 
the occupancy of the mediator was much higher in such super enhancers (SEs) than in 
classical or typical enhancer (TEs). Whyte et al. further demonstrate that in addition to the 
high Mediator occupancy, SEs span much larger DNA regions (as much as 50kb) than TEs 
(Figure 20A). Furthermore, SEs presented higher levels of H3K27ac/H3K4me1 and higher 
occupancy by Klf4 and Essrb (not the case for Oct4/Sox2/Nanog) (Figure 20B). In ES cells 
SE were shown to be associated with important ES cell key genes, including the core 
transcription factor genes, DNA-modifying enzymes, miRNA where they play a role in 
driving a high-level expression. On the other hand, SEs were found to be associated with very 
few housekeeping genes. 
Interestingly, SEs were not only detected in ES cells, different cell types also present SEs that 
drive the expression of cell identity genes (Hnisz et al., 2013; Whyte et al., 2013). In addition, 
SEs variations were detected in different diseases. For instance, cancerous cells can generate 
SEs at oncogenes and other genes for tumor sustaining (Hnisz et al., 2013). 
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Figure 20 Characteristics of typical enhancers and super enhancers in ES cells. A) Mediator ChIP-seq density and 
ChIP-seq fold difference for enhancer features Mediator, H3K27ac, H3K4me1, and DNaseI hypersensitivity at super-
enhancers versus typical enhancers. B) Oct4, Sox2, Nanog, Klf4, and Esrrb ChIP-seq density across the consti 
constituent enhancers within the 8,563 typical enhancers and the 231 super-enhancer regions. (Whyte et al., 2013) 
 
      
b. CTCF-binding sites and insulators 
The genome in eukaryotes is organized in a three-dimensional way, with packaging at 
different levels, starting from nucleosomes ending with the chromosomes. Gene expression is 
highly dependent on this genome architecture that provides spatial-temporal control of 
transcription. CTCF or CCCTC-binding factor was shown to be one of the architectural 
proteins responsible for the DNA looping of two sequences resulting in various functional 
outcomes depending on the nature of these sequences and their bound proteins. CTCF 
contains a highly conserved DNA-binding domain with 11 zinc fingers (Ohlsson et al., 2001); 
it binds to a high number of sites in the mammalian genome (~55000-65000 sites) (Chen et 
al., 2012) and normally targets linker regions with well positioned nucleosomes (Cuddapah et 
al., 2009). CTCF is the best characterized insulator (capacity to interfere with the interaction 
between regulatory sequences/buffering transgenes from the heterochromatin effect) protein 
in vertebrates. CTCF was first identified as a transcription factor that activates or represses 
gene expression in heterologous reporter assays (Baniahmad et al., 1990; Lobanenkov et al., 
1990). 
A B 
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The sole role of CTCF as an insulator was debated in later studies. A recent review even 
replaces the name of insulator by rather architectural protein (Ong and Corces, 2014). CTCF-
binding sites were identified in various genomic regions (intergenic, promoter-proximal and 
intragenic) (Chen et al., 2012, 2008b). CTCF was suggested to play a role in tethering distant 
enhancers to their promoters, where it was found to bind active enhancers; indeed promoters 
and enhancer elements were observed to be enriched with CTCF binding sites (Sanyal et al., 
2012; Shen et al., 2012). In mouse ES cells, a study further shows the importance of CTCF in 
promoter-enhancer interactions (Liu et al., 2011), where it was shown to bind to an 
endodermal differentiation factor (TAF3) along with cohesion. Indeed, in mouse ES cells 
genome-wide analysis using ChIA-PET (Chromatin Interaction Analysis by Paired-End Tag 
Sequencing), revealed CTCF-mediated promoter/enhancer interaction for the establishment of 
‘transcription factories’ at certain genes (Handoko et al., 2011).  
The higher eukaryotes genome is organized into topologically associating domains (TADs). 
These TADs are defined by the high frequency of DNA interaction within such domains 
(intra-domain interactions); however inter-TAD interactions are very low. This topological 
domain phenomenon may account for the two different roles assured by CTCF as an insulator 
or an activator. CTCF-binding site were found at TAD boundaries (15% of all CTCF-binding 
sites), whereas the rest 85% were shown to be located within TAD domains (Dixon et al., 
2012). The presence of CTCF at TAD boundaries may confer to its enhancer insulator 
properties between different TADs; on the other hand, intra-TAD interactions of 
promoter/enhancer elements are facilitated by CTCF proteins found with each TAD domain 
(Figure 21). Moreover, CTCF was shown to create insulated regions of promoter/super-
enhance interactions in ES cells, where with cohesion, CTCF is able to create an insulated SE 
domain (Figure 22) (Dowen et al., 2014). Dowen et al. also demonstrate the role of CTCF in 
insulating Polycomb domains for the correct silencing of developmental genes in ES cells 
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(Figure 22). This insulation activity is essential in order to inhibit any inappropriate gene 
activation/repression in nearby domains.  
 
Figure 21 The role of CTCF as an enhancer blocker or facilitator (Ong and Corces, 2014) 
 
Figure 22 The role of CTCF in the creation of both super enhancer domains (SD) and polycomb insulated domains 
(PD) in ES cells (Dowen et al., 2014) 
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Chapter III. ATP-dependent Chromatin Remodeling Factors and 
Pluripotency 
 
ATP-dependent chromatin remodeling factors or remodelers belong to the class of chromatin 
modifying enzymes. By using the energy of ATP, they can alter the chromatin structure by 
acting on the chromatin building block, the nucleosomes.  Remodelers were shown to have 
important roles in different cellular mechanisms such as DNA repair, replication and more 
importantly in the transcriptional control of genes.  
A. The Snf2 family of ATP-dependent chromatin remodeling factors: 
Classification 
The classification and nomenclature of ATP-dependent chromatin factors have been debated 
in several studies. ATP-dependent chromatin remodeling enzymes are usually referred to as 
Snf2 or SWI/SNF related enzymes; this nomenclature originated from the first discoveries on 
ATP-dependent chromatin remodeling mechanisms of the SWI/SNF (Switch/sucrose non-
fermenting) complex observed in the yeast Saccharomyces cerevisiae (Côté et al., 1994).  
The Snf2 family of ATP-dependent chromatin remodeling factors contains a domain 
homologous to the yeast Snf2 domain (Laurent et al., 1992). This Snf2 domain has seven 
conserved helicase-related sequence motifs that allows the further classification of the Snf2 
family as a part of the SF2 superfamily encompassing helicase-like proteins without a helicase 
detected activity and with ATP-dependent remodeling functions (detailed later) (Eisen et al., 
1995; Flaus et al., 2006). Flaus et al. propose an interesting sub-classification of the Snf2 
family into 24 subfamilies, based on multiple sequence alignment of the helicase-like regions.  
These 24 subfamilies can be further regrouped into six groups ( Rad5/6-like, Swr1-like, Snf2-
like, Rad 54-like, SSO1653-like and the distant SMARCAL1) based on specific functional 
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domain similarities (Figure 23). To avoid any confusion it is worth mentioning that the Snf2 
family encompasses a group named Snf2-like composed of 7 subfamilies including the Snf2 
subfamily, which encompasses the yeast Snf2 (Drosophila melanogaster Brahma and 
mammalian Brg1).  The different subfamilies, their archetypal organism, the different 
nomenclature and members are represented in Table2.  
An alternative classification exists for the ATP-dependent chromatin remodeling factors. This 
classification simplifies the observed diversity of Snf2 remodelers and partitions them into 4 
families which are SWI/SNF, ISW1, CHD and INO80 (Clapier and Cairns, 2009b; 
Hargreaves and Crabtree, 2011). However, such classification does not take into consideration 
the diversity within the CHD family and fails to correctly categorize remodelers such as Alc1 
and Atrx. To conclude, the classification of ATP-dependent remodelers is not an easy task, 
taking into account the diversity of the flanking domains and the absence of robust domain-
finding tools necessary to assign many sequences.   
 
Figure 23 Schematic diagram of the hierarchical classification of ATP-dependent helicase-like proteins. Adapted from 
(Flaus et al., 2006). 
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Subfamily Archetype gene Members and their variant nomenclature  
Snf2 S. Cerevisiae (Snf2) Yeast Snf2/ Drosophila Brahma/mammalian 
BRG1(SMARCA4)  
Iswi D. melanogaster Iswi SMARCA1 (Snf2l), SMARCA5 (Snf2h) 
Lsh M. musculus Hells HELLS (SMARCA6,/Lsh) 
ALC1 H. Sapiens  CHD1L ALC1(CHD1L/SNF2P) 
Chd1 M. musculus CHD1 CHD1, CHD2 
Mi-2 H. Sapiens CHD3 CHD3 (Mi2α/ZFH), CHD4 (Mi2β), CHD5 (Kiaa0444) 
CHD7 H. Sapiens CHD7 CHD6, CHD7, CHD8, CHD9 
Swr1 S. Cerevisiae (SWR1) SRCAP (domino/PIE1) 
Ep400 H. sapiens EP400 EP400 (Domino) 
Ino80 S. Cerevisiae (INO80) INO80 
Etl1 M.. musculus (Smarcad1) SMARCAD1  
Rad54 S. Cerevisiae (Rad54) RAD54 
Atrx H. sapiens  (Atrx) Atrx 
Arip4 M.. musculus (Srisnf21) ARIP4 
DRD1 Arabidopsis thaliana (DRD1) DRD1 
JBP2 T. brucei (JBP2) JBP2 
Rad5/16 S. Cerevisiae (RAD5, 
RAD16) 
SMARCA3 (HLTF) 
Ris1 S. Cerevisiae (RIS1) RIS1 
Lodstar D. melanogaster (Lodestar) Lodestar (HuF2) 
SHPRH H. sapiens (SHPRH)   SHRPH (YLR247C) 
Mot1 S. Cerevisiae (MOT1) MOT1 (BTAF1) 
ERCC6 H. sapiens  (ERCC6) ERCC6 (RAD26L) 
SSO1653 S. solfataricus (SSO1653)  SSO1653 (SsoRad54like) 
SMARCAL1 H. sapiens  (SMARCAL1) SMARCAL1 (DAAD) 
 
Table 2 The different Snf2 subfamilies, the archetype organism and the different constituting members. Subfamilies 
and members marked in bold letters are of particular interest in the lab and thesis project. Adapted from (Flaus et al., 
2006). 
 
B. The Snf2 family of ATP-dependent chromatin remodeling factors: 
Mode of action 
1. The chromatin state 
Chromatin is identified as a combination of DNA, RNA and proteins. This macromolecular 
structure is essential for DNA compaction and the correct cellular state maintenance 
(replication, repair and transcription).  
 In eukaryotes, the 1 meter DNA fiber is subjected to different levels of packaging in order to 
fit in the nucleus. The basic building block of chromatin is the nucleosome (Kornberg, 1974). 
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The nucleosome consists of 146bp of DNA rapped around the histone octamer that comprises 
a homodimer of each of H2A, H2B, H3 and H4 histones. This packaging level represents the 
well-known “beads on a string” chromatin structure that is further compacted to form the 
30nm fiber thought to be stabilized by H1 linker histone (Felsenfeld and Groudine, 2003a). 
Nevertheless, this compaction level represents just a 50 fold of a 5000 fold required level to 
attain the chromosome state (Figure 24); this sheds the light on various other yet undiscovered 
mechanisms interfering in chromatin compaction (Hargreaves and Crabtree, 2011).  
 
Figure 24 The different compaction levels of the chromatin (Felsenfeld and Groudine, 2003b) 
The extensive DNA compaction, on the other hand, should not hinder the accessibility to 
insure the appropriate cellular processes such as gene transcription. As mentioned previously 
two types of enzymes assure the proper DNA accessibility, histone modifying enzymes and 
chromatin remodeling factors.  Cells require remodeling factors in order to package the 
genome and at the same time assure a regulated DNA accessibility (Clapier and Cairns, 
2009b). 
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2. Mode of action of ATP-dependent chromatin remodeling enzymes 
ATP-dependent chromatin remodeling enzymes or factors (remodelers), and as their name 
implies, are capable to remodel the chromatin by using the energy of ATP. Nucleosome or 
chromatin remodeling factors act at different levels of nucleosome organization by a sliding 
mechanism (Figure 25). First, some remodelers can modify nucleosome spacing; second, they 
assure the phasing of the nucleosomal arrays with respect to a barrier, which can be DNA-
bound protein, or the so called nucleosome free regions (NFR), which are typically found at 
eukaryotic promoter elements. Last, the nucleosome sliding activity of remodelers assures a 
proper regulation of the DNA sequence accessibility (reviewed in (Mueller-Planitz et al., 
2013)).  
 
Figure 25 The outcomes of nucleosome sliding on nucleosome organization (Mueller-Planitz et al., 2013) 
Several mechanisms were proposed in order to explain how remodelers interfere in the DNA 
accessibility.  By using the energy of ATP, remodelers can expose a DNA binding domain by 
several mechanisms. Remodelers can expose the DNA regulatory domain either by 
repositioning or ejecting a nucleosome, or by causing the unwrapping of a DNA filament. 
Another proposed mechanism is by altering the histone composition of nucleosomes, where 
the original histone dimers can be replaced by histone variants, or eventually a dimer ejection 
can take place in order to assure proper DNA accessibility (Clapier and Cairns, 2009b). 
Figure 26 illustrates the different outcomes of chromatin remodeling. 
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Figure 26 Mode of action of ATP-dependent chromatin remodeling factors (Clapier and Cairns, 2009) 
In addition to the central ATPase catalytic domain of remodelers, several other accessory 
domains are present. Such domains play various roles in covalent histone modification 
recognition, regulation of the action of the central ATPase domain, and in the interaction with 
other chromatin remodelers and TFs. So what are the different mechanistic features of ATP-
dependent chromatin remodeling factors? 
The ATPase motor of Snf2 ATP-dependent chromatin remodeling factors presents a DNA 
3’>5’ translocase activity that helps moving on the DNA helix and drawing DNA from one 
entry/exit site and pump it in a directional wave (Lavelle et al., 2011). Moreover,  the 
remodeler binding to nucleosomes eventually causes DNA/Histone distortion and loosening 
that might allow for the later DNA translocase activity for required for the DNA bulge 
creation (Lorch et al., 2010).  
On the other hand the accessory domains (at the C and N termini) of each remodeler contain 
regulatory regions. For instance, the N-terminal domain in the CHD protein CHD1 changes its 
conformation and facilitates the binding of the ATPase catalytic region to promote correct 
remodeling activity (McKnight et al., 2011). The action of such accessory domains is to 
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provide the appropriate specificity for nucleosomes and to inhibit ATP hydrolysis in the 
absence of an adequate substrate (Mueller-Planitz et al., 2013). Moreover, some Snf2 family 
remodelers present domains such as SANT and SLIDE DNA binding domains (Ryan and 
Owen-Hughes, 2011) that recognize the nucleosomal entry site and its adjacent linker. Such 
domains improve ATPase catalysis activity by the remodeling factor through anchoring it on 
DNA and increasing the chances for the exertion of a translocase activity (Dang and 
Bartholomew, 2007; Yamada et al., 2011).  
To conclude, the sequence diversity of Snf2 family ATP-dependent chromatin factors 
suggests different and specific functions exerted by the ATPase catalytic domain (Flaus and 
Owen-Hughes, 2011). 
C. The functional output of ATP-dependent chromatin remodeling 
factors on nucleosome positioning 
1. Nucleosome positioning in the genome 
As previously discussed, nucleosome chemical histone modifications and histone composition 
play an essential role in gene transcription regulation. A third essential aspect adds to the 
complexity of the genome access control, which is the nucleosome positioning across the 
genome. So how are nucleosomes positioned across the genome? 
It has been long debated on whether the deposition of nucleosomes across the genome occurs 
in a random or rather a defined manner. Genome-wide mapping of nucleosome positioning 
has deepened our understanding of nucleosome deposition across the genome. One of the first 
organisms where a CHIP-seq based high-resolution nucleosome mapping was conducted was 
the yeast Saccharomyces cerevisiae (Albert et al., 2007). In later studies, the nucleosome 
positioning of other organisms such as Drosophila melanogaster and humans have been 
published (Barski et al., 2007; Mavrich et al., 2008).  
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The exploration of such nucleosome positioning maps revealed a Gaussian distribution of 
nucleosomes around specific gene loci (reviewed in (Jiang and Pugh, 2009)). In such 
distributions, nucleosomes show to adapt preferential positions, a phenomenon referred to as 
nucleosome phasing. These positioned nucleosomes show equal spacing from each other with 
short linker parts between them. The linker length can vary; long stretches of linkers with no 
nucleosomes are referred to as nucleosome free regions (NFRs). It was demonstrated that 
NFRs presence links the involvement of nucleosome positioning and organization in gene 
regulation (Jiang and Pugh, 2009). 
The nucleosome organization on genes in yeast showed the presence of phased nucleosomes 
around the TSS (transcription start site), with more random positioning further away 
(reviewed in (Jiang and Pugh, 2009)). The -1 nucleosome is located upstream the TSS and 
plays a role in the promoter accessibility. A 5’ NFR is located just downstream the -1 
nucleosome that is followed directly by a TSS. The +1 nucleosome is located after the TSS 
and showed to have the tightest position (highest phasing). The +1 nucleosome usually 
contains histone variants and histone tail modifications necessary for rapid eviction during 
transcription initiation. The more downstream nucleosomes start showing a less phased 
organization that continues covering the gene body until reaching a 3’ NFR where 
transcription termination takes place (Figure 27).  
 
Figure 27 Nucleosome organization on yeast genes 
Moreover, in mammals nucleosome distribution was shown to change during differentiation 
(Teif et al., 2012). Teif et al. show that distinct nucleosome positioning profiles at important 
functional regulatory sequences are observed between different cell types (ES cells, NP cells 
Introduction  Chromatin remodeling factors 
67 
 
and Mouse fibroblasts). Moreover, the authors observed an increase in the NRL (Nucleosome 
Repeat Length) during differentiation, confirming the necessity of chromatin structure 
variations to assure the correct cell state. This observation also is concordant with the 
different studies that demonstrate that ES cells have a less compact chromatin compared to 
their differentiated counterparts.  
Several studies tried to explain the origins of nucleosome positioning (Gupta et al., 2008; 
Ioshikhes et al., 2006; Rando and Ahmad, 2007). It was proposed that nucleosome positioning 
across the genome could be a combination of a dual mechanism of independent and statistical 
positioning where nucleosomes are in a dynamic state (Jiang and Pugh, 2009). In this model, 
the presence of favorable sequences and unfavorable linker regions (NFRs) for nucleosome 
deposition creates this thermodynamic state responsible for the correct balance between 
transcription permissiveness and DNA inaccessibility. So how is the access to DNA 
regulated?  
Several studies proposed a non-catalytic site exposure of DNA on the nucleosome surface due 
to the presence of thermal DNA fluctuations (Polach and Widom, 1995, 1996). However, the 
access to deeper sequences within the nucleosome core requires the interference of chromatin 
remodeling enzymes. 
2. ATP-dependent nucleosome remodeling enzymes and nucleosome 
positioning 
The dynamic organization of the nucleosomes needs the presence of ATP-dependent 
chromatin remodeling enzymes. A number of studies have highlighted the importance of such 
enzymes in the nucleosomes positioning in both the goal of facilitating DNA accessibility and 
hindering the regulatory sequences inaccessible (Morris et al., 2014; Ramirez-Carrozzi et al., 
2009; Yen et al., 2012).  
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Several studies proposed a non-catalytic site exposure of DNA on the nucleosome surface due 
to the presence of thermal DNA fluctuations (Polach and Widom, 1995, 1996). However, the 
access to deeper sequences within the nucleosome core requires the interference of chromatin 
remodeling enzymes. 
It was shown that  inside genes, ATP-dependent remodelers pack nucleosomes into arrays 
with a specific distance from the TSS, leaving a 3’ NFR upstream and a 5’NFR downstream 
(Morris et al., 2014). MNase-CHIP experiments on a selection of Snf2 ATP-dependent 
chromatin remodeling factors in yeast showed the preferential binding of certain remodelers 
to specific nucleosome positions (Yen et al., 2012). According to Yen et al., ATP-dependent 
remodelers can be separated into three classes according to the nucleosomes they interact 
with:  Remodelers that mostly bind to the +1 nucleosome, remodelers that bind to 
nucleosomes in coding regions and are depleted on the +1 nucleosome and remodelers that 
bind NFR flanking nucleosomes. The authors further suggest that remodelers show an 
activation or inhibition of transcription characteristics depending on the directionality of 
nucleosome positioning according to the NFR. Remodelers that move nucleosomes towards 
NFR are generally considered repressive and remodelers that on the contrary move 
nucleosomes away from the NFR show transcription activation properties.  
A complementary study focused on the genome-wide positions of three essential Snf2 
chromatin remodelers (Brg1, Chd4 and Snf2h) (Morris et al., 2014). Similar distribution 
patterns on regulatory regions were observed for the three remodelers with specific slight 
remodeler-linked preferences, an observation already reported where remodelers showed 
similar gene regulatory profiles (Yen et al., 2012). The authors propose that this remodeler co-
localization might be due to a sequential binding events rather than direct interaction. Loss-of-
function of each remodeler followed by DHS profiling (DNase Hypersensitive Sites) showed 
a change in the DHS profile of the genome, with both lost and newly acquired DHS upon the 
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depletion of each of the three remodelers (Morris et al., 2014). This observation confirms the 
double role of remodelers in both opening and closing the chromatin. So such a co-
localization might reflect a cooperative mechanism where remodelers act together in order to 
position nucleosomes. Interestingly, recent studies have also highlighted the antagonistic 
remodeling events at specific sites and during specific processes especially for the two 
remodelers Brg1 (Snf2) and Chd4 (Curtis and Griffin, 2012; Gao et al., 2009; Ramirez-
Carrozzi et al., 2006).  
To conclude, it remains essential to understand the way remodelers are recruited to their 
specific sites. Such recruitment might be assured due to the presence of specific motifs for 
transcription factor clustering that attracts remodelers to regulatory element sites or it might 
be due to the presence of certain histone modifications (remodelers were shown to possess 
bromo/chromo domains that could recognize such modifications) (Hassan et al., 2002; Sims et 
al., 2005; Won et al., 2009). Another study links CpG rich promoters to remodeler 
independency, where such promoters are readily unstable and do not require remodeler 
interference (Ramirez-Carrozzi et al., 2009); on the other hand, their non-CpG counterparts 
require remodeling activity for transcription (where a more regulated gene expression is 
required). 
 
D. Chromatin Remodeling Complexes Function in ES cells 
ATP-dependent chromatin remodeling factors were shown to play important roles in the 
regulation of the particular chromatin landscape in ES cells. Most remodelers are a part of 
large complexes with variable subunit compositions. So what are the to-date remodeling 
complexes shown to have a role in ES cell state control? 
 
Introduction  Chromatin remodeling factors 
70 
 
 
1. The NuRD complex (encompassing Chd4)  
The NuRD complex (Nucleosome Remodeling and Deacetylase complex) is mainly 
composed of the core Mbd3 (Methyl-CpG binding domain protein 3) responsible for complex 
assembly (Kaji et al., 2006; Zhang et al., 1999), histone deacetylase subunits (HDAC1/2) and  
ATP-dependent chromatin remodeling subunits encompassing the Snf2 family remodelers 
Chd3 or Chd4 (also called Mi-2α and Mi-2β, respectively) (Lai and Wade, 2011; McDonel et 
al., 2009) responsible for the enzymatic activity of the complex. 
NuRD is characterized by its repressive functions through its capacity to deacetylate 
H3K27ac, where it was shown to trigger the recruitment of the PRC2 repressive complexes 
and the eventual deposition of the H3K27me3 repressive mark (Reynolds et al., 2012a). In ES 
cells, the Mbd3 subunit of NuRD was shown to be essential for differentiation rather than  the 
maintenance of the self-renewal state (Kaji et al., 2006). Through the analysis of Mbd3 loss-
of-function, the NuRD complex was shown to suppress the expression level of pluripotency 
genes to a certain level in order to permit the exit from the self-renewal state for lineage 
commitment (Reynolds et al., 2012b) (Figure 28). On the other hand, a more recent study 
(also based on Mbd3) shows that the NuRD complex can  play a positive facilitating role 
during the reprogramming to iPS cells of certain cell types (Santos et al., 2014). Interestingly, 
components of the NuRD complex were found to be a part of the Oct4 interactome, 
suggesting a  role in the transcriptional regulation of the ES cell genome (van den Berg et al., 
2010a; Pardo et al., 2010). More particularly, Chd4 (Mi-2β) was detected at promoters and 
gene bodies of pluripotency associated genes in ES cells (Reynolds et al., 2012b) .In addition 
to the central ATPase/Helicase unit, it consists of accessory regulatory domains that confer its 
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DNA/nucleosome binding activity (PHD fingers and chromodomains that recognize DNA and 
H3K4 methylation). 
Furthermore, Chd4 was shown to associate with the PRC2 component Ezh2, where it plays a 
dual role during neural differentiation (Sparmann et al., 2013). At the early neurogenesis 
stage, Chd4 recruits Ezh2 on astrogenic genes to repress astrogenesis; on the other hand, at 
the end of neurogenesis Chd4 localizes Ezh2 on neurogenic genes to repress neurogenesis and 
start astrogenesis. This dual role of a chromatin remodeling factor such as Chd4 illustrates 
how the same remodeling factor can be involved in different mechanisms during 
development. 
 
Figure 28 The role of NuRD in ES cells. NuRD balances the expression of pluripotency genes and differentiation genes  
in order to permit lineage commitment under the appropriate cues (Reynolds et al., 2012b) 
 
2. INO80 complex 
The INO80 complex is a large complex composed of different subunits including Ino80 and 
Snf2 remodeler responsible for the complex’s catalytic activity (Shen et al., 2000; Tosi et al., 
2013). The INO80 complex was shown to play an important role in the regulation of the 
distribution of the histone variant H2A.Z (Papamichos-Chronakis et al., 2011). This histone 
variant was shown to be particularly enriched at active and bivalent promoters in ES cells (Ku 
et al., 2012). Moreover, several RNAi screens identified Ino80 as a self-renewal regulator 
(Fazzio et al., 2008; Hu et al., 2009b).  
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 A more recent study highlights the special importance of Ino80 in the control of the ES self-
renewal (Wang et al., 2014). Wang et al. demonstrate that Ino80 exerts a direct regulation of 
the core pluripotency circuitry, even forming a kind of auto-regulatory loop with the master 
TFs. Furthermore, the authors show that Ino80 occupies pluripotency gene proximal regions 
where it interferes in the activation of such genes by preserving an open chromatin state 
facilitating the recruitment of Mediator and Pol II to such regions. On the other hand, Ino80 
was not detected on differentiation genes, suggesting a major role in ES cell self-renewal gene 
transcriptional control but not in the repression of differentiation genes.  Microarray 
transcriptomic analysis comparison in Ino80 depleted cells with ES cells depleted for any of 
the master TFs (Oct4/Sox2/Nanog) showed common deregulated gene profiles, further 
insisting on the role of Ino80 in the maintenance of the ES gene program within the core 
circuitry (Wang et al., 2014). 
3. esBAF complex (encompassing Brg1) 
BAF complexes have been show to play important roles in mammalian development (Chi et 
al., 2003; de la Serna et al., 2001; Lessard et al., 2007). This complex is composed of about 11 
subunits encompassing the Snf2 family ATP-dependent chromatin remodeling family with 
complex cell-specific diversity (Olave et al., 2002; Wang et al., 1996). In ES cells, esBAF is 
the specialized complex shown to be important in ES cell state maintenance (Ho et al., 
2009a). Ho et al. demonstrate that the knockdown of the catalytic subunit of esBAF (Brg1 or 
Smarca4) causes proliferative problems in ES cells represented by flattened colonies. 
However, the loss of the expression of the core pluripotency factors is not observed until 
about ten cell passages. Moreover, the authors show that Brg1 depleted cells were 
differentiation deficient, conferring the probable role of Brg1 in pluripotency as well. 
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Genome-wide analysis of Brg1 distribution using CHIP-seq revealed the colocalization of 
Brg1with the target genes of the core transcriptional regulatory network (Ho et al., 2009b). In 
addition, Ho et al. detect the colocalization of Brg1 with STAT3 and Smad1 gene targets. 
Moreover, the authors demonstrate that Brg1 can oppose the repressive effect of PcG. 
Interestingly, Brg1 acute depletion resulted in an increased expression in the core 
pluripotency TFs; in addition, the analysis of Brg1 gene targets showed that it works both in 
coordination and in opposition to the Oct4/Sox2/Nanog trio. Ho et al. speculate that Brg1 is 
required for the fine-tuning of the expression of the ES cell TFs in order to maintain a stable 
ES call state.   
A third study conducted by Ho et al. further illustrates the role of Brg1 in pluripotency 
maintenance through the establishment an accessible chromatin at STAT3 targets and 
opposing PcG action (Ho et al., 2011b). Strikingly, the authors demonstrate that Brg1 also 
acts synergistically with PcG at certain HOX gene loci. This gives Brg1 a dual role, where it 
can act synergistically or antagonistically with repressive complexes in order to maintain the 
ES cell state. Figure 29 illustrates the different roles of esBAF in ES cells.  
 
Figure 29 The different control mechanisms exerted by the esBAF complex in order to maintain ES pluripotency and 
self-renewal (Ho et al., 2011b) 
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The esBAF complex was also shown to facilitate the reprogramming to iPS cells by 
enhancing the binding of Oct4 to its target genes (Singhal et al., 2010) where an 
overexpression of esBAF subunits replaces the requirement for c-Myc.  
4. Chd1 
Chd1 is an Snf2 ATP-dependent chromatin remodeling factor belonging to the Snf-like group. 
Chd1 contains two chromodomains responsible for H3K4 methylation recognition (Sims et 
al., 2005) Chd1 is known to play roles in active transcription in the different eukaryotic 
organisms (Simic et al., 2003; Sims et al., 2007; Stokes et al., 1996).  Core transcription factor 
distribution revealed their binding on Chd1 regulatory elements (Chen et al., 2008a).  
Chd1 was demonstrated to be required for the maintenance of the open chromatin and the 
pluripotency of ES cells (Gaspar-Maia et al., 2009.). Gaspar-Maia et al. shown that the RNAi 
depletion of Chd1 affects the expansion of the ES cell, decreases clonogenic capacity and 
decrease in the Oct4 levels. Moreover, Chd1 is described to be a euchromatin protein 
(association with H3K4me3) that opposes the effect of heterochromatin formation and 
preserves the open chromatin state of ES cells. In addition, Chd1 was shown to increase the 
efficiency of reprogramming to iPS cells (Gaspar-Maia et al., 2009). However, Chd1 RNAi 
ES cells remain undifferentiated elucidating a rather complementary/redundant role for 
Chd1in the control of the ES cell state. 
5. Ep400 
The Ep400/Tip60 complex is composed of Ep400, an Snf2 ATP-dependent chromatin 
remodeling factor and Tip60 a histone acetyltransferase (HAT). An RNAi screen discussed 
previously in Chapter II revealed the importance of Ep400 in ES cells (Fazzio et al., 2008). 
Fazzio et al. showed that depletion of the Ep400/Tip60 complex strongly affected self-
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renewal and pluripotency. In addition, the KD of Ep400 effected the expression of about 802 
genes, where most of the upregulated genes are key developmental loci. Interestingly, Nanog 
knock down showed an overlap in the transcriptomic deregulation profile with Ep400 
suggesting a mutual regulation of a set of genes. Moreover, a strong correlation between 
H3K4me3 and Ep400 binding was observed both at active and silent genes (presenting the 
H3K27me3: bivalent genes) with highest binding at the most active genes. In addition, Nanog 
was shown to be indirectly involved in the binding of Ep400 to its target genes suggesting that 
the Tip60/p400 complex is important effector of Nanog transcriptional repression.  
6. Atrx 
Atrx (alpha thalassemia/mental retardation syndrome X-linked) was shown to be localized on 
pericentric heterochromatin regions and nuclear bodies in mouse primary embryonic 
fibroblasts (Ishov et al., 2004). In addition, Atrx was found to bind telomeric regions in ES 
cells during interphase and was demonstrated to interact with H3.3 histone variant to insure its 
proper deposition at telomeres (Wong et al., 2010). However, a very recent study 
demonstrates that Atrx’s role in H3.3 deposition is not exclusive to pericentric 
heterochromatin and telomeres but also occurs at heterochromatic repeats across the genome 
(Voon et al., 2015) . Voon et al. show that ATRX/H3.3 specifically localizes to silence 
imprinted alleles in mouse ES cells.  Moreover, Atrx plays an essential role in directing the 
binding of the repressive PRC2 complex to Xist RNA causing X chromosome inactivation 
(Sarma et al., 2014). This role in X chromosome inactivation highlights the importance of 
Atrx in ES cell differentiation where imprinting is a crucial process. The role of Atrx in ES 
cell state maintenance is less studied.  
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7. Other remodelers (Smarca5, Smarcad1, Chd1l) 
A number of other remodelers were less studied in the context of their role in ES cells but 
merit to be better analyzed.  
a. Smarca5 
Smarca5 was shown to be required during the preimplantation stage and ES cell deficient for 
Smarca5 fail to differentiate (Stopka and Skoultchi, 2003). Moreover, Smarca5 was shown to 
be a part of the Oct4 proteomic network in ES cells (van den Berg et al., 2010a). 
b. Smarcad1   
Few studies have examined the role of this remodeler. An RNAi and gene expression 
profiling screen identified Smarcad1 to contribute to ES cell state preservation (Hong et al., 
2009). Moreover, a genome wide Smarcad1 localization in embryonic carcinoma cells 
revealed its binding to active gene transcription start site conferring its probable role also in 
ES cells (Okazaki et al., 2008). 
c. Alc1 (Chd1l) 
Chd1l was shown to be a proteomic partner of Oct4 (van den Berg et al., 2010a). The 
depletion of Chd1l in ES cells causes severe proliferative problems suggesting its importance 
in self-renewal (Efroni et al., 2008). Interestingly, Chd1l contains a domain that recognizes 
PAR or poly-ADP ribose which is a posttranslational modification added to nuclear receptor 
proteins (Mohrmann and Verrijzer, 2005). This posttranslational modification was shown to 
be important during the initial steps of reprogramming to iPS cells, where PARP1 protein was 
shown to interact with Chd1 through its PAR domain (Jiang et al., 2015). Moreover,  CHIP 
analysis suggest that PARP1 and Chd1l co-occupy key pluripotency gene loci (Jiang et al., 
2015). 
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Background and Objectives          
 
 
Several studies have shown the importance of a number of ATP-dependent chromatin 
remodeling factors in the control of the ES cell state and differentiation. However, no global 
view of how these factors are recruited onto the mammalian genome was conducted. 
In this work, we try to deal with several aspects regarding the role of Snf2 family of ATP-
dependent chromatin remodeling factors in the transcriptional regulation of the mouse ES cell 
genome. Primarly, we focus on the distribution of remodelers in the genome, more precisely, 
on proximal (promoters) and distal regulatory (enhancers and CTCF-binding sites) DNA 
elements. Next, we try to understand whether remodelers are differentially recruited to 
specific target genes and how they integrate promoter nucleosomal architecture to regulate ES 
cell transcription programs. Further on, we analyze the extent by which chromatin remodeling 
factors contribute to the transcription networks that control ES cell pluripotency and self 
renewal. 
We conducted a genome-wide analysis of the function of a selection of thirteen chromatin 
remodeling factors in the transcriptional control of the mouse ES cell state using mainly a 
double experimental strategy. First a ChIP-seq approach was used to identify the binding 
profiles of remodelers across the regulatory elements of the genome. Next, we performed 
loss-of function transcriptional analysis to reveal specific functional roles of remodelers in the 
ES cell transcriptional regulation.  
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Part I 
Article 1: Genome-wide nucleosome specificity and function of 
chromatin remodellers in embryonic stem cells  
(article in review) 
 
 
Maud de Dieuleveult
1
*, Kuangyu Yen
2,3
*, Isabelle Hmitou
1
*, Arnaud Depaux
1
*, Fayçal 
Boussouar
1,4
, Daria Bou Dargham
1
, Sylvie Jounier
1
, Hélène Humbertclaude
1
, Florence 
Ribierre
5
, Céline Baulard
5
, Céline Keime
6
, Lucie Carrière
1
, Soizick Berlivet
1
, Marta Gut
7
, Ivo 
Gut
7
, Michel Werner
1
, Jean-François Deleuze
5
, Robert Olaso
5
, Jean-Christophe Aude
1
, 
Sophie Chantalat
5
, B. Franklin Pugh
2
, Matthieu Gérard
1
 
 
* These authors contributed equally to this work 
Correspondence and requests for materials should be addressed to M.G. 
(matthieu.gerard@cea.fr), K.Y. (kuangyuyen@gmail.com), or B.F.P. (bfp2@psu.edu) 
 
Affiliations: 
1
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, CEN 
Saclay, 91191 Gif-sur-Yvette, France 
Results  Part I 
80 
 
2
Center for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, 
The Pennsylvania State University, University Park, Pennsylvania 16802, USA.  
3
Present address: Department of Cell Biology, Southern Medical University, Guangzhou 
510515, PR China 
4
Present address : INSERM, U823, Université Joseph Fourier - Grenoble 1, Institut Albert 
Bonniot, Faculté de Médecine, La Tronche, France 
5
Centre National de Génotypage, Institut de Génomique, CEA, Evry, France 
6
IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), INSERM, U964, 
CNRS, UMR7104, Université de Strasbourg, 67404 Illkirch, France 
7
Centre Nacional D'Anàlisi Genòmica, Barcelona, Spain 
 
  
  
Results  Part I 
81 
 
 
Summary 
How various ATP-dependent chromatin remodellers bind to nucleosomes to regulate 
transcription is not well defined in mammalian cells. Here, we present genome-wide 
remodeller-interacting nucleosome profiles for Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 
and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind to nucleosomes at 
specific positions, either at one or both nucleosomes that flank each side of nucleosome-free 
promoter regions (NFRs), at enhancer elements, or within gene bodies. Surprisingly, large 
NFRs that extend downstream of transcriptional start sites are nevertheless chromatinized 
with non-nucleosomal histone modifications and variants. Thus, RNA polymerase II must 
navigate several hundred bp of noncanonical chromatin at the 5’ ends of these genes. At 
promoters, bidirectional transcription commonly initiates on the flanks of remodeller-bound 
nucleosomes that reside at NFR boundaries. Transcriptome analysis upon remodeller 
depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. At 
active genes, certain remodellers are positive regulators of transcription, whereas others act as 
repressors. At bivalent genes, which are bound by repressive Polycomb complexes, the same 
remodellers act in the opposite way. Together, these findings reveal how remodellers integrate 
promoter nucleosomal architecture to regulate ES cell transcription programs. 
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Main Text 
Embryonic stem (ES) cell pluripotency and differentiation are controlled by the coordinated 
action of multiple epigenetic factors that affect the structure of chromatin and regulate gene 
expression. Chromatin remodelling, mediated by the Snf2 family of ATP-dependent 
chromatin remodellers, is a key factor in these processes
1-5
. These remodellers are classified 
in 24 subfamilies that regulate transcription, DNA repair and DNA replication
6-9
. In yeast, 
remodellers interact with specific nucleosome positions at promoters and induce directional 
sliding of nucleosomes
10,11
. Remodellers also catalyze nucleosome destabilization and 
eviction at DNA regulatory elements
12-14
. These activities regulate access to DNA for 
transcription activators, as well as for the general TFs and RNA polymerase (pol) II, 
ultimately allowing or preventing the formation of the preinitiation complex (PIC) at 
promoters
15-17
. Subsequent transcription by pol II occurs in two phases. The first phase occurs 
at the 5’ ends of genes and is marked by serine 5 phosphorylation (S5ph) of pol II, histone H3 
lysine 4 trimethylation (H3K4me3), and transcriptional pausing of pol II
18-21
. The second 
phase occurs downstream in the 3’ direction, and is marked by pol II S2ph, H3K36me3, and a 
lack of pausing
18-21
. 
  In mouse ES cells, several remodellers are essential for the regulation of pluripotency 
and differentiation
1-5
. However, it is unclear whether mammalian remodellers target specific 
nucleosomes to regulate transcription. To explore this, we applied the genome-wide factor-
nucleosome interaction assay
10,22
 (remodeller MNase-seq) to ES cells. We first engineered an 
affinity tag onto individual remodellers at their endogenous loci. Proteins were then 
formaldehyde-crosslinked to chromatin in vivo, MNase digested to release individual 
nucleosomes, then immunoprecipitated sequentially with two distinct antibodies against the 
tag, using a tandem affinity protocol (Extended Data Fig. 1a). DNA fragments 
immunoprecipitated with each remodeller were then identified by deep sequencing.  
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Positionally-linked and positionally-independent remodellers 
Since nucleosomes in cultured cell populations tend to have fuzzy positioning (not well 
resolved from each other), we began our analysis by examining 500 bp of remodeller-
enriched genomic intervals, then subsequently focused on individual nucleosome positions. 
We employed Pearson Correlation to examine the connections between the remodellers, pol 
II, selected histone marks, and TFs (Fig. 1a). We focused on DNase I hypersensitive sites 
(DHSs), which reveal promoters and distal regulatory elements such as enhancers
23
. High 
correlation scores were observed among the remodellers Brg1, Ep400, Chd1, Chd4, Chd6 and 
Chd8, as well as with the mediator (Med1), suggesting that these factors tend to occupy the 
same genomic regions in ES cells.  
In contrast, Chd9 and Chd2 generally did not occupy the same nucleosomes as these other 
remodellers, nor with each other (Fig. 1a), although they did interact with nucleosomes that 
Chd1 interacted with. Chd2 was the only remodeller associated with the transcription 
elongation-associated histone mark H3K36me3, and thus may be enriched in gene bodies and 
depleted near transcription start sites. One potential reconciliation of these results is that Chd9 
and Chd2 target different nucleosomes on the same genes (e.g. 5’ versus the inside of 
transcription units), with Chd1 extending across both types.  
Ep400, Chd8, and Chd1 had correlated occupancies with pol II ser5ph (Fig. 1a), indicating 
that they may be present at the 5’ end of genes that are transcriptionally active and/or paused. 
However, when we examined the pluripotency-associated transcription factor (pTF) 
Oct4/Pou5f1, which is active in ES cells, it tended to be associated with Brg1 and Chd4. This 
contrast suggests that stem cell-specific TFs work with a largely distinct cadre of remodellers 
compared to the general transcription machinery. 
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A specific analysis of active promoter regions within the DHSs revealed that most 
remodellers were correlated to varying degrees with components of the general transcription 
machinery, including pol II S5ph and TBP (Fig. 1b). A similar focus on enhancers confirmed 
the tight association of Brg1 and Chd4 with pTFs Oct4/Pou5f1, Sox2 and Nanog (Extended 
Data Fig. 2). Inspection of remodeller distributions at individual genes confirmed their 
widespread binding to promoters and enhancers, and specifically for Chd2, within transcribed 
units (Fig. 1c). 
In this study, we chose to focus our analysis on remodeller function at promoters. To visualize 
in more detail where remodellers bind to around promoter regions, we examined their 
distribution around transcriptional start sites (TSSs). Locations were then sorted according to 
the local H3K4me3 signal, which is a mark of transcriptional activity (Fig. 1d). Remarkably, 
some remodellers like Brg1, Chd4, Chd6 bound similarly to all active genes, regardless of 
their H3K4me3/transcription level, while others, such as Chd1, Chd2, Chd9 and Ep400, were 
tightly linked to H3K4me3/transcription levels (Fig. 1d and Extended Data Fig. 3). Chd8 had 
a distribution pattern intermediate between these two groups. 
Chd1 and Chd2, which are both related to S. cerevisiae (yeast) Chd1, showed strikingly 
different distributions. Whereas Chd1 is present near the 5’ ends of genes, Chd2 enrichment 
pattern starts a few hundred base pairs downstream of the TSS, encompasses the entire 
transcription unit, and decreases to background levels at the transcription termination site 
(Fig. 1c, d). This is consistent with how yeast Chd1 works
24,25
, and thus mammalian Chd2 
and yeast Chd1 may be functionally equivalent.  
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Promoters are embedded in noncanonical chromatin, which is bordered by remodeller-
bound nucleosomes 
Since our assay detects primarily remodellers that are bound to nucleosomes, we next 
investigated more closely the relationship between individual remodeller-bound nucleosomes 
and promoter regions. We took advantage of a published dataset
26
 to generate a reference 
nucleosome map for ES cells. Their use of MNase and size-selection ensured that native 
structures of fully assembled nucleosome were being reported. We first delimited for each 
gene their 5’ nucleosome free region (NFR), which is a hallmark of promoters
27
. We aligned 
nucleosomes to the midpoint of these NFRs, which we define here as the half-way distance 
between the two MNase-defined nucleosomes that flank an annotated TSS. Nucleosomal 
patterns were then sorted by NFR length (Fig. 2a). We observed that Brg1, Chd1, Chd4, 
Chd6, Chd8 and Ep400 targeted specific nucleosomes that bounded both sides of the NFR. 
These nucleosomes also represent the boundaries of CpG islands (CpGIs), as reported 
previously
28
 (Fig. 2a). A comparison of our Chd4 dataset with a ChIP-seq dataset previously 
obtained using sonicated chromatin
29
 showed that the tandem MNase ChIP-seq allows a far 
better resolution of the nucleosome positions bound by this remodeller and further validates 
this experimental approach (Extended Data Fig. 1d). Moreover, the sonication-based method 
demonstrates that Chd4 is not bound within NFRs in a non-nucleosomal manner. 
The pattern of remodeller-bound nucleosomes contrasted with TSSs, which generally stayed 
towards the upstream side of the NFR (i.e., distal to gene bodies) (Fig. 2a). GRO-seq 
transcripts
30
, which measure the location and direction of engaged pol II, tracked with 
annotated TSSs, and revealed previously described divergent noncoding transcripts
20,31
 
located at a fixed distance upstream of the TSS.  
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When DHSs were examined, they matched the more narrow positions of annotated TSSs, 
rather than reflecting the dimensions of NFRs. DHSs may represent relatively open accessible 
promoter/enhancer regions within NFRs since they are digested by both DNase I and MNase. 
(The former releases accessible DNA fragments generating a positive signal, whereas the 
latter destroys them thereby generating a negative signal.). The rest of the NFR may contain 
chromatin (being DNase I resistant), but may not be forming canonical nucleosomal structures 
(being MNase sensitive). We also probed these promoter regions using FAIRE 
(Formaldehyde Assisted Isolation of Regulatory Elements) method
32
, and observed that the 
FAIRE signal was concentrated at the level of DHSs, but absent in the 3’ part of the NFR 
(Fig. 2b). Thus, accessible promoter regions may be of fixed size and embedded on the 
upstream edge of islands of remarkably noncanonical chromatin. 
To test this idea, we examined the distribution of histone marks and variants
33,34
 in NFRs, 
measured by standard ChIP-seq. Remarkably, histone variant H3.3 was enriched both at 
nucleosomes flanking NFRs and inside NFRs, whereas H2A.Z, as well as histone marks 
H3K4me3 and H3K27ac were enriched primarily on the downstream half of NFRs (Fig. 2b). 
The CpG-rich NFR regions immediately downstream of the TSS are thus located within 
noncanonical chromatin containing H3.3 and H2A.Z. 
To identify more precisely the nucleosome organization of remodellers surrounding NFRs, we 
divided genes into two different classes based on the length of the promoter NFR: class 1 
(short NFR) and class 2 (large NFR), (Fig. 2a). Each of these two main classes was further 
subdivided into two subclasses: class 1a (NFR < 15 bp), class 1b (15-115 bp NFR), class 2a 
(116-504 bp), class 2b (505-1500 bp). At the short class 1 NFRs, Ep400 and Chd4 crosslinked 
predominantly to the two nucleosomes flanking the TSS, at positions -1 and +1 (Fig. 2a and 
3). Chd6, Chd8 and Brg1 interacted predominantly with the +1 position, and at lower levels 
with -1 and -2. Chd1 was also enriched at +1, and had a diffuse distribution on several 
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additional nucleosomes on both sides of the TSS, but had diminished interactions at the -1 
position (Fig. 2a and 3). Thus, the first nucleosome (+1 position) encountered by pol II after 
release from the pause state is one that is highly enriched with remodellers. These remodellers 
might play a role in the passage of pol II through these nucleosome barriers. 
At the larger class 2 NFRs, Ep400 and Chd4 were preferentially bound to -1, and relatively 
less to +1 position. More strikingly, Chd6, Chd8 and Brg1 had shifted from their preferential 
binding to +1 at short NFRs toward a predominant enrichment at -1 position at large NFRs. 
Thus, mammalian remodellers interact with nucleosomes in a position-specific manner, with a 
distribution pattern adapting to NFR size. 
To more closely explore the relation between the binding of remodellers to specific 
nucleosomes and to transcription initiation, we compared their positioning with 
transcriptionally engaged pol II (defined by GRO-seq) (Fig. 2a and Fig. 3). We observed that 
where NFRs were small, pol II that was initiated/paused in the sense direction was flanked by 
remodeller-interacting nucleosomes -1 and +1. However, antisense pol II accumulated as a 
peak present upstream of the -1 position. Thus, remodeler-bound -1 nucleosomes are 
boundaries between sense and antisense pol II (Fig. 3, top panels). Intriguingly, the peak of 
DHSs coincided with the -1 position in the short NFR promoter category. As the TSS either 
overlaps or is very close to the -1 position, the Ep400 and Chd4 remodellers that bind this 
nucleosome might be required for its destabilization, ejection or repositioning to regulate 
sense and antisense preinitiation complex (PIC) formation.  
In contrast to short NFRs, large NFR promoters had DHS peaks and the midpoint between 
sense and antisense pol II residing downstream of -1, near the 5’ part of the NFR. This is 
precisely at the location where we detect a minor population of remodeler-bound nucleosomes 
(asterisk in Fig. 3). It is thus remarkable that for all categories of promoters, bidirectional 
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transcription initiates on either side of remodeller-bound nucleosomes. These nucleosomes are 
highly accessible, in that they are readily released by DNase I and correspond to the peak of 
DHSs (Fig. 2a and Fig. 3). 
Control of ES cell transcriptome by remodellers 
While virtually all transcribed genes in ES cells are marked by H3K4me3 at the promoter, a 
subset of less active genes is marked by a combination of H3K4me3 and H3K27me3, defining 
them as bivalent
35-37
 (Fig. 1d). Bivalent genes were bound by remodellers with three distinct 
patterns: i) Chd4, Chd6 and Brg1 bound these genes with similar intensities as non-bivalent 
H3K4me3-only (hereafter referred to as H3K4me3) genes, ii) Ep400 and Chd8 showed 
substantially lower enrichments at bivalent promoters, but were nevertheless bound to most (> 
95 %) of them, iii) Chd1 and Chd9 were bound at low levels to fewer than half of the total 
number of bivalent promoters (Extended Data Fig. 3 and 4). To investigate how the 
remodellers bound at these distinct classes of genes are involved in transcription regulation, 
we profiled mRNA expression in ES cells depleted of each remodeller using shRNA vectors 
(Extended Data Fig. 1a and 5). For Brg1, we took advantage of a published dataset obtained 
using cells depleted of Brg1 by genetic ablation
38
.  
We observed that Chd4, Ep400 and Brg1, among the tested remodellers, were the most 
required for transcriptional regulation in ES cells, in both the H3K4me3 and bivalent 
categories (Fig. 4). Ep400 and Chd4 were primarily involved in transcriptional activation of 
H3K4me3 promoters, whereas Brg1 showed a preferential involvement in transcription 
repression in this category (Fig. 4a). At bivalent promoters, Ep400 and Chd4 were mostly 
involved in transcriptional repression (Fig. 4b). In contrast, the dominant activity of Brg1 at 
bivalent genes was to counteract transcriptional repression, underlining a previously identified 
anti-silencing function associated with this remodeller
38
. 
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Loss-of-function of the other remodellers resulted in more limited changes in gene expression. 
Chd1 depletion triggered the down-regulation of genes with H3K4me3 promoters, whereas 
bivalent genes were much less affected (Fig. 4a). Loss of Chd6 and Chd8 function resulted 
each in similar numbers of up- and down-regulated genes with H3K4me3 promoters, showing 
that they are equally involved in positive and negative modulation of this category. However, 
bivalent target genes were mostly up-regulated, suggesting that Chd6 and Chd8 are 
principally transcription repressors at these loci. We validated the results of this analysis by 
RT-qPCR using two different shRNA vectors for each remodeller (Extended Data Fig. 6 and 
Methods).  
Relationships of NFR size and CpG islands with remodeller function 
CpGIs were previously proposed to be a major determinant of remodeller requirements in 
transcriptional control
39
. We wondered how NFR length and CpG content could influence 
remodeller-mediated transcription regulation of genes with H3K4me3 and bivalent promoters. 
We thus compared the percentages of genes either down- or up-regulated by loss of function 
of each remodeller in the following two groups: 1) NFR length classes subdivided into 
H3K4me3 and bivalent subclasses (Fig. 5a); 2) mouse genes divided into four quartiles based 
on GC/CpG content at promoters (GC/CpG class 1, 2, 3, 4: low, moderate, intermediate, high, 
see Extended Data Fig. 7), then further subdivided into H3K4me3 and bivalent subclasses 
(Fig. 5b).  
We focused our analysis on Chd4, Ep400 and Brg1, which, among the studied remodellers, 
are the most involved in transcriptional control. At H3K4me3 promoters, Chd4 and Ep400 
were the most frequently required for the transcriptional activation of genes with short NFRs, 
suggesting that these remodellers stimulate transcription by destabilizing or repositioning 
nucleosomes at these densely occupied promoters (Fig. 5a). Accordingly, Chd4 function was 
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more often essential for the transcriptional activation of genes with CpG-poor promoters than 
those with CpG-rich promoters (Fig. 5b). 
At bivalent promoters, at which Chd4 and Ep400 are potent transcription repressors, the 
repression of large NFR/high CpG content promoters was more frequently dependent on 
Chd4 and Ep400 function, compared to short NFR/low-CpG content promoters (Fig. 5a,b). 
These two remodellers might be involved in the stabilization or repositioning of labile 
nucleosomal particles within the NFR. 
In contrast to Chd4 and Ep400, genes having short NFRs and/or low CpG content were 
relatively repressed by Brg1, and those having long NFRs and/or high CpG content were 
relatively activated, regardless of whether they were of the H3K4me3 class or bivalent (Fig. 
5a,b). These regulatory properties of Brg1 in ES cells contrast with those previously reported 
for Brg1 and Brm in the regulation of inflammation-induced genes in macrophages
39
. At those 
genes, Brg1/Brm function was preferentially required for transcriptional activation at a subset 
having non-CpGI promoters, and thus short NFRs with dense nucleosome occupancy. In ES 
cells, an equivalent function in remodeller-dependent transcription activation of H3K4me3, 
non-CpGI promoters is supported by Ep400 and Chd4, but not by Brg1.  
 
Conclusion 
The results presented here paint three contrasting stereotypes of remodeller control of gene 
expression in mouse ES cells (Fig. 5c), although not all genes fall into these stereotypes. 
First, at active (H3K4me3-only) genes with short NFRs, the upstream (-1) and downstream 
(+1) flanking nucleosomes are engaged with positive-acting Chd4 and Ep400. The 
downstream +1 nucleosome is engaged with negatively acting Brg1, as well as Chd1, Chd6 
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and Chd8. Further downstream, where transcription-linked H3K36me3 is found, so too is 
Chd2. Conceivably, Chd2 may be utilizing the H3K36me3 mark to organize nucleosomes 
analogously to Chd1 or Isw1b in budding yeast
25
. 
The second type of organization is at active genes with large NFRs, in which the TSS is 
present in a region of low nucleosomal occupancy, within the 5’ part of a CpGI. While NFRs 
are larger, they are nevertheless mostly chromatinized. There, Chd4 and Ep400, which are 
engaged with the upstream -1 nucleosome, are less frequently required for transcription 
activation than at short NFR promoters. However, Brg1, which is preferentially engaged at -1 
position at these large NFRs active promoters, is now mostly involved in transcriptional 
activation. 
The third stereotypic organization is at bivalent genes, which often have a large NFR and 
CpGI, and which are epigenetically marked by Polycomb Repressive Complex (PRC) 2. 
Since repression of transcription by PRC2 is only effective in differentiating, but not in self-
renewing ES cells
40
, a possible function of Chd4 and Ep400 might be to keep bivalent genes 
repressed in ES cells until differentiation initiates. In contrast, Brg1 also predominates at -1 
nucleosomes at these promoters, and is activating rather than inhibiting. This function of Brg1 
might be required to keep a certain level of transcription at bivalent genes, preventing a fully 
repressed status.  
Thus, we have two types of reciprocal relationships among chromatin remodellers at non-
bivalent and bivalent gene classes: 1) An activating remodeller in one class is an inhibitor 
remodeller in the other class; 2) Within the same class, an activating remodeller can be 
counteracted by an inhibitor remodeller.  
Taken together, the work presented here reveals that the various remodellers in mouse ES 
cells work together. They do so in a position-specific manner, organizing nucleosomes and 
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regulating gene expression either positively or negatively depending on 
nucleosomal/chromatin architecture flanking the core promoters. 
 
METHODS  
Full Methods are available in the Supplementary Information section. 
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Figure LEGENDS 
 
Figure 1. Binding of ATP-dependent remodellers to cis-acting regulatory sequences on the ES 
cell genome 
a, Heat map representing Pearson correlations between remodellers, DNase I hypersensitivity 
(DNase-seq), histone marks, Oct4 (Pou5f1), mediator (Med1) and Pol II S5ph at 138,582 
genomic regions centred on DHSs. b, Similar as in (a) but for 16,300 promoter-like, 
H3K4me3-, TBP- and Pol II S5ph-positive DHSs. c, Binding profiles at a representative 
locus. Counts indicate reads per 10 millions. Promoters and enhancers are highlighted by blue 
and yellow squares, respectively. d, Heat-map representation of ChIP-seq binding for 
remodellers at 14,623 RefSeq promoters, rank-ordered from highest to lowest H3K4me3 
deposition level. Color intensity represents sequencing tag counts. For each promoter, 
remodeller occupancy is indicated within a 10 kb window centred on the TSS. All promoters 
are transcribed from left to right. RNA expression level of the corresponding genes is 
indicated on the right (color intensity reflects expression level).  
 
Figure 2. Remodellers target specific nucleosomes on both sides of promoter NFRs  
Remodeller-bound nucleosomal tags were aligned to the promoters of 14,623 RefSeq genes 
rank-ordered from smallest to largest NFR length. Remodeller occupancy and other features 
are indicated within a 4 kb window centred on mid-NFR. a, Panels show from left to right : 
reference nucleosome map in grey with positions of TSSs in green, presence of CpG islands, 
DNase I hypersensibility (red) superposed with reference nucleosome map, pol II (GRO-seq 
signal) engaged in sense (blue) and antisense (red) transcription, and the tandem ChIP 
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MNase-seq signal for each remodeller. Color intensity represents sequencing tag counts. Chd2 
did not crosslink with any particular nucleosome position in the promoter regions. Chd9 
exibited a restricted number of specific binding sites at promoters, and thus shows no clear 
preference for particular nucleosome positions. The delimitation of the four subclasses of 
promoters defined by NFR length are indicated by dashed lines. b, same as in (a) for histone 
variant H3.3, histone marks H3K4me3, H3K27me3, H3K27ac, H2A.Z, and FAIRE-seq 
signal. 
 
Figure 3. Bidirectional transcription initiates on either side of remodeller-bound nucleosomes  
Average binding profiles of remodellers at active (H3K4me3-only) promoters with short 
NFRs (left, subclass 1b from Fig. 2) and large NFRs (right, subclass 2b). The top panels show 
in grey the reference nucleosome map (derived from MNase-seq data). Tags from reference 
nucleosomes, remodeller-interacting nucleosomes and GRO-seq were aligned to -1 and +1 
nucleosome dyad positions, and plotted upstream or downstream of these reference 
nucleosomes. Distances (bp) are indicated from -1 and +1 dyad positions. A gap in the NFR 
was introduced to normalize variations in NFR length inside each class. Sense and antisense 
pol II, which are defined by GRO-seq signal, are indicated as blue and red dashed lines, 
respectively. Asterisks point to remodeller-bound nucleosomes that were not detected in the 
reference ES cell map. 
 
Figure 4. Remodellers differentially regulate active versus bivalent genes 
The transcriptome of ES cells depleted of each remodeller was analyzed by microarray 
hybridization. The number of genes either down-regulated (dark grey) or up-regulated (light 
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grey) following the depletion of each remodeller was defined for genes transcribed from 
H3K4me3 promoters (a), and for genes with bivalent promoters (b), using a 1.5 fold-change 
threshold. Statistical analysis was performed using a 2-sample test for equality of proportions 
with continuity correction. * P < 0.05, ** P < 0.01, *** P < 0.001. 
 
Figure 5. Remodellers distinctively control the transcription of genes having either large NFR, 
CpGI-rich, or small NFR, CpGI-poor promoters  
a, b. The percentages of genes down-regulated and up-regulated by remodeller depletion in 
ES cells were determined for each of the indicated subgroups. a, Genes were divided in 4 
subclasses based on NFR length at the promoter, as defined in Fig. 2. Each of these subclasses 
was further divided in two categories with H3K4me3 or bivalent promoters. Statistical 
analysis of small NFRs (class 1a) versus large NFRs (class 2b) is shown in black and grey for 
genes down- and up-regulated by remodeller depletion, respectively. Statistical analysis was 
performed as in Fig. 4. * P < 0.05, ** P < 0.01, *** P < 0.001. b, Genes were divided in 4 
classes based on GC/CpG content at the promoter (Extended Data Fig. 7), and analyzed as in 
(a). Statistical analysis was carried out to compare GC/CpG class 1, which is composed of 
genes with CpGI-poor promoters, and CpG class 4, which is CpGI-rich. c, Model illustrating 
the binding patterns and transcriptional control exerted by remodellers at H3K4me3 
promoters with either short or large NFRs, and at bivalent genes. Several of the Chd-named 
remodellers are designated by their number only. 
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SUPPLEMENTARY INFORMATION 
EXTENDED DATA Figure LEGENDS 
 
Extended Data Figure 1: MNase-ChIP-seq of tagged ATP-dependent remodellers in ES cells 
a, Experimental strategy. Using homologous recombination in ES cells, a sequence encoding 
a combination of FLAG and hemagglutinin (HA) epitopes was introduced at the 3’ end of the 
coding sequence of the genes encoding the catalytic subunit of each remodeller. After in vivo 
crosslinking, chromatin was prepared and fragmented to mononucleosomes by MNase. 
Remodeller-bound mononucleosomes were isolated using a double immunoaffinity 
procedure. Immunopurification efficiency was assessed by Western Blotting. Deep 
sequencing of the DNA from purified nucleosomes allowed the mapping of remodeller-bound 
nucleosomes across the mouse genome. The same tagged ES cell lines were used for shRNA-
mediated depletion of remodellers and transcriptome analysis. b, Scheme of the remodellers 
tagged in this study, with known domains: Chromo, (Chromatin organization modifier) 
domain; PHD, (Plant Homeo Domain) finger; BRK domain; Bromo, bromodomain; Helicase, 
Helicase conserved C-terminal domain; SNF2, SNF2 family N-terminal domain, which 
contains the ATP-binding domain. c, Tagging of remodellers does not alter ES cell 
pluripotency. ES cell colonies tagged for the indicated remodellers were assayed for alkaline 
phosphatase activity. Colonies fully positive, partially positive, and negative for alkaline 
phosphatase activity were scored as undifferentiated, mixed, and differentiated, respectively. 
Results show the average and s.d. of the percentages of ES cell colonies belonging to each 
category in three independent experiments. d, Comparison of MNase ChIP-seq and sonication 
ChIP-seq for Chd4. The left panel shows the reference nucleosome map of 14,623 RefSeq 
genes, rank-ordered from smallest to largest NFR length, as in Fig. 2. On the right are 
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compared the distribution patterns obtained for Chd4 either by MNase ChIP-seq, with 
chromatin prepared from Chd4-tagged ES cells, or by ChIP-seq with sonicated chromatin 
(dataset accession number: GSM687284). 
 
Extended Data Figure 2: Remodellers at enhancer elements 
Heat map representing Pearson correlations between remodellers, DNase I hypersensitivity 
(DNase), histone marks, Oct4 (Pou5f1), Sox2, Nanog and the mediator (Med1) at 25,547 
enhancer-like DHSs. 
 
Extended Data Figure 3: Relation between remodeller enrichment at promoters and RNA 
expression level 
Average binding profile of remodellers at promoters, divided in four quartiles based on RNA 
expression level of the corresponding genes. All promoters are transcribed from left to right. 
Promoter binding intensity of Chd1, Chd2, Chd9 and Ep400 at H3K4me3 promoters was 
correlated with RNA expression (see Methods). Accordingly, binding of these remodellers to 
bivalent promoters, which are transcribed at lower levels, showed a significant reduction 
compared to H3K4me3 promoters. In contrast, Chd4, Chd6, and Brg1 enrichment at 
promoters showed little correlation with the transcription level of the corresponding genes, 
and was only slightly lower at bivalent, compared to H3K4me3 promoters. 
 
Extended Data Figure 4: Nucleosome targeting by remodellers at H3K4me3-only and bivalent 
promoters 
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a, Remodeller-bound nucleosomal tags were aligned to the promoters of 6,481 active 
(H3K4me3 promoters) genes, rank-ordered from smallest to largest NFR length. Reference 
nucleosome map, remodeller occupancy and the other indicated features are shown as in Fig. 
2. b, same as in (a) for the promoters of 3,411 bivalent genes. 
 
Extended Data Figure 5: Western blot analysis of remodeller depletion by shRNA for 
transcriptome analysis 
ES cells tagged for each remodeller were transfected with the corresponding shRNA vector, 
or a control plasmid. After puromycin selection, ES cells were collected for RNA preparation 
and Western blot analysis. Three independent experiments were performed for each 
remodeller. Remodeller depletion was assessed using antibodies against FLAG or HA 
epitopes. Loading control: Gapdh. 
 
 
Extended Data Figure 6: Representative examples of genes regulated by chromatin 
remodellers in ES cells. 
Remodellers and histone marks enrichment profiles are shown as indicated on the left of each 
panel. A control ChIP profile, obtained with untagged ES cells, is shown for comparison. 
Scores indicate reads per 10 millions. On the right of each panel are shown the results of RT-
qPCR analysis that indicate how the RNA expression level of the corresponding genes is 
affected by remodeller depletion in ES cells. Two distinct shRNA vectors (shRNA1 and 
shRNA2, see Methods) were used for each remodeller. Scores on the y axis indicate the 
relative expression of the indicated genes compared to reference genes. 
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Extended Data Figure 7: Remodeller distribution at promoters in relation to GC/CpG content 
Heat-map representation of ChIP-seq binding for remodellers and transcription landmarks at 
6317 promoters, ordered by increasing GC content, as in (Fenouil et al, 2012), and centred on 
mid-NFR. Promoters in close proximity to other annotations were excluded from the analysis. 
All promoters are transcribed from left to right. Colour intensity represents sequencing tag 
counts. The limits of the four classes of increasing GC content are indicated by dashed lines. 
 
Extended Data Figure 8: Quality control of ChIP-seq replicate experiments 
Heat-maps showing each chromatin remodeller bound to its most enriched genomic binding 
sites in ES cells. These genomic regions were defined for all remodellers, except Chd2, by 
peak calling using SICER software (see Methods), and were ordered from most to less 
binding. For Chd2, the 2,500 genes the most bound by Chd2 are presented in the heat-map. 
Two independent experiments, replicate 1 and 2, are presented for each remodeller, in 
comparison with a control ChIP-seq experiment, realized with chromatin from untagged ES 
cells, and an unrelated dataset to control the specificity of each pattern. Rows are linked 
among heat maps that are adjacent to each other along the horizontal axis. For Chd4 and 
Brg1, publicly available datasets (GSM687284 and GSM359413, respectively) obtained by 
ChIP-seq with sonication-fragmented chromatin are shown for comparison. Distances are 
indicated in kb from the centre of each genomic region, or from the TSS for Chd2. 
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Extended Data Tables 
 
Extended Data Table 1. Sequencing experiments characteristics 
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Extended Data Table 2: Primers used in RT-qPCR experiments 
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SUPPLEMENTARY METHODS 
Cell line and ES cell culture  
Mouse 46C ES cells have been described previously
41
. 46C ES cells and their tagged 
derivatives were cultured at 37°C, 5% CO2, on mitomycin C-inactivated mouse embryonic 
fibroblasts, in DMEM (Sigma) with 15% foetal bovine serum (Invitrogen), L-Glutamine 
(Invitrogen), MEM non-essential amino acids (Invitrogen), pen/strep (Invitrogen), 2-
mercaptoethanol (Sigma), and a saturating amount of leukemia inhibitory factor (LIF), as 
described in reference
42
. 
Knock-in of a TAP-tag in the genes encoding the remodellers through homologous 
recombination in ES cells 
The recombineering technique
43
 was adapted to construct all targeting vectors for homologous 
recombination in ES cells. Retrieval vectors were obtained by combining 5’ miniarm 
(NotI/SpeI), 3’ miniarm (SpeI/BamHI) and the plasmid PL253 (NotI/BamHI). SW102 cells 
containing a BAC encompassing the C terminal part of the gene encoding the remodeller, 
were electroporated with the SpeI-linearized retrieval vector. This allowed the subcloning of 
genomic fragments of approximately 10 kb comprising the last exon of the gene encoding 
each remodeller. The next step was the insertion of a TAP-tag into the subcloned DNA, 
immediately 3’ to coding sequence. The TAP-tag was (FLAG)3-TEV-HA for Chd1, Chd2, 
Chd4, Chd6, Chd8, Ep400, Brg1, and 6His-FLAG-HA for Chd9. We first inserted the TAP-
tag and an AscI site into the PL452 vector, in order to clone 5’ homology arms as SalI/AscI 
fragments into the PL452TAP-tag vector. 46C ES cells were electroporated with NotI-
linearized targeting constructs and selected with G418. In all cases, G418-positive clones 
were screened by Southern blot. Details on the Southern genotyping strategy, as well as 
sequences of primers and plasmids used in this study are available upon request. Correctly 
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targeted ES cell clones were karyotyped, and the expression of each tagged remodeller was 
controlled by western blot analysis, using antibodies against FLAG and HA epitopes (see 
Extended Data Fig. 5). We also verified by immunofluorescence, using antibodies against 
FLAG and HA epitopes, that each tagged remodeller was properly localized in the nucleus of 
ES cells (data not shown).  
Assessment of pluripotency in tagged ES cell line 
ES cell lines expressing a tagged remodeller were all indistinguishable in culture from their 
mother cell line (46C). Pluripotency of tagged ES cell lines was verified by detecting alkaline 
phosphatase activity on ES cell colonies five days after plating, using the Millipore alkaline 
detection kit, following manufacturer’s instructions. Three independent experiments were 
performed for each tagged ES cell line. The results of these experiments are shown in 
Extended Data Fig. 1c. In addition, we verified by immunofluorescence that expression of the 
pluripotency-associated transcription factor Oct4/Pou5f1 was uniform in each tagged ES cell 
line (data not shown). 
Antibodies 
Antibodies used for western blot were as follows: 
Monoclonal antibodies anti-HA (H7, Sigma H3663) and anti-FLAG (M2, Sigma F1804), anti-
GAPDH (Abcam ab9485). 
Antibodies used for immunofluorescence : Oct4/Pou5f1 (Abcam ab9857), monoclonal 
antibodies anti-HA (HA.11, Covance MMS-101P), and anti-FLAG (M2, Sigma F1804). 
Tandem affinity purification of remodeller-nucleosome complexes 
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ES cells were fixed either with formaldehyde, or with a combination of disuccinimidyl 
glutarate (DSG) and formaldehyde, then permeabilized with IGEPAL, and incubated with 
micrococcal nuclease (MNase) in order to fragment the genome into mononucleosomes. This 
nucleosome preparation was next incubated with agarose beads coupled with an antibody 
anti-HA or anti-FLAG. Anti-HA-agarose (ref. A2095) and anti-FLAG-agarose  (ref. A2220) 
beads were purchased from Sigma. After a series of washes, tagged-remodeller-nucleosome 
complexes were eluted, either by TEV protease cleavage or by peptide competition. The 
eluted complexes were then subjected to a second immunopurification step, using beads 
coupled to the antibody specific of the second HA or FLAG epitope. After elution, DNA was 
extracted from the highly purified mononucleosome fraction, and processed for high-
throughput sequencing. As a negative control, chromatin from untagged ES cells was 
subjected to the same protocol to define background signal. A detailed version of this protocol 
is available on the protocol exchange website: http://dx.doi.org/10.1038/protex.2014.040. 
High-throughput sequencing of tandem ChIP samples 
After crosslink reversion, phenol-chloroform extraction and ethanol precipitation, the DNA 
from remodeller-nucleosome complexes was quantified using the picogreen method 
(Invitrogen) or by running 1/20e of the ChIP material on a High sensitivity DNA chip on a 
2100 Bioanalyzer (Agilent, USA). 5 to 10 ng of ChIP DNA were used for library preparation 
according to the Illumina ChIP-seq protocol (ChIP-seq sample preparation kit). Following 
end-repair and adapter ligation, fragments were size-selected on an agarose gel in order to 
purify genomic DNA fragments between 140 and 180 bp. Purified fragments were next 
amplified (18 cycles) and verified on a 2100 Bioanalyzer before clustering and single-read 
sequencing on a Genome Analyzer (GA) or GA II (Illumina), according to manufacturer’s 
instructions. Sequencing experiments characteristics are shown in Extended Data Table 1. 
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Analysis of gene expression in 46C ES cells by RNA-seq  
46C ES cells were amplified on feeder cells except for the last passage, at which cells were 
plated onto 60-mm dishes coated with gelatine, and grown to 70% confluence in D15 medium 
with LIF. Total RNA was extracted using an RNeasy Kit (Qiagen), and depleted of ribosomal 
RNA using the eukaryotic Ribominus kit (Invitrogen). RNA quality was verified on a 2100 
Bioanalyzer. Library preparation was performed using the Illumina total RNAseq sample 
preparation kit according to manufacturer’s instructions. After RNA fragmentation, reverse 
transcription and PCR amplification, single-read sequencing of 75 bp tags was carried out on 
a GA. 
In order to keep only sequences of good quality we retained the first 40 bp of each read and 
discarded all sequences with more than 10% of bases having a quality score below 20, using 
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Mapping of these sequences onto 
the mm9 assembly of mouse genome and RPKM computation were then performed using 
ERANGE v3.1.0 
44
 and bowtie v0.12.0 
45
. Briefly, a splice file was created with UCSC known 
genes and maxBorder=36. Then an expanded genome containing genomic and splice-
spanning sequences was created using bowtie-build and bowtie was used to map the reads 
onto this expanded genome. Then the ERANGE runStandardAnalysis.sh script was used to 
compute RPKM values following steps previously described
44
, using a consolidation radius of 
20kb. 
RNA preparation from ES cells depleted of each remodeller by shRNA 
We used the pHYPER shRNA vector for remodeller depletion in ES cells, as previously 
described
46
. shRNA design was performed using DESIR software 
(http://biodev.extra.cea.fr/DSIR/DSIR.html). Below are listed the shRNA selected for each 
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remodeller. The sense strand sequence is given; the rest of the shRNA sequence is as 
described
46
. 
Chd1 shRNA 1: GCAAAGACGGCGACTAGAAGA  
Chd1 shRNA 2: GACAGTGCTTAATCAAGATCG  
Chd4 shRNA 1: GGACGACGATTTAGATGTAGA  
Chd4 shRNA 2: GCTGACGTCTTCAAGAATATG  
Chd6 shRNA 1: GTACTATCGTGCTATCCTAGA  
Chd6 shRNA 2: CAGTCAGAACCCACAATAACT  
Chd8 shRNA 1: GCAGTTACACTGACGTCTACA  
Chd8 shRNA 2: GACTTTCTGTACCGCTCAAGA  
Chd9 shRNA 1: TATACCAATTGAACAAGAGCC  
Chd9 shRNA 2: AGTTAAAGTCTACAGATTAGT  
Ep400 shRNA 1: GGTAAAGAGTCCAGATTAAAG  
Ep400 shRNA 2: GGTCCACACTCAACAACGAGC  
Each shRNA was transfected in its corresponding tagged ES cell line, in order to follow 
remodeller depletion by Western blotting using antibodies against Flag or HA epitopes 
(Extended Data Fig. 5). 
The pHYPER shRNA vectors were transfected in ES cell by electroporation, using an Amaxa 
nucleofector (Lonza). 24 h after transfection, puromycin (2 μg/ml) selection was applied for 
an additional 48 h period, before cell collection and RNA preparation, except for Chd4, for 
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which cells were collected after 30 h of selection. Total RNA was extracted using an RNeasy 
Kit (Qiagen). Total RNA yield was determined using a NanoDrop ND-100 (Labtech). Total 
RNA profiles were recorded using a Bioanalyzer 2100 (Agilent). For each remodeller, RNA 
was prepared from three independent transfection experiments, and processed for 
transcriptome analysis. 
Transcriptome analysis in remodeller depleted ES cells 
cRNA was synthesized, amplified, and purified using the Illumina TotalPrep RNA 
Amplification Kit (Life Technologies) following Manufacturer’s instructions. Briefly, 200 ng 
of RNA were used to prepare double-stranded cDNA using a T7 oligo (dT) primer. Second 
strand synthesis was followed by in vitro transcription in the presence of biotinylated 
nucleotides. cRNA samples were hybridized to the Illumina BeadChips Mouse WG-6v2.0 
arrays. These BeadChips contain 45,281 unique 50-mer oligonucleotides in total, with 
hybridization to each probe assessed at 30 different beads on average. 26,822 probes (59%) 
are targeted at RefSeq transcripts and the remaining 18,459 (41 %) are for other transcripts. 
BeadChips were scanned on the Illumina iScan scanner using Illumina BeadScan image data 
acquisition software (version 2.3). Data were then normalized using the ‘normalize quantiles’ 
function in the GenomeStudio Software. Following analyses were done using Genespring 
software. 
For Brg1, we used a previously published transcriptome dataset, in which loss of Brg1 
function was obtained by genetic ablation
38
. All array analyses were undertaken using the 
Limma package from the R/Bioconductor software (R-Development-Core-Team, 2007). 
Microarray spot intensities were normalized using the RMA method as implemented in the R 
affy package. Normalized measures served to compute the log2-ratios for each gene between 
the wild-type strain and the Brg1 KO mutant. Then, to identify genes with a log2-ratios 
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significantly different between the mutant and wild- type strain, p-values were calculated for 
each gene using a moderated t-test. The moderated t-test applied here was based on an 
empirical Bayes analysis and was equivalent to shrinkage (or expansion) of the estimated 
sample variances towards a pooled estimate, resulting in a more stable inference. Finally, 
adjusted p-values were calculated using the Benjamini & Hochberg method and filtered using 
the thresholds of 0.05 for the p-value and 1.5 for the fold-change. 
Quantitative RT-PCR 
Random-primed reverse transcription was performed at 52°C in 20l using Maxima First 
strand cDNA synthesis kit (Thermo Scientific) with 10 g of total RNA isolated from ES 
cells (Qiagen), quantified with NanoDrop instrument (Thermo Scientific). Reverse 
transcription products were diluted 40-fold before use. Composition of quantitative PCR 
assay included 2.5 l of the diluted RT reaction, 0.2 to 0.5 mM forward and reverse primers, 
and 1X Maxima SYBR Green qPCR Master Mix (Thermo Scientific). Reactions were 
performed in a 10l total volume. Amplification was performed as follows: 2 min at 95°C, 40 
cycles at 95°C for 15 sec and 60°C for 60 sec in the ABI/Prism 7900HT real-time PCR 
machine (Applied Biosystems). The real-time fluorescent data from quantitative PCR were 
analyzed with the Sequence Detection System 2.3 (Applied Biosystems). Each quantitative 
real-time PCR was performed using the set of primer pairs listed in Extended Data Table 2, 
validated for their specificity and efficiency of amplification. All reactions were performed in 
triplicates, using RNA prepared from three independent cell transfection experiments. Control 
reactions without enzyme were verified to be negative. Relative expression was calculated 
after normalization with three reference genes (Actb, Nmt1 and Ddb1), validated for this 
study.  
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FAIRE-seq 
FAIRE was performed as described
32
 with modifications. 46C ES cells were amplified as 
described above for RNA preparation. Formaldehyde was added directly to the growth media 
(final concentration 1%), and cells were fixed for 5 min at room temperature. After quenching 
with glycine and several washes, cells were collected, resuspended in 500 µl of cold lysis 
buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA) 
and disrupted using glass beads for five 1-min sessions with 2 min incubations on ice between 
disruption sessions. Samples were then sonicated for 16 sessions of 1 min (30 sec on/30 sec 
off) using a bioruptor (Diagenode) at max intensity, at 4°C. After centrifugation, the 
supernatant was extracted twice with phenol-chloroform. The aqueous fractions were 
collected and pooled, and a final phenol-chloroform extraction was performed before DNA 
precipitation. Prior to sequencing, FAIRE DNA was analyzed and quantified by running 
1/25e of the FAIRE material on a High sensitivity DNA chip on a 2100 Bioanalyzer (Agilent, 
USA). 20 ng of FAIRE DNA was used for library preparation according to the Illumina ChIP-
seq protocol (ChIP-seq sample preparation kit). Single-read sequencing was performed on a 
Genome Analyzer II (Illumina) according to manufacturer’s instructions. 
Analysis of ChIP-seq datasets (Fig. 1d, Extended Data Fig. 7 and 8) 
Short read alignment onto mouse mm9 genome was performed with Bowtie 0.12.7 with the 
followings settings : -a -m1 --best --strata -v2 -p3. Datasets were next converted to BED 
format files, and data analysis was performed using the seqMINER platform
47
. 
Peak calling was performed by running SICER software
48
 with a control library obtained by 
applying the tandem ChIP protocol to untagged ES cells. The following settings were used: 
window size, 200 bp ; gap size, 200 bp ; FDR=1e-9. 
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In order to examine the distribution of remodellers at individual genes, we used WigMaker3 
(default settings) to convert BED files into wig files, which were uploaded onto the IGV 
genome browser. 
The reproducibility of ChIP-seq replicate experiments was assessed for each remodeller in 
Extended Data Fig. 8. 
Lists of genes 
The list of 14,623 genes used in Fig. 1 and 2 was obtained by filtering all mm9 RefSeq genes. 
We removed redundancies (that is, genes having the same start and end sites), unmappable 
genes and those with high ChIP-seq background, as well as genes shorter than 2 kb. The 
purpose of this last filtering step was to unambiguously distinguish the promoter region from 
the end of the genes in heat-maps. Transcription start sites (TSS) correspond to the location of 
the 5’ RNA end. 
Lists of genes with H3K4me3 and bivalent promoters: We first defined, among the 14,623 
RefSeq genes, those with a promoter positive for H3K4me3 (accession number: 
GSM590111). Operating with the seqMINER platform, tag densities from this dataset were 
collected in a -500/+1,000 bp window around the TSS, and subjected to three successive 
rounds of k-means clustering, in order to remove all genes with a promoter negative for 
H3K4me3. We next conducted on this series of H3K4me3-positive promoters three 
successive rounds of k-means clustering, using several published datasets for H3K27me3. The 
genes with a promoter positive for H3K27me3 in four distinct H3K27me3 datasets (accession 
numbers: GSM590115, GSM590116, GSM307619 and GSM392046/GSM392047) were 
considered as bivalent. We eventually obtained a list of 6,481 genes with H3K4me3-only 
promoters, and a list of 3,411 bivalent genes. 
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For the generation of GC-content-based lists of promoters, we used the list of promoters 
defined in Fig. 3 of reference 28, that we crossed with the 14,623 promoter list, to obtain a list 
of 6,317 promoters rank ordered according to GC content, from least to most, shown in 
Extended Data Figure 7.  
Pearson correlation analysis 
We used DNaseI-Seq data from the Mouse ENCODE Consortium (GSM1004653) for the 
identification of DNase hypersensitive (DHS) regions in the mouse ES cell genome. DHS 
regions were defined using MACS 2.0 
49
 (default setting), which resulted in the identification 
of 139,454 DHS regions. Each of these DHS regions was represented as a 500bp window (-
250bp / +250bp) centred on the midpoint of the DHS peak. DHS regions overlapping with the 
blacklisted (high background signal) genomic areas (mm9) were removed, resulting in a final 
list of 138,582 DHS regions. Tags from each tested ChIP-seq dataset were summed up for 
each DHS region before pair-wise Pearson correlation comparison. The R
2
 value from each 
pair-wise Pearson correlation was then visualized by heatmap (Fig. 1a). 
Pearson correlation analysis at promoter-like DHS regions. Operating with the seqMINER 
platform, we retrieved, from the 138,582 DHS regions list, those positive for H3K4me3, TBP 
and Pol II S5ph. We obtained 16,300 promoter-like DHS regions befitting the criteria. Pair-
wise Pearson correlation was performed and plotted (Fig. 1b) as described for Fig 1a.   
Pearson correlation analysis at enhancer-like DHS regions. After having removed promoter-
like DHS regions from the list of 138,582 DHS regions, we next retrieved those positive for 
Med1, Oct4, Sox2 and Nanog, following the criteria described for enhancer function in ES 
cells
50,51
. We obtained a list of 24,547 putative enhancer elements. Pair-wise Pearson 
correlation was performed and plotted (Extended data Fig.2) as described above. 
Reference ES cell nucleosome map  
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Mouse ES nucleosomal tags were acquired from a published MNase-seq dataset
26
 to make the 
reference map shown in Fig. 2. Reference nucleosomes were called using MACS 2.0 before 
assigning the first nucleosomes downstream and upstream of TSSs as +1 and -1, respectively. 
Regions between the associated +1 and -1 nucleosomes were defined as nucleosome free 
regions (NFR). ChIP-seq tags from remodeller-nucleosome interaction assays were first 
globally shifted as described
10
. GRO-seq tags
30
 sharing the same or opposite orientation with 
the TSS were assigned as sense and antisense tags, respectively. The orientation of each NFR 
was arranged so that sense transcription proceeds to the right. ES nucleosomal tags
26
, globally 
shifted tags from remodeller-nucleosome interaction assays (this current study), tags from 
DHS regions (Mouse ENCODE), GRO-seq oriented tags from transcriptionally engaged pol 
II and CpG islands (UCSC, mm9 build) were then aligned to the midpoint of each NFR. 
Promoter regions were then sorted by NFR length and visualized by JavaTree. 
CpG island information was retrieved from UCSC (mm9 build) and assigned to the closest 
TSS by using bedtools. We noticed that promoters with large NFRs were mostly CpG island 
(CpGI)-rich, while those with small NFRs were globally CpGI-poor, in agreement with a 
previous report showing that CpGIs induce nucleosome exclusion
28
.  
Construction of the composite plot shown in Fig. 3 
Tags from reference nucleosomes
26
, remodeller-interacting nucleosomes (this study) and 
transcriptionally engaged pol II (GRO-seq)
30
 were aligned to nucleosome (nuc) -1 and nuc +1 
dyad positions. The direction of each -1/+1 dyad was assigned according to the orientation of 
its associated TSS, whose orientation was arranged so that the transcription proceeds to the 
right. After normalization with the amount of genes in the two different NFR subclasses, tags 
were plotted from 500 bp upstream or downstream of reference points (-1 or +1, respectively) 
until the midpoint of NFR.  
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Average binding profiles (Extended Data Fig. 3) :  
Genes were rank ordered according to rpkm and divided in four quartiles (highest:Q4, 
second:Q3, third:Q2 and lowest:Q1). Operating with the k-means clustering function of 
seqMINER, genes in each quartile were further subdivided in H3K4me3-only and bivalent 
genes, as described above.  
Using these lists of genes, tag densities from remodeller ChIP-seq datasets were collected in a 
window of –2kb/+2kb around the TSS, except for Chd2, for which densities were collected 
from the TSS until +4kb. Output tag density files were first analyzed using R software to 
establish average binding profiles. Statistical comparisons were performed between 
remodeller distributions at H3K4me3 promoters, to assess a significant increasing trend 
among distributions. Differences between successive pairs of quartiles (Q4 - Q3, Q3 - Q2, Q2 
- Q1) were compared against a null distribution using a one side t-test. 
The respective p values are reported for each remodeller:  
Chd1, Q4 - Q3  p =  1.371138e-27 ; Q3 - Q2 p = 1.728126e-16 ; Q2 - Q1 p = 7.985217e-23. 
Chd2, Q4 - Q3  p =  7.543473e-33 ; Q3 - Q2 p = 1.115223e-25 ; Q2 - Q1 p = 3.283427e-38. 
Chd4, Q4 - Q3  p =  0.2094255 ; Q3 - Q2 p = 0.1081455 ; Q2 - Q1 p = 0.07202865. 
Chd6, Q4 - Q3  p =  0.4168748 ; Q3 - Q2 p = 0.1534144 ; Q2 - Q1 p = 0.01138035. 
Chd8, Q4 - Q3  p =  4.031959e-15 ; Q3 - Q2 p = 1.231527e-06 ; Q2 - Q1 p = 1.34455e-09. 
Chd9, Q4 - Q3  p =  9.484578e-44 ; Q3 - Q2 p = 1.059783e-14 ; Q2 - Q1 p = 4.646352e-28. 
Ep400, Q4 - Q3  p =  3.046796e-20 ; Q3 - Q2 p = 1.215304e-14 ; Q2 - Q1 p = 6.462667e-11. 
Brg1, Q4 - Q3  p =  3.512021e-24 ; Q3 - Q2 p = 2.515217e-07 ; Q2 - Q1 p = 0.977422.  
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We concluded from this analysis that Chd1, Chd2, Chd9 and Ep400 binding at promoters is 
tightly linked to gene expression level. In contrast, Brg1, Chd4 and Chd6 deposition showed 
little correlation with gene expression level (statistical test failed for at least one comparison 
for these remodellers). Whilst statistical analysis of Chd8 distributions concluded to 
significant differences between quartiles, inspection of distributions in Extended Data Fig. 3 
showed that Chd8 binding profile was intermediate between these two categories. 
Statistical analysis of the differences in transcriptional activation and repression by 
remodelers (Fig. 4 and 5)  
This analysis was performed using a 2-sample test for equality of proportions with continuity 
correction. 
Accession numbers and references of the publicly available Datasets used in Fig. 1 and 2 and 
Extended Data Fig. 1, 4 and 7: 
Brg1
1
: GSM359413  
DNase-seq : GSM1014154 
Ezh2
52
: GSM590132  
GRO-seq
30
: GSM665994  
H2A.Z
53,54
: GSM958501, DRP001103  
H3.3
55
: GSM1386359  
H3K27ac
56
: GSM594578 
H3K27me3
52
: GSM590115  
H3K36me3
52
: GSM590119  
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H3K4me3
52
: GSM590111  
Med1
51
 : GSM560347  
Mi2b (Chd4)
29
: GSM687284  
MNase-seq
26
: GSM1004653  
Oct4/Pou5f1, Sox2, Nanog
57
 : GSM1082340  
Pol II S5ph
21
: GSM515662  
TBP : GSM958503 
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Part II:  
 
Article 2: ATP-dependent Chromatin Remodeling Factors Target Regulatory 
Regions and Contribute to the Transcriptional Network in ES Cells  
(Preliminary version) 
 
Abstract  
Embryonic stem (ES) cell pluripotency and self-renewal are controlled by a defined series of 
transcription factors that together control the ES cell transcriptional network. These factors, 
identified as pluripotency-associated transcription factors (pTFs) directly interact with 
chromatin modifying enzymes, including several members of the Snf2 family of ATP-
dependent chromatin remodelers. Here, we analyzed how remodelers bind to ES cell DNA 
regulatory elements, and how they contribute to the regulation of the ES cell transcription 
network. We show that remodelers bind with specific patterns to enhancer elements, as well 
as to CTFC-binding sites and promoter elements. We observed that a subset of remodelers, 
including Chd4, Ep400, Brg1, Chd1 and Smarcad1, contribute to the regulation of genes 
controlled by super enhancers. We also analyzed how each remodeler contributes to the 
regulation of pTFs target genes. Together, this data provides a more detailed view of how 
remodelers regulate ES cell fate. 
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Introduction 
Mammalian embryonic stem cells have the capacity to self-renew indefinitely, and to 
differentiate into almost all cell types of the body, a property known as pluripotency (Keller, 
1995). Self-renewal and pluripotency are primarily controlled by a series of transcription 
factors, which together establish a self-perpetuating transcription regulatory network. This 
transcription network is controlled by a series of pluripotency-associated transcription factors 
(pTFs), including the core TFs Oct4 (Pou5f1), Sox2 and Nanog (Chambers and Smith, 2004; 
Niwa, 2007; Silva and Smith, 2008) . In addition, other important pTFs integrate the ES 
transcription network such as Esrrb, Tcfcp2l1, Klf4, Klf2, STAT3 and Smad1 (van den Berg 
et al., 2010a; Pardo et al., 2010). The pTFs STAT3 and Smad1 are the terminal effectors that 
integrate to the transcription network external stimuli from two major signaling pathways in 
ES cells, the leukemia inhibitory factor (LIF) and the transformation growth factor beta 
(TGFβ) signaling pathways (Chen et al., 2008a; Ying et al., 2003a; Zhang et al., 2010).  
Pluripotency-associated TFs are DNA-binding proteins that bind to the ES cell genome at the 
level of promoters and distal regulatory elements to activate the transcription of genes 
required for ES cell phenotype, and repress differentiation-associated genes. Moreover, pTFs 
regulate their own promoters forming an interconnected autoregulatory loop that provides 
positive feedback expression for pluripotency maintenance. Several studies showed that pTFs 
physically interact with a large series of chromatin modifying enzymes, including several 
members of the Snf2 family of ATP-dependent chromatin remodeling factors (also called 
remodelers) (van den Berg et al., 2010b; Liang et al., 2008; Pardo et al., 2010).  
Several members of the Snf2 family of remodelers were shown to be of specific importance 
for ES cell self-renewal and during differentiation (Fazzio et al., 2008; Gaspar-Maia et al., 
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2009; Ho et al., 2011; Reynolds et al., 2012; Wang et al., 2014), indicating that this family of 
enzyme has a particular importance in ES cells.  
The Snf2 family is composed of 24 subfamilies (Supplementary Figure 2) that share a 
conserved  catalytic ATPase domain (Flaus et al., 2006). These factors are believed to play 
essential roles in modifying the chromatin landscape through their capacity to position 
nucleosomes and determine their occupancy throughout the genome, making the chromatin 
more or less accessible to DNA binding factors (Clapier and Cairns, 2009; Hargreaves and 
Crabtree, 2011; Jiang and Pugh, 2009). Although several members of the Snf2 remodelers 
were shown to play essential function in the control of ES cell phenotype, there is so far no 
global, comparative view of how they work together to control ES cell fate.  
Here we present a genome-wide comparative analysis of the function of a series of ATP-
dependent chromatin remodelers (Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1, Ep400, 
ATRX, Smarca3, Smarca5, Smarcad1 and Alc1) in ES cells. We first used a high 
performance ChIP-seq (Chromatin Immunoprecipitation followed by deep sequencing) 
strategy based on ES cells tagged for each factor to define the genomic binding profiles of 
each remodeler. Second, we performed transcriptome analysis in ES cells depleted of each 
remodeler to understand their role in transcription regulation. We specifically analyzed how 
each remodeler contributes to the transcription program controlled by pTFs. Integration of 
these data allowed us to better understand the function of remodelers in the transcriptional 
network of ES cells.   
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Results 
Remodelers extensively bind cis-regulatory DNA elements in the ES cell genome 
In order to map the genomic distribution of remodelers onto the ES cell genome, we applied a 
tandem ChIP-seq protocol using ES cells tagged at the gene encoding for the different 
remodelers, as described in article 1 (De Dieuleveult et al., 2015, in revision). To identify ES 
cell DNA regulatory elements, we extensively mapped DNase I hypersensitive sites (DHS) 
onto the ES cell genome using a publicly available ENCODE DNase-seq dataset. We 
identified 139,454 DHS sites across the ES cell genome, which we annotated using selected 
ChIP-seq datasets for pTFs and histone modifications. We were able to detect 24,357 
canonical enhancer-like elements, based on high Oct4/Sox2/Nanog binding, combined with 
Mediator and cohesin occupancy (Chen 2008, Kagey 2010), 39,462 non-canonical enhancer-
like elements (having variable Oct4/Sox2/Nanog signals and thus differing from canonical 
enhancers) and 20,182 CTCF binding sites, identified by the presence of bound CTCF and 
cohesin (Smc1) (Kagey et al., 2010). We also identified about 16,300 DHS bearing promoter-
like histone modifications. 
We first analyzed the distribution of remodelers at each category of distal regulatory 
elements. Our analysis shows that the studied remodelers all bind to canonical enhancers, 
though with distinct intensities (Figure 1A). The highest binding signals were observed for 
Chd4 and Brg1. Ep400, Chd6, Chd8 and Smarca3 were also found enriched at most canonical 
enhancers. Relatively lower signals were detected for Chd1, Chd9, Smarca5, Smarcad1 and 
ATRX. Finally, a weak signal was observed for Alc1, which could be detected at low levels at 
only a subset of enhancers. 
Enhancers can be distinguished by their level of H3K27ac, which identifies active (high 
H3K27ac) and poised (low H3K27ac) enhancers. The latter category is believed to be inactive 
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in ES cells and corresponds to enhancers that become activated during differentiation and 
development (Creyghton et al., 2010). We observed that remodelers bind to both active and 
poised enhancers, with an about two-fold higher enrichment at active enhancers (Figure 1B). 
In addition to canonical enhancer elements, the ES cell genome includes a large number 
(39,462) of DNA elements that have most characteristics of enhancer elements, such as 
DNase I hypersensitivity, presence of mediator and cohesin, and pTFs. We refer to these 
elements as non-canonical enhancer-like, because they differ from their canonical 
counterparts by being bound either at low levels or by various combinations of the three OSN 
pTFs (see below). Interestingly, analysis of these non-canonical enhancer-like elements, 
revealed also binding of remodelers at these sites (Supplementary Figure 1). This is an 
indication that these non-canonical, enhancer-like elements might also be part of the 
repertoire of ES cell distal regulatory elements.  
Next, we checked whether the different remodelers are present at the 20,182 identified CTCF 
binding sites. CTCF is an architectural protein that plays an important role in creating 
boundaries between topologically associating domains in chromosomes, further facilitating 
interactions between transcription regulatory sequences such as enhancers and promoters 
(Ong and Corces, 2014). Almost all remodelers were bound (though with distinct intensities) 
at CTCF sites, with the exception of Chd1 and Chd9 (Figure 2A). Smarca3 and Chd4 were the 
remodelers that presented the highest binding signal intensity. Brg1, Ep400, Chd6, Chd8, 
Smarca5, Smarcad1 and ATRX were also detected on CTCF-bound elements, but only a very 
low signal could be detected for Alc1. To detect potential difference in the binding pattern of 
the different remodelers, we performed a clustering analysis of the 20,182 CTCF, which 
revealed two broad groups of elements with specific remodeler combinations (Figure 2B). 
The first group (A) is characterized by a widespread enrichment for most remodelers. In 
contrast, the second group (B) was bound by a more restricted set of remodelers, including 
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Smarca3, Smarca5, Smarcad1 and ATRX. Although further investigations will be required to 
test the importance of remodelers in the function of CTCF binding sites, these data suggests 
the existence of at least two distinct functional categories of CTCF-binding sites, based on 
remodeler distribution pattern. 
 
Remodelers bind super enhancer elements and regulate the transcription of super 
enhancer-associated genes 
A small subgroup of enhancer elements can be distinguished from typical enhancer elements 
by an especially high level of Mediator enrichment, and by their unusual size, spanning large 
genomic regions (Whyte et al.  2013). Super enhancers were shown to control the expression 
of key genes for the control of cell phenotype, and are thus of special importance in the 
control of ES cell fate. We tested whether some remodelers might have a specific function in 
regulating the activity of these cis-acting regulatory elements.  
We first analyzed the ChIP-seq binding profile of each remodeler at the level of the 
previously identified 231 super enhancers (Whyte et al., 2013a), in comparison with their 
distribution at typical enhancers (TE) (Figure 3A). We observed that the remodelers that are 
bound to typical enhancers generally show a similar binding intensity at super-enhancers, with 
some important exceptions: we found both Chd1 and Chd9 present at higher levels at super-
enhancers, compared to typical enhancers. In contrast, Chd4 and Brg1, which are extensively 
bound to enhancer elements (Figure 1A), show a similar binding intensity at typical and super 
enhancer (Figure 3A). These specificities of remodeler distribution are further illustrated at 
the Nanog locus, which contains several super enhancers (Figure 3B).  
To examine the function of remodelers in the transcriptional control of the genes associated 
with super enhancers, we analyzed whether the expression of these genes was effected upon 
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remodeler depletion by knockdown (Figure 5A). Depletion of Smarcad1, Brg1, Chd4 or 
Ep400 resulted in high number of deregulated genes in this category, revealing that these 
remodelers are important actors in the control of super enhancer activity. Chd1, which is 
particularly enriched at super enhancers, was also required for the proper level of expression 
of a significant number of genes associated with super enhancer, revealing a new function for 
this factor. In contrast, Chd9 depletion caused the deregulation of only one gene associated 
with super enhancer, despite its higher enrichment at these elements. Moderate deregulation 
of SE-associated genes was observed for Chd8 and Chd6. Finally, Smarca3 and Atrx 
knockdown had almost no effect on the expression of SE-associated genes. 
To confirm the transcriptomic results regarding SE-associated genes deregulation obtained 
upon remodeler depletion, we performed qPCR validation experiments on a selection of SE-
associated genes (Figure 5B). Downregulation of F2rl1, a SE-associated gene was observed 
upon Chd1 KD. Remarkably, depletion of Chd4 caused the downregulation of the two pTFs 
Oct4 (Pou5f1) and Nanog, revealing a function of Chd4 in controlling the expression of major 
pTFs. Nanog expression was also downregulated upon depletion of Chd8.      
Altogether, this analysis suggests that remodelers play an essential function in the 
maintenance of ES cell fate through the regulation of super enhancer function. 
 
Differential regulation of promoter types by remodelers 
In our previous study (article 1), we analyzed the binding pattern of Chd1, Chd2, Chd4, Chd6, 
Chd8, Chd9, Ep400 and Brg1 in the promoter regions. We concluded that each of these 
remodeler bind specific nucleosome positions at promoters, except Chd2 which bind 
nucleosomes in gene bodies, suggesting a function in transcription elongation.   
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The additional remodelers Atrx, Smarcad1, Smarca5, Smarca3 and Alc1 were generally 
present at lower intensities at promoters compared to remodelers in the first series, with 
Smarca3 and Smarca5 having the highest binding signal (Figure 4A). Alc1 seems to be 
present at particularly low levels at promoters. 
To understand the link between remodeler binding at promoters and functional control of gene 
expression, we analyzed the transcriptome of ES cells depleted of each remodeler.  
The transcriptome of ES cells depleted of Chd1, Chd4, Chd6, Chd8, Chd9, Ep400 and Brg1 is 
described in article 1. As we observed in article 1, remodelers differentially affect the 
regulation of genes having H3K4me3-only versus bivalent promoters, we performed a similar 
analysis to analyze the the consequence of depleting Atrx, Smarca3, Smarca5 and Smarcad1. 
Among these four remodelers, Smarcad1 was the most involved in transcriptional control 
(Figure 4B). We observed that Smarcad1 acts both as an activator and a repressor of 
H3K4me3-only genes, but that it is mostly a repressor of bivalent genes. Smarca3 and 
Smarca5 had a comparatively lower impact on the transcriptome, with a number of genes 
deregulated in the same order of magnitude as Chd1. Finally, Atrx depletion caused the 
deregulation of very few genes, showing that this remodeler has only a minor function in ES 
cells. 
 
Analysis of remodeler function in the control of ES cell transcriptional network  
In order to understand how remodelers contribute to the regulation of ES cell transcriptional 
circuitry, we analyzed how each remodeler positively or negatively regulates the target genes 
of Oct4, Sox2 and Nanog (OSN), using a dataset published by Ivanova et al in 2006 (Ivanova 
et al., 2006b). This analysis revealed that remodelers have each a distinct contribution to the 
ES cell transcriptional circuitry. Ep400 and Chd4 positively regulate the expression of 17% 
Results  Part II 
145 
 
and 10% of OSN-activated genes, respectively, and thus contribute to a large extend to the 
regulation of the ES cell transcription circuitry. To a lesser extent Smarcad1 and Chd1 (Figure 
6) also acted as co-activators of OSN at their target genes, as depletion of these remodelers 
caused the downregulation of about 4% of OSN-activated target genes. Similarly, Brg1 seems 
to play mostly a co-activator function at OSN-target genes (8% of these genes are activated by 
both Brg1 and OSN), but has also a co-repressive function at (4% of OSN-target genes are 
repressed by both OSN and Brg1). Chd8, Chd6, Smarca5, Smarca3, regulate only few genes 
controlled by OSN, and thus are expected to play a minor function in the regulation of ES cell 
transcriptional circuitry. Finally, Atrx and Chd9 do not contribute to the ES cell pTFs-
controlled transcriptional circuitry. 
 
Conclusion 
In this study we conducted a comparative analysis of how various remodelers belonging to the 
Snf2 family of ATP-dependent chromatin remodeling factors contribute to the transcriptional 
control in ES cells. We show that a considerable number of remodelers bind proximal and 
distal regulatory elements at variable intensities. Moreover, we show that a number of 
remodelers interfere directly in the transcriptional regulation the ES self-renewal and 
pluripotency network and are essential for ES cell phenotype conservation. 
The implication of chromatin remodeling factors in the control of the ES cell state has been 
studied before where remodelers were shown to be a part of the pluripotency core network 
(van den Berg et al., 2010; Liang et al., 2008; Pardo et al., 2010) . Other studies demonstrated 
the importance of certain remodelers such as Ep400, Chd1 and Brg1 in the conservation of the 
ES cell state (Fazzio et al., 2008; Gaspar-Maia et al., 2009; Ho et al., 2011). In our study we 
try to attribute to a global understanding of the role of large set of Snf2 remodelers in the 
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control of the ES cell state. Previously we have demonstrated how remodelers integrate 
promoter nucleosomal architecture to regulate ES cell transcription programs.  
 
We have shown that remodelers bind canonical enhancer elements characterized by the 
abundant presence of the core transcription regulatory network; in addition to non-canoncial 
enhancer-like elements that might increase ES cell regulatory elements repertoire. Ep400, 
Brg1, Chd4, Chd1 and Smarcad1 were shown to be of special importance in the regulation of 
SE-associated genes, genes typically important in the ES cell state maintenance. Moreover, 
we demonstrate that remodelers, in particular Smarca3 present significant binding patterns 
along with architectural proteins such as CTCF (Ong and Corces, 2014) conferring a probable 
role of remodelers in the definition of chromatin boundaries and in the assuring of long-range 
promoter-enhancer interactions. Indeed, remodelers were also detected on promoter elements 
of a large number of genes, where they regulate in various ways the expression of active and 
bivalent promoters of genes. For instance, Ep400, Chd4 and Smarcad1 seem to exert a rather 
positive function on active genes and negatively control the expression of bivalent genes. On 
the contrary, Brg1 rather activates the expression of bivalent promoter-associated genes. 
Furthermore, we show that remodelers especially Ep400, Brg1, Chd4, Chd1 and Smarcad1 
contribute to the ES pluripotency and self-renewal network.  
 
To sum up, in the current study we conducted a genome-wide analysis of the distribution and 
function in ES cells of the different chromatin remodeling factors belonging to the Snf2 
family of remodelers. More concentration should be shed on how such various yet related 
remodelers contribute synergistically or antagonistically to the control of the ES cell state.  
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Materials and Methods 
Cell line and ES cell culture  
Mouse 46C ES cells have been described previously (Ying et al., 2003b)
 
. 46C ES cells and 
their tagged derivatives were cultured at 37°C, 5% CO2, on mitomycin C-inactivated mouse 
embryonic fibroblasts, in DMEM (Sigma) with 15% foetal bovine serum (Invitrogen), L-
Glutamine (Invitrogen), MEM non-essential amino acids (Invitrogen), pen/strep (Invitrogen), 
2-mercaptoethanol (Sigma), and a saturating amount of leukemia inhibitory factor (LIF), as 
described in reference (Southon and Tessarollo, 2009). 
Knock-in of a TAP-tag in the genes encoding the remodelers through homologous 
recombination in ES cells 
The recombineering technique
 
(Liu et al., 2003) was adapted to construct all targeting vectors 
for homologous recombination in ES cells previously described in article 1 (De Dieuleveult et 
al., 2015). Briefly, a TAP-tag was inserted into the subcloned DNA, immediately 3’ to the 
coding sequence. The TAP-tag was (FLAG)3-TEV-HA for Chd1, Chd2, Chd4, Chd6, Chd8, 
Ep400, Brg1, Smarca3, Smarcad1, Smarca5, Atrx and Alc1 and 6His-FLAG-HA for Chd9. 
Cell line verification and recombineering success are also described in article 1. 
Antibodies 
Antibodies used for western blot were as follows: 
Monoclonal antibodies anti-HA (H7, Sigma H3663) and anti-FLAG (M2, Sigma F1804), anti-
GAPDH (Abcam ab9485). 
Tandem affinity purification of the remodeler-nucleosome complexes 
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As described previously (De Dieuleveult et al., 2015) ES cells were fixed either with 
formaldehyde, or with a combination of disuccinimidyl glutarate (DSG) and formaldehyde, 
then permeabilized with IGEPAL, and incubated with micrococcal nuclease (MNase) in order 
to fragment the genome into mononucleosomes. This nucleosome preparation was next 
incubated with agarose beads coupled with an antibody anti-HA or anti-FLAG. Anti-HA-
agarose (ref. A2095) and anti-FLAG-agarose (ref. A2220) beads were purchased from Sigma. 
After a series of washes, tagged-remodeler-nucleosome complexes were eluted, either by 
TEV protease cleavage or by peptide competition. The eluted complexes were then subjected 
to a second immunopurification step, using beads coupled to the antibody specific of the 
second HA or FLAG epitope. After elution, DNA was extracted from the highly purified 
mononucleosome fraction, and processed for high-throughput sequencing. As a negative 
control, chromatin from untagged ES cells was subjected to the same protocol to define 
background signal. A detailed version of this protocol is available on the protocol exchange 
website: http://dx.doi.org/10.1038/protex.2014.040 
High-throughput sequencing of tandem ChIP samples 
After crosslink reversion, phenol-chloroform extraction and ethanol precipitation, the DNA 
from remodeller-nucleosome complexes was quantified using the picogreen method 
(Invitrogen) or by running 1/20e of the ChIP material on a High sensitivity DNA chip on a 
2100 Bioanalyzer (Agilent, USA). 5 to 10 ng of ChIP DNA were used for library preparation 
according to the Illumina ChIP-seq protocol (ChIP-seq sample preparation kit). Following 
end-repair and adapter ligation, fragments were size-selected on an agarose gel in order to 
purify genomic DNA fragments between 140 and 180 bp. Purified fragments were next 
amplified (18 cycles) and verified on a 2100 Bioanalyzer before clustering and single-read 
sequencing on a Genome Analyzer (GA) or GA II (Illumina), according to manufacturer’s 
instructions. 
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RNA preparation from ES cells depleted of each remodeler by shRNA 
We used the pHYPER shRNA vector for remodeller depletion in ES cells, as previously 
described (Berlivet et al., 2010). shRNA design was performed using DESIR software 
(http://biodev.extra.cea.fr/DSIR/DSIR.html). Below are listed the shRNA selected for each 
remodeller. 
Smarca3 shRNA 1: CGCACGAGAGAACAGTAAA 
Smarca3 shRNA 2: AGCAGGATCTCCTACGATA 
Smarca5 shRNA 1: GGATTCGATAGTAATTCAA 
Smarca5 shRNA 2: CCTCCTTCGTCGAATTAAA 
Smarcad1 shRNA 1: GGACTATAGCAGTTGTGAA 
Smarcad1 shRNA 2: GACGTAGTTATAAGACTTA 
Atrx shRNA 1: CGATGTATTGACAAAGCAA 
Atrx shRNA 2: GATGCTAGATCATCAGTAA 
Alc1 shRNA 1: GAAGGTAGAGACTATTCTA 
Alc1 shRNA 2: CGAATTGGACATGCTACAA 
Each shRNA was transfected in its corresponding tagged ES cell line, in order to follow 
remodeler depletion by Western blotting using antibodies against Flag or HA epitopes 
(Supplementary Figure 3). 
The pHYPER shRNA vectors were transfected in ES cell by electroporation, using an Amaxa 
nucleofector (Lonza). 24 h after transfection, puromycin (2 μg/ml) selection was applied for 
an additional 48 h period, before cell collection and RNA preparation, except for Smarcad1 
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and Alc1, for which cells were collected after 32 h of selection. Total RNA was extracted 
using an RNeasy Kit (Qiagen). Total RNA yield was determined using a NanoDrop ND-100 
(Labtech). Total RNA profiles were recorded using a Bioanalyzer 2100 (Agilent). For each 
remodeler, RNA was prepared from three independent transfection experiments, and 
processed for transcriptome analysis. 
Transcriptome analysis in remodeler depleted ES cells 
cRNA was synthesized, amplified, and purified using the Illumina TotalPrep RNA 
Amplification Kit (Life Technologies) following Manufacturer’s instructions. Briefly, 200 ng 
of RNA were used to prepare double-stranded cDNA using a T7 oligo (dT) primer. Second 
strand synthesis was followed by in vitro transcription in the presence of biotinylated 
nucleotides. cRNA samples were hybridized to the Illumina BeadChips Mouse WG-6v2.0 
arrays. These BeadChips contain 45,281 unique 50-mer oligonucleotides in total, with 
hybridization to each probe assessed at 30 different beads on average. 26,822 probes (59%) 
are targeted at RefSeq transcripts and the remaining 18,459 (41 %) are for other transcripts. 
BeadChips were scanned on the Illumina iScan scanner using Illumina BeadScan image data 
acquisition software (version 2.3). Data were then normalized using the ‘normalize quantiles’ 
function in the GenomeStudio Software. Following analyses were done using Genespring 
software. 
To identify genes with a log2-ratios significantly different between the mutant and wild- type 
strain, p-values were calculated for each gene using a moderated t-test. The moderated t-test 
applied here was based on an empirical Bayes analysis and was equivalent to shrinkage (or 
expansion) of the estimated sample variances towards a pooled estimate, resulting in a more 
stable inference. Finally, adjusted p-values were calculated using the Benjamini & Hochberg 
method and filtered using the thresholds of 0.05 for the p-value and 1.5 for the fold-change.  
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Quantitative RT-PCR 
Random-primed reverse transcription was performed at 52°C in 20l using Maxima First 
strand cDNA synthesis kit (Thermo Scientific) with 10 g of total RNA isolated from ES 
cells (Qiagen), quantified with NanoDrop instrument (Thermo Scientific). Reverse 
transcription products were diluted 40-fold before use. Composition of quantitative PCR 
assay included 2.5 l of the diluted RT reaction, 0.2 to 0.5 mM forward and reverse primers, 
and 1X Maxima SYBR Green qPCR Master Mix (Thermo Scientific). Reactions were 
performed in a 10l total volume. Amplification was performed as follows: 2 min at 95°C, 40 
cycles at 95°C for 15 sec and 60°C for 60 sec in the ABI/Prism 7900HT real-time PCR 
machine (Applied Biosystems). The real-time fluorescent data from quantitative PCR were 
analyzed with the Sequence Detection System 2.3 (Applied Biosystems). Each quantitative 
real-time PCR was performed using the set of primer pairs validated for their specificity and 
efficiency of amplification. All reactions were performed in triplicates, using RNA prepared 
from three independent cell transfection experiments. Control reactions without enzyme were 
verified to be negative. Relative expression was calculated after normalization with three 
reference genes (Actb, Nmt1 and Ddb1), validated for this study.  
Analysis of ChIP-seq datasets 
Lists of genes 
The list of 14,623 genes used in Fig. 1 and 2 was obtained by filtering all mm9 RefSeq genes. 
We removed redundancies (that is, genes having the same start and end sites), unmappable 
genes and those with high ChIP-seq background, as well as genes shorter than 2 kb. The 
purpose of this last filtering step was to unambiguously distinguish the promoter region from 
the end of the genes in heat-maps. Transcription start sites (TSS) correspond to the location of 
the 5’ RNA end. 
Results  Part II 
152 
 
Lists of genes with H3K4me3 and bivalent promoters: We first defined, among the 14,623 
RefSeq genes, those with a promoter positive for H3K4me3 (accession number: 
GSM590111). Operating with the seqMINER platform, tag densities from this dataset were 
collected in a -500/+1,000 bp window around the TSS, and subjected to three successive 
rounds of k-means clustering, in order to remove all genes with a promoter negative for 
H3K4me3. We next conducted on this series of H3K4me3-positive promoters three 
successive rounds of k-means clustering, using several published datasets for H3K27me3. The 
genes with a promoter positive for H3K27me3 in four distinct H3K27me3 datasets (accession 
numbers: GSM590115, GSM590116, GSM307619 and GSM392046/GSM392047) were 
considered as bivalent. We eventually obtained a list of 6,481 genes with H3K4me3-only 
promoters, and a list of 3,411 bivalent genes. 
List of enhancer-like elements and CTCF-binding sites from DHS data 
We used DNaseI-Seq data from the Mouse ENCODE Consortium (GSM1004653) for the 
identification of DNase hypersensitive (DHS) regions in the mouse ES cell genome. DHS 
regions were defined using MACS 2.0 (Feng et al., 2012) (default setting), which resulted in 
the identification of 139,454 DHS regions. Each of these DHS regions was represented as a 
500bp window (-250bp / +250bp) centred on the midpoint of the DHS peak. DHS regions 
overlapping with the blacklisted (high background signal) genomic areas (mm9) were 
removed, resulting in a final list of 138,582 DHS regions.  
Enhancer-like DHS regions 
 After having removed promoter-like DHS regions from the list of 138,582 DHS regions, we 
next retrieved those highly positive for Med1, Oct4, Sox2 and Nanog, following the criteria 
described for enhancer function in ES cells (Chen et al., 2008b; Kagey et al., 2010)
 
. We 
obtained a list of 24,547 canonical putative enhancer elements, further repartitioned according 
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to H3K27ac to active and poised enhancer-like elements. Further clustering analysis allowed 
us to identify an additional number of potential enhancer-like elements (non-canonical: 
various presence of Oct4/Sox2/Nanog) that we divided into six categories (Supplementary 
figure 1). 
CTCF-bound DHS regions 
After having removed promoter-like DHS regions and the enhancer-like DHS regions from 
the list of 138,582 DHS regions, we identified CTCF-binding sites also bound by the cohesin 
Smc1 (Kagey et al., 2010). Clustering analysis helped us in identifying two groups of CTC-
binding site with distinct remodeler binding composition. 
Transcriptomic data correlation with pluripotency gene networks and SE-associated 
genes 
In order to evaluate the degree of involvement of each remodeler in the core pluripotency 
network in ES cells, data from (Ivanova et al., 2006) pattern 2 of the 237 genes downregulated 
upon core transcription factor depletion were compared with transcriptomic data of 
deregulated genes upon remodelling factor depletion.  
The same analysis was done to reveal SE-associated genes that are deregulated upon 
remodeler factor depletion by using the data of the 231 identified SE-associated genes 
identified in (Whyte et al., 2013b). 
  
 
 
 
Results  Part II 
154 
 
Figure legends 
 
Figure 1  
Remodelers’ distribution at ES cell enhancer elements 
A) Heatmap representing ChIP-seq binding of remodelers at 24,357 DHS canonical enhancer-
like elements ranked from highest to lowest H3K27ac presence. Color intensity represents 
sequencing tag counts. For each enhancer-like element, remodeler occupancy is indicated 
within a 6kb window centered on the DHS. B) ChIP-seq binding profiles (mean density) of 
the remodelers (series 1 and series 2) at active and poised enhancers based on H3K27ac 
presence within a 6kb window centered on DHS.  
Figure 2  
Remodelers’ distribution at ES cell CTCF-binding sites 
A) Heatmap representing ChIP-seq binding of remodelers at 20,182 DHS CTCF-binding sites 
based on CTCF and Smc1 presence. Color intensity represents sequencing tag counts. For 
each CTCF-binding element, remodeler occupancy is indicated within a 3kb window centered 
on the DHS. Clustering analysis   reveals the presence of two distict groups of CTCF-binding 
sites with different remodeler-binding profiles. B) ChIP-seq binding profiles (mean density) 
of the remodelers (series1 and series 2) at group A and B at CTCF binding sites within a 3kb 
window centered on DHS. 
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Figure 3 
Differential remodeling factor binding on typical enhancer (TE) and super enhancer 
(SE) 
A) Comparative ChIP-seq binding profiles (mean density) of each remodeler at TE within a 
6kb window and at SE within a 30kb window. ChIP-seq binding profiles of pluripotency 
transcription factors (Oct4/Sox2/Nanog) and Mediator subunit (Med1) are also illustrated. 
Signals at TE appear more precise and centered, on the contrary to signals at SE which 
disperse on a larger genomic scale. B) Binding profiles at a representative locus. Scores 
indicate reads per 10 million. Grey rectangles represent super-enhancers.  
Figure 4 
Remodelers bind promoter elements and regulate differentially H3K4me3-only and 
bivalent promoters 
A) Heatmap representing ChIP-seq binding of remodelers at 14,623 RefSeq promoters. Color 
intensity represents sequencing tag counts. For each promoter, remodeler occupancy is 
indicated within a 10kb window centered on the TSS. B) The transcriptome of ES cells 
depleted for each remodeler was analyzed by microarray hybridization. The number of 
upregulated (light grey) and down regulated (dark grey) genes was defined for gene with 
H3K4me3-only promoters (upper) and bivalent promoters (lower). A 1.5 fold-change 
threshold was used. Statistical analysis was performed using a 2-sample test for equality of 
proportions with continuity correction. *p<0.05, **p<0.01, ***p<0.001 
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Figure 5 
Transcriptional regulation of SE-associated genes by remodelers 
A) The transcriptome of ES cells depleted for each remodeler was compared to a set of SE-
associated genes. The numbers of upregulated (light grey) and down regulated (dark grey) 
SE-associated genes are shown. B) qPCR validation analysis of the downregulation SE-
associated genes upon the depletion of remodelers. 
Figure 6 
Remodelers contribute to the ES cell transcription network  
 The transcriptome of ES cells depleted for each remodeler was compared to Ivanonva et al. 
2006 published transcriptome data in ES cells depleted for the core transcription factors 
(Oct4/Sox2/Nanog). The numbers of upregulated (light grey) and down regulated (dark grey) 
genes upon each remodeler depletion that are downregulated by Oct4/Sox2/Nanog depletion 
are shown. 
Supplementary Figure legends 
Figure 1S 
Binding of remodelers at non-canonical enhancer-like elements 
Table showing the different non-canonical enhancer-like categories. ChIP-seq binding 
profiles (mean density) of each remodeler (from series 1 and 2) at the different categories of 
non-canonical enhancer-like elements within a 6kb window. Remodelers are presented by 
different colors for each series.  
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Figure 2S 
Snf2-dependent chromatin remodeling factors 
A) A tree illustration representing the different subfamilies that compose the Snf2 family of 
chromatin remodeling enzymes. B) The studied Snf2 ATP-dependent chromatin remodeling 
factors and their composing domains. 
Figure 3S 
Western blot analysis of depleted ES cell for each remodeler 
Western blot validation analysis of the efficiency of the used shRNA in the depletion of the 
series 2 of remodelers. Anti-flag antibody was used to detect each remodeler (tagged ES cells 
used) and anti-GAPDH was used for normalization.  
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Discussion and Conclusion 
 
The main objective of this work was to understand how ATP-dependent chromatin 
remodeling factors belonging to the Snf2 family interfere in the transcriptional control of 
mouse embryonic stem cells (ES).  ES cells were shown to present a more ‘open’ chromatin 
(Meshorer et al., 2006). This chromatin state would work in parallel with a specific gene 
expression program that favors the expression of self-renewal genes and poises the 
differentiation genes. In order to maintain this epigenetic state in ES cells, several actors 
participate in the conservation of the genomic ES cell state. ATP-dependent Snf2 chromatin 
remodeling factors were shown to play important roles in the regulation of the particular 
chromatin landscape in ES cells. In this project, we conducted a genome-wide analysis of the 
distribution and function of ATP-dependent chromatin remodeling factors in mouse ES cells. 
To achieve this goal, we followed an adapted double experimental strategy consisting of 
initial ChIP-seq experiments in order to reveal the distribution of remodelers on ES cell 
regulatory elements followed by transcriptomic analysis on depleted ES cells for each 
remodeler.   
We chose to study the role of a selection of thirteen chromatin remodeling factors among 
which several were shown to have an important role in ES cells and during differentiation. 
Those factors include Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Ep400, Brg1, Smarca3, 
Smarca5, Smarcad1, Alc1 and Atrx.  
Previous studies have concentrated on a small number of individual remodelers with no global 
comparative view on how those factors are recruited on the mammalian genome (Gaspar-
Maia et al., 2011; Ho et al., 2009; Reynolds et al., 2012). In our study, we revealed the 
binding profiles of thirteen chromatin remodelers at ES promoter elements. We showed that 
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almost all the studied remodelers bind at various intensities promoter regions in ES cells.   
Some remodelers like Brg1, Chd4, Chd6, Smarca3 and Smarca5 bound similarly to all active 
genes, regardless of their H3K4me3/transcription level, while others, such as Chd1, Chd2, 
Chd9 and Ep400, were tightly linked to H3K4me3/transcription levels.  
Promoters in ES cells can be active (H3K4me3-only) or poised (bivalent, H3K4me3 and 
H3K27me3) (Azuara et al., 2006; Bernstein et al., 2006). Closer analysis of the binding of 
remodelers at the two different types of promoters revealed differential binding of the various 
remodelers. Chd4, Chd6, Smarca5 and Brg1 bind bivalent and active promoters with similar 
intensities; Ep400 and Chd8 highly bind active promoters and present substantially lower 
enrichments at bivalent promoters, but were nevertheless bound to most (> 95 %); Chd1 and 
Chd9 mainly bind active promoters and at low levels to fewer than half of the total number of 
bivalent promoters; Smarca3 moderately binds only active promoters while Smarcad1 and 
Atrx present low binding intensities at only a few active promoters.   
Our transcriptional analysis of ES cells depleted for the various remodelers revealed a 
prominent role for Ep400, Chd4, Brg1 and Smarcad1 and to a lesser extent Chd1 in the 
control of ES cells gene expression. Previously, Ep400 was shown to be essential in ES cell 
state conservation (Fazzio et al., 2008). In our study we have validated this observation; in 
addition we provided a better vision on the way Ep400 controls genes expression in ES cells. 
We showed that Ep400 acts as a gene activator at active genes (H3K4me3-only) and as a 
repressor at bivalent genes along with Chd4 and Smarcad1. On the other hand, Brg1 seemed 
to rather have a double repressing and activating role at active genes and an activating role at 
bivalent genes, an observation already demonstrated before in ES cells (Ho et al., 2009). Brg1 
seems to counteract the inhibitory effect of the other remodeling factors at bivalent genes, 
seemingly to allow the low expression levels of bivalent genes that become essential during 
differentiation. Strikingly, and in contrary to what was published before, Chd4 known mostly 
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to be necessary during differentiation of ES cells as a part of the NuRD complex (Kaji et al., 
2006; Reynolds et al., 2012; Sparmann et al., 2013) seems to have an important role in the 
conservation of the ES cell state. As Chd4-depleted ES cells die shortly after its depletion, this 
observation might be due to a better depletion of Chd4 in our experiment.  
Several studies have demonstrated the involvement of remodelers in the core pluripotency 
transcriptional network of ES cells (van den Berg et al., 2010; Liang et al., 2008; Pardo et al., 
2010). The further analysis of the genes deregulated upon the depletion of the factors Ep400, 
Chd4, Brg1, Smarcad1 and Chd1 revealed their implication in the core pTF regulatory 
network of ES cells, where a significant number of genes are common targets with 
Oct4/Sox2/Nanog. We showed that Ep400 and Chd4 positively regulate the expression of 
OSN-activated genes. To a lesser extent Smarcad1 and Chd1 act as co-activators of 
pluripotency genes along with Oct4/Sox2/Nanog. On the other hand, Brg1 seems to play a 
dual co-repressive and co-activator role at those genes. This further demonstrates the variable 
control mechanisms exerted by remodelers to control the ES cell state. 
To further understand how remodelers control the ES cell genomic landscape, we analyzed 
the distribution of a selection of remodelers on nucleosomes. This analysis revealed variant 
nucleosome binding profiles depending on the nucleosome free region (NFR) size of genes. 
We have demonstrated that at active genes with short NFR, Ep400 and Chd4 bind equally the 
-1 and +1 nucleosomes and positively regulate their transcription; while Brg1 seems to mainly 
bind the +1 nucleosome and negatively control the transcription of such genes. At active 
genes with long NFR, we observe a prominent role for Brg1 bound at the -1 nucleosome and 
acting as a gene activator. On the other hand, at bivalent genes that usually possess long NFR; 
Ep400, Chd4 and Brg1 all bind the -1 nucleosome, and as mentioned previously, Ep400 and 
Chd4 negatively regulate this class of genes while Brg1 exerts a positive regulatory effect. 
Moreover, we observed that for both promoter types transcription initiates on either side 
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(sense and antisense) of the remodeler-bound nucleosomes where the TSS is present at the -1 
nucleosome for short NFR and downstream the -1 nucleosome for long NFR. The -1 
nucleosome position (presenting the TSS) of genes with short NFR is enriched with 
remodelers needed to rapidly evict the histone octamer in order to allow the formation of the 
preinitiation complex; in contrast the TSS of genes with long NFR located in a non-canonical 
histone region contains less remodeler-enrichment probably due to the fact that these CpG 
island rich sites are readily unstable (Deaton and Bird, 2011; Krinner et al., 2014) and need 
less but necessary remodeler involvement  in order to stabilize (case of Ep400 and chd4) or 
reposition (case of Brg1) such labile nucleosomes.  
Next, we analyzed the binding of the different remodelers at distal enhancer elements. CHIP-
seq data revealed also a large remodeler presence on such elements in the ES cell genome. We 
showed that the studied remodelers all bind to canonical enhancers (characterized by high 
core pTFs binding), though with distinct intensities. The highest binding signals were 
observed for Chd4, Brg1 and Ep400 as expected with regard to their important role previously 
described. Interestingly, we have shown that the ES cell genome contains an additional large 
number of enhancer-like regulatory sequences bound by remodeling factors that we call non-
canonical and differ from canonical enhancers by the variant presence/combination of the 
pTFs. This observation allows speculating that the regulatory sequence repertoire is much 
bigger than expected. Interestingly, remodelers showed also binding at super-enhancers of ES 
cells. Super-enhancers were shown to be particularly present for important pluripotency and 
self-renewal genes in ES cells (Whyte et al., 2013). Among the 231 super-enhancer associated 
genes, Brg1, Ep400, Chd4 and Smarcad1 regulate positively a considerable number of such 
genes revealing that these remodelers are important actors in the control of super enhancer 
activity, confirming their importance in the control of the ES cell state. Interestingly, Chd1 
was also required for the proper level of expression of a significant number of genes 
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associated with super enhancer, revealing a new function for this factor. Remarkably, 
depletion of Chd4 caused the downregulation of the two pTFs Oct4 (Pou5f1) and Nanog, 
revealing a function of Chd4 in controlling the expression of major pTFs. Nanog expression 
was also downregulated upon depletion of Chd8. Altogether; this analysis suggests that 
remodelers play an essential function in the maintenance of ES cell fate through the regulation 
of super enhancer function. 
Furthermore, we showed that the set of thirteen remodeling factors also bind architectural 
elements represented by CTCT-binding sites. CTCF is an architectural protein that plays an 
important role in creating boundaries between topologically associating domains in 
chromosomes further facilitating interactions between transcription regulatory sequences such 
as enhancers and promoters (Ong and Corces, 2014). Almost all remodelers were found 
bound at CTCF sites at the exception of Chd1 and Chd9 conferring a probable role of 
remodelers in the definition of chromatin boundaries and in assuring of long-range promoter-
enhancer interactions. Smarca3 was the remodeler that presented the highest binding signal 
intensity. Interestingly, clustering analysis CTCF-binding sites revealed two dominant groups 
with various remodelers binding. Group A showed binding patterns for all remodelers. On the 
other hand, group B showed specific binding for each of Smarca3, Smarca5, Smarcad1 and 
ATRX. Although further investigations will be required to test the importance of remodelers 
in the function of CTCF binding sites, these data suggests the existence of at least two distinct 
functional categories of CTCF-binding sites, based on remodeler distribution pattern. 
 
To conclude, our results create a better understanding of how the various ATP-dependent 
Snf2 chromatin remodeling factors contribute to the transcriptional control of the ES cell 
state. Our future goal is to analyze more profoundly the involvement of the chromatin 
remodelers in the transcriptional regulation of the ES cell genome. To achieve this goal, 
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several experimental approaches are to be considered. First, we would like to concentrate 
more on the effect of the depletion of chromatin remodelers in particular Ep400, Chd4, Brg1 
and Smarcad1 on several transcriptional aspects. CHIP-Exo (Chromatin immunoprecipitation 
followed by exonuclease digestion) will be performed on ES cells depleted for each of the 
factors mentioned above, this will allow the detection of any Polymerase II aberrant binding. 
Furthermore, we will conduct Mnase-seq experiments for the detection of various 
modifications in nucleosome positioning upon remodeler depletion. Second, it will be 
interesting to focus on the role of the less studied chromatin remodelers with potential 
functions in ES cells such as Smarcad1 and Smarca5 using similar approaches as for the first 
series of remodelers.  
In order to understand better how remodelers interfere in the transcriptional regulation during 
development, it will be essential to analyze the distribution and function of the various 
remodelers during ES cell differentiation to create a comparative genomic profile between the 
two cell states and to reveal the new set of remodelers required during differentiation. 
Moreover, analysis of remodeler functions in various types of tissues will be essential to 
understand how such a heterogeneous yet functionally related family of remodelers controls 
the transcription of the mammalian genome. 
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Rapport détaillé en français 
 
Analyse de la fonction des facteurs de remodelage de la chromatine ATP-
dépendants dans le contrôle de l’expression du génome des cellules souches 
embryonnaires 
 
Résumé:  
Les cellules souches embryonnaires (cellules ES) constituent un excellent système modèle 
pour étudier les mécanismes épigénétiques contrôlant la transcription du génome mammifère. 
Un nombre important de membres de la famille des facteurs de remodelage de la chromatine 
ATP-dépendants a une fonction essentielle dans l’auto-renouvèlement des cellules ES, ou au 
cours de leur différentiation. On pense que ces facteurs exercent ces rôles essentiels en 
régulant l’accessibilité à la chromatine au niveau des éléments régulateurs de la transcription, 
en modulant la stabilité et le positionnement des nucléosomes. Dans ce projet, nous avons 
conduit une étude génomique à grande échelle du rôle d’une dizaine des remodeleurs (Chd1, 
Chd2, Chd4, Chd6, Chd8, Chd9, Ep400, Brg1, Smarca3, Smarcad1, Smarca5, ATRX et 
Chd1l) dans les cellules ES. Pour ce faire, une double stratégie expérimentale a été utilisée. 
D’une part, nous avons mené des expériences d’immunoprécipitation de la chromatine suivies 
par un séquençage à haut-débit (ChIP-seq) sur des cellules ES étiquetées pour les différents 
remodeleurs afin  étudier leur distribution sur le génome. D’autre part, nous avons eu recours 
une approche transcriptomique qui implique l’utilisation des cellules déplétées de chaque 
remodeleur par traitement avec des vecteurs shRNA (knockdown). Nous avons établi les 
profils de liaison des remodeleurs sur des éléments régulateurs (promoteurs, enhancers et sites 
CTCF) sur le génome, et montré que ces facteurs occupent toutes les catégories d’éléments 
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régulateurs du génome. La corrélation entre les données ChIP-seq et les données 
transcriptomiques nous a permis d’analyser le rôle des remodeleurs dans les réseaux de 
transcription essentiels des cellules ES.  Nous avons notamment démontré l’importance 
particulière de certains remodeleurs comme Brg1, Chd4, Ep400 et Smarcad1 dans la 
régulation de la transcription dans les cellules ES.  
 
Introduction 
Les cellules souches embryonnaires (cellules ES) de mammifères ont la capacité dauto-
renouveler indéfiniment et de se différencier en tous types cellulaires  du corps, une propriété 
connue comme la pluripotence (Keller, 1995). L’auto-renouvèlement et la pluripotence sont 
principalement contrôlés par une série de facteurs de transcription, qui établissent ensemble 
un réseau de régulation de transcription auto-entretenu. Ce réseau de transcription est contrôlé 
par une série de facteurs de transcription, y compris Oct4 (POU5F1), Sox2 et Nanog 
(Chambers and Smith, 2004; Niwa, 2007; Silva and Smith, 2008) qui constituent le réseau 
central responsable de la conservation de l’état des cellules ES. En outre, d'autres facteurs de 
transcription importants intègrent le réseau de transcription ES tels que ESRRB, Tcfcp2l1, 
Klf4, Klf2, STAT3 et Smad1 (van den Berg et al., 2010a; Pardo et al., 2010a).  Les facteurs 
de transcription STAT3 et Smad1 sont les effecteurs terminaux qui intègrent au réseau de 
transcription les stimuli externes de deux voies majeures de signalisation dans les cellules ES, 
la voie LIF (Leukemia Inhibitory Factor) et la voie TGF (Transformation Growth Factor)  
(Chen et al., 2008; Ying et al., 2003; Zhang et al., 2010).  
 
Les facteurs de transcription sont des protéines qui se lient à l'ADN. Dans le génome des 
cellules ES, ils sont présents au niveau des promoteurs et des éléments régulateurs distaux (les 
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enhancers et les elements liés au CTCF). Ils activent la transcription des gènes nécessaires à la 
conservation du phénotype des cellules ES et répriment les gènes de différenciation. En outre, 
ces facteurs de transcription régulent leurs propres promoteurs formant une boucle 
autorégulatrice qui assure un rétrocontrôle positif nécessaire pour conserver la pluripotence 
des cellules ES. Plusieurs études ont montré que ces facteurs de transcription interagissent  
avec un grand nombre de facteurs de remodelage de la chromatine, y compris plusieurs 
membres de la famille SNF2 de facteurs de remodelage de la chromatine ATP-dépendents 
(aussi appelés les remodeleurs) ) (van den Berg et al., 2010b; Liang et al., 2008a; Pardo et al., 
2010a).  
Plusieurs membres de la famille SNF2 des remodeleurs se sont avérés importants pour l’auto-
renouvèlement et la différenciation des cellules ES (Fazzio et al., 2008; Gaspar-Maia et al., 
2009; Ho et al., 2011; Reynolds et al., 2012a; Wang et al., 2014). 
La famille SNF2 est composée de 24 sous-familles qui partagent un domaine ATPase 
catalytique (Flaus et al., 2006). Ces facteurs sont soupçonnés de jouer un rôle essentiel dans la 
modification du paysage de la chromatine par leur capacité à positionner les nucléosomes et à 
déterminer leur occupation dans l'ensemble du génome ce qui rend la chromatine plus ou 
moins accessible (Clapier and Cairns, 2009; Hargreaves and Crabtree, 2011; Jiang and Pugh, 
2009).  Bien qu’il a été demontré que plusieurs membres de la famille des remodeleurs SNF2 
jouent une fonction essentielle dans le contrôle du phénotype des cellules ES, il n’existe 
jusqu'ici aucune vision globale, comparative de la façon dont ils travaillent ensemble pour 
contrôler le destin des cellules ES. 
 
Contexte du projet 
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Plusieurs études ont montré l'importance d'un certain nombre de facteurs de remodelage de la 
chromatine ATP-dépendants dans le contrôle de l'état des cellules ES et de leur 
différenciation. Cependant, aucune  étude globale de la façon dont ces facteurs sont recrutés 
sur le génome des mammifères n’a été menée. 
Dans ce travail, nous essayons de comprendre le rôle de la famille SNF2 de facteurs de 
remodelage de la chromatine dans la régulation de la transcription du génome des cellules ES 
chez la  souris. Nous étudions la distribution des remodeleurs dans le génome, plus 
précisément, sur les éléments proximaux (promoteurs) et distaux (enhancers et les sites 
CTCF-liés). Ensuite, nous essayons de comprendre la manière dont les remodeleurs sont 
recrutés sur des gènes cibles et comment ils sont impliqués dans l’architecture de 
nucléosomes dans le but de contrôler la transcription des cellules ES. Plus loin, nous 
analysons comment les facteurs de remodelage de la chromatine contribuent aux réseaux de 
transcription qui contrôlent la pluripotence et l’auto-renouvèlement des cellules ES. 
. Dans ce projet, nous avons conduit une étude génomique à grande échelle du rôle d’une 
dizaine des remodeleurs (Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Ep400, Brg1, Smarca3, 
Smarcad1, Smarca5, ATRX et Chd1l) dans le contrôle de la transcription dans  les cellules 
ES. Une double stratégie expérimentale a été utilisée. D’une part, nous avons mené des 
expériences d’immunoprécipitation de la chromatine suivies par un séquençage à haut-débit 
(ChIP-seq) sur des cellules ES étiquetées pour les différents remodeleurs afin  étudier leur 
distribution sur le génome. D’autre part, nous avons eu recours une approche 
transcriptomique qui implique l’utilisation des cellules déplétées de chaque remodeleur par 
traitement avec des vecteurs shRNA (knockdown). 
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Résultats et Discussion 
 
Dans notre étude, nous avons révélé les profils de liaison de treize remodeleurs de la 
chromatine à des  promoteurs des cellules ES. Nous avons montré que presque tous les 
remodeleurs étudiés se lient à différentes intensités aux régions promotrices dans les cellules 
ES. Certains remodeleurs comme Brg1, Chd4, Chd6, Smarca3 et Smarca5 se lient avec un 
niveau similaire à tous les gènes actifs, indépendamment de leur niveau de H3K4me3/ 
transcription, tandis que la liaison d'autres, tels que Chd1, Chd2, Chd9 et EP400, est liée aux 
niveaux H3K4me3 / transcription. 
Les promoteurs dans les cellules ES peuvent être actifs (H3K4me3 seule) ou bivalents 
(H3K4me3 et H3K27me3) (Azuara et al., 2006; Bernstein et al., 2006). Une analyse plus 
approfondie de la liaison de remodeleurs à ces deux types de promoteurs révèle une liaison 
différente entre les remodeleurs. Chd4, Chd6, Smarca5 et Brg1 se  lient aux promoteurs 
bivalents et actifs avec des intensités semblables. Néanmoins, EP400 et Chd8 se lient 
principalement aux promoteurs actifs et présentent des enrichissements sensiblement 
inférieurs aux promoteurs bivalents, mais sont liés à la plupart (> 95%). Chd1 et Chd9 se lient 
principalement aux promoteurs actifs et à des niveaux plus faibles à la moitié des promoteurs 
bivalents. Smarca3 se lie modérément seulement aux promoteurs actifs tandis que Smarcad1 
et ATRX présentent des faibles intensités de liaison à seulement quelques promoteurs actifs. 
 
L’analyse du transcriptome des cellules ES deplétées pour les différents remodeleurs a révélé 
un rôle important pour EP400, Chd4, Brg1 et Smarcad1 dans le contrôle de l'expression des 
gènes des cellules ES. Auparavant, EP400 a été montré comme essentiel dans la conservation 
de l’état des cellules ES (Fazzio et al., 2008). Dans notre étude, nous avons validé cette 
observation. En outre, nous avons fourni une meilleure vision sur la façon dont EP400 
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contrôle l'expression des gènes dans les cellules ES. Nous avons montré que EP400 agit 
comme un activateur des gènes actifs (H3K4me3 seule) et comme un répresseur des gènes 
bivalents de la même façon comme Chd4 et Smarcad1. D'autre part, Brg1 semble avoir plutôt 
un double rôle de répression et d’activation des gènes actifs et un rôle  d'activation au niveau 
des gènes bivalents, ce qui est en concordance avec une observation  démontrée auparavant 
dans des cellules ES (Ho et al., 2009). Brg1 semble contrecarrer l'effet inhibiteur des autres 
facteurs de remodelage sur les gènes bivalents, apparemment pour assurer les  faibles niveaux 
d'expression de ces gènes qui deviennent indispensables lors de la différenciation. 
Contrairement à ce qui a été publié avant, Chd4 surtout connu pour être nécessaire au cours de 
la différenciation des cellules ES en tant que membre du complexe NuRD (Kaji et al., 2006; 
Reynolds et al., 2012b; Sparmann) semble avoir un rôle important aussi dans la conservation de 
l'état des cellules ES.  
Plusieurs études ont démontré l'implication des remodeleurs dans le réseau transcriptionnel 
central de la pluripotence des cellules ES (van den Berg et al., 2010a; Liang et al., 2008b; 
Pardo et al., 2010b). L’analyse des gènes dérégulés dans les cellules ES déplétées pour 
différents remodeleurs a révélé l’implication de  Ep400, Chd4, Brg1, Smarcad1 et Chd1 dans 
le réseau transcriptionnel central des cellules ES, où un nombre important de gènes sont des 
cibles communes avec Oct4/Sox2/Nanog (OSN). Nous avons montré que Ep400 et Chd4 
régulent positivement l'expression des gènes activés par OSN. Smarcad1 et Chd1 agissent 
aussi, mais à un plus faible niveau, comme des co-activateurs de gènes de pluripotence activés 
par OSN. D'autre part, Brg1 semble exercer un double rôle de co-répresseur et co-activateur 
sur ces gènes. Cela démontre que les mécanismes de contrôle de l'état des cellules ES exercés 
par les remodeleurs de la chromatine sont variables. 
Ensuite, nous avons analysé la liaison des différents remodelers à des éléments regulateurs 
distaux (enhancers et site liés au CTCF). Les données de ChIP-seq ont révélé également une 
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grande présence des remodeleurs sur ces éléments dans le génome des cellules ES. Nous 
avons montré que les remodeleurs étudiés se lient aux enhancers canoniques (caractérisés par 
des niveaux d’expression élevés des facteurs OSN) avec des intensités différentes. Les 
signaux de liaison les plus élevés ont été observés pour Chd4, Brg1 et Ep400. Nous avons 
démontré que le génome des cellules ES contient un grand nombre supplémentaire 
d’enhancers liés par des facteurs de remodelage de la chromatine que nous appelons les 
enhancers non-canoniques. Les enhancers non-canoniques diffèrent des enhancers canoniques  
par une plus faible présence d’OSN. Cette observation permet de spéculer que le répertoire 
des séquences régulatrices dans le génome des cellules ES est beaucoup plus grand que prévu. 
Pour aller plus loin, nous avons démontré que les remodeleurs étaient présentes sur les super-
enhancers des cellules ES. Dans les cellules ES, les super-enhancers sont particulièrement 
présentes sur les gènes importants pour la  pluripotence et l’auto-renouvèlement (Whyte et al., 
2013). Parmi les 231 gènes associés auxsuper-enhancers, Brg1, Ep400, Chd4 et Smarcad1 
régulent positivement un nombre considérable de ces gènes. CHD1 a été également nécessaire 
pour le bon niveau d'expression d'un nombre important de gènes associés à des super-
enhacers, révélant une nouvelle fonction de ce facteur. Remarquablement, l'épuisement des 
Chd4 dérégule négativement l’expression des facteurs Oct4 et Nanog, ce qui révèle une 
fonction importante de Chd4 dans le contrôle de l'expression des facteurs de transcription 
majeurs des cellules ES. L’expression de Nanog a également été dérégulée  lors de la 
déplétion de Chd8. En conclusion, cette analyse suggère que les remodeleurs jouent un rôle 
essentiel dans le maintien des cellules ES par la régulation des super-enhancers. 
En plus, nous avons démontré que l'ensemble des treize facteurs de remodelage se lie 
également à des éléments architecturaux représentés par des sites CTCF-liés. CTCF est une 
protéine architecturale qui joue un rôle important dans la création des limites entre les TAD 
(Topologically Associated Domains) et dans la facilitation des interactions entre les séquences 
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régulatrices telles que les enhancers et les promoteurs (Ong and Corces, 2014). Presque tous 
les remodeleurs ont été trouvés liés sur les sites CTCF à l'exception de CHD1 et Chd9, ce qui 
confère aux remodeleurs un rôle probable  dans la définition des TAD et dans l’assurance des 
interactions entre les promoteurs et les enhancers. Smarca3 était le remodeler qui a présenté la 
plus forte intensité de liaison. L’analyse des sites de liaison CTCF analyse ont révélé deux 
groupes dominants liés différemment par les remodeleurs. D’une part, le groupe A est lié par 
tous les remodeleurs de la même manière. D'autre part, le groupe B est lié spécifiquement par 
les remodelerus Smarca3, Smarca5, Smarcad1 et Atrx. Bien que d'autres investigations soient 
nécessaires pour valider l'importance des remodeleurs dans la fonction de sites de liaison 
CTCF, ces données  basées sur la distribution des remodeleurs suggèrent l'existence d'au 
moins deux catégories fonctionnelles distinctes de sites CTCF-liés. 
 
Pour conclure, nos résultats créent une meilleure compréhension de la façon dont les 
différents facteurs SNF2 de remodelage de la chromatine ATP-dépendants contribuent au 
contrôle transcriptionnel associé auu maintien de l'état  des cellules ES. Notre objectif pour 
l'avenir est d'analyser plus profondément l'implication des remodeleurs de la chromatine dans 
la régulation de la transcription du génome des cellules ES. Pour atteindre cet objectif, 
plusieurs approches expérimentales sont à considérer. Tout d'abord, nous tenons à nous 
concentrer davantage sur l'effet de la déplétion des remodeleurs en particulier Ep400, Chd4, 
Brg1 et Smarcad1 sur plusieurs aspects de la transcription. Des expériences ChIP-Exo 
(immunoprécipitation de la chromatine suivie par une digestion exonucléase) seront réalisées 
sur des cellules ES déplétées pour chacun des facteurs mentionnés ci-dessus, ce qui permettra 
la détection de toute présence aberrante de polymérase II. En outre, nous allons mener des 
expériences MNase-seq pour la détection de diverses modifications dans le positionnement 
des nucléosomes lors de la déplétion des remodeleurs. Deuxièmement, il serait intéressant de 
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se concentrer sur le rôle des remodeleurs moins étudiés avec des fonctions potentielles dans 
les cellules ES tels que Smarcad1 et Smarca5 en utilisant des approches similaires. 
Afin de mieux comprendre comment les remodeleurs interfèrent dans la régulation de la 
transcription au cours du développement, il serait essentiel d'analyser la distribution et la 
fonction des divers remodeleurs au cours de la différenciation des cellules ES. Cela aiderait à 
créer un profil génomique comparatif entre les deux états cellulaires et de révéler la nouvelle 
série des remodeleurs nécessaires lors de la différenciation. En outre, l'analyse des fonctions 
des remodeleurs dans divers types de tissus serait essentielle pour mieux comprendre 
comment une telle famille contrôle la transcription du génome des mammifères. 
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